<html><head></head><body vlink="PURPLE" link="BLUE" bgcolor="#FFFFFF"><document>
<type>10-K
<sequence>1
<filename>a2201962z10-k.htm
<description>10-K
<text>




<br>

<p style="font-family:times;text-align:justify"><font size="2">


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> </b></font></p><div style="width:100%;border-top:solid #000000 3.0pt;padding:0in 0in 0in 0in;font-size:3.0pt;"></div><font size="2"><b>
<div style="width:100%;border-top:solid #000000 1.0pt;padding:0in 0in 0in 0in;font-size:4.0pt;"></div>  </b></font><p></p>

<p style="font-family:times;" align="CENTER"><font size="4"><b>UNITED STATES<br>
SECURITIES AND EXCHANGE COMMISSION<br>  </b></font><font size="2"><b>WASHINGTON, D. C. 20549</b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><i>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="25%" ALIGN="CENTER" -->
</i></font></p><hr width="25%" size="1.0PT" noshade="" color="#000000" align="CENTER"><font size="2"><i>


 </i></font><font size="2">

<!-- COMMAND=ADDING_LINEBREAK -->

<br></font><p></p>

<p style="font-family:times;" align="CENTER"><font size="4"><b>FORM 10-K  </b></font></p>
 <div style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="84pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width=""></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="TOP">
<td style="font-family:times;"><font size="2"><b>(MARK ONE)</b></font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2"><b><font face="WINGDINGS">ý</font></b></font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"><b>ANNUAL REPORT PURSUANT TO SECTION&nbsp;13 OR 15(d) OF<br>
THE SECURITIES EXCHANGE ACT OF&nbsp;1934</b></font></td>
</tr>
<tr valign="TOP">
<td colspan="3" style="font-family:times;" align="CENTER"><font size="2"><b> OR</b></font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2"><b><font face="WINGDINGS">o</font></b></font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"><b>TRANSITION REPORT PURSUANT TO SECTION&nbsp;13 OR 15(d) OF<br>
THE SECURITIES EXCHANGE ACT OF&nbsp;1934</b></font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2"><i>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="25%" ALIGN="CENTER" -->
</i></font></p><hr width="25%" size="1.0PT" noshade="" color="#000000" align="CENTER"><font size="2"><i>


  </i></font><font size="2"><b>

<!-- COMMAND=ADDING_LINEBREAK -->

<br>  </b></font><p></p>
 <div style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="48%"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="48%"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<td style="font-family:times;" valign="TOP"><font size="2"><b>For the fiscal year ended December&nbsp;31, 2010</b></font></td>
<td style="font-family:times;" valign="TOP"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="TOP" align="RIGHT"><font size="2"><b>Commission file number&nbsp;1-2189</b></font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;" align="CENTER"><font size="4"><b>Abbott Laboratories  </b></font></p>
 <div style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="48%"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="48%"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="TOP">
<td style="font-family:times;" align="CENTER"><font size="2"><b>An Illinois Corporation</b></font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="CENTER"><font size="2"><b> 36-0698440</b></font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;" align="CENTER"><font size="2"><b>100 Abbott Park Road<br>
Abbott Park, Illinois 60064-6400</b></font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="CENTER"><font size="2"> (I.R.S. employer identification number)<br></font> <font size="2"><b>(847)&nbsp;937-6100<br> </b></font><font size="2">(telephone number)</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2"><b>Securities Registered Pursuant to Section&nbsp;12(b) of the Act:  </b></font></p>
 <div style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="48%"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="48%"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="3" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="CENTER"><font size="1"><b>Title of Each Class</b></font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th style="font-family:times;" align="CENTER"><font size="1"><b>Name of Each Exchange on Which Registered</b></font><br></th>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="3" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="TOP">
<td style="font-family:times;" valign="BOTTOM"><font size="2">Common Shares, Without Par Value<br></font>
</td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> New York Stock Exchange<br>
Chicago Stock Exchange</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="3" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2"><b>Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&nbsp;405 of the Securities Act.  </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b>Yes <font face="WINGDINGS">ý</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No <font face="WINGDINGS">o</font>  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b>Indicate by check mark if the registrant is not required to file reports pursuant to Section&nbsp;13 or 15(d) of the Act.  </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b>Yes <font face="WINGDINGS">o</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No <font face="WINGDINGS">ý</font>  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b>Indicate by check mark whether the registrant (1)&nbsp;has filed all reports required to be filed by Section&nbsp;13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12&nbsp;months (or for such shorter period that the registrant was required to file such reports), and (2)&nbsp;has been subject to such filing
requirements for the past 90&nbsp;days.  </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b>Yes <font face="WINGDINGS">ý</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No <font face="WINGDINGS">o</font>  </b></font></p>


<p style="font-family:times;text-align:justify"><font size="2"><b>Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File
required to be submitted and posted pursuant to Rule&nbsp;405 of Regulation&nbsp;S-T during the preceding 12&nbsp;months (or for such shorter period that the registrant was required
to submit and post such files).  </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b>Yes <font face="WINGDINGS">ý</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No <font face="WINGDINGS">o</font>  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b>Indicate by check mark if disclosure of delinquent filers pursuant to Item&nbsp;405 of Regulation&nbsp;S-K (§229.405 of this
chapter) is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part&nbsp;III of this
Form&nbsp;10-K or any amendment to this Form&nbsp;10-K. <font face="WINGDINGS">o</font>  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b>Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule&nbsp;12b-2 of the Exchange Act.  </b></font></p>
 <div style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="21%"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="21%"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="21%"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="25%"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="TOP">
<td style="font-family:times;"><font size="1">Large Accelerated Filer <font face="WINGDINGS">ý</font></font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="CENTER"><font size="1">Accelerated Filer <font face="WINGDINGS">o</font></font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="CENTER"><font size="1">Non-accelerated Filer <font face="WINGDINGS">o</font></font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">Smaller Reporting Company <font face="WINGDINGS">o</font></font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2"><b>Indicate by check mark whether the registrant is a shell company (as defined in Rule&nbsp;12b-2 of the Act).  </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b>Yes <font face="WINGDINGS">o</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No <font face="WINGDINGS">ý</font>  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b>The aggregate market value of the 1,489,596,595 shares of voting stock held by nonaffiliates of the registrant, computed by reference to the closing price
as reported on the New York Stock Exchange, as of the last business day of Abbott Laboratories' most recently completed second fiscal quarter (June&nbsp;30, 2010), was $69,683,328,714. Abbott has no
non-voting common equity.  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b>Number of common shares outstanding as of January&nbsp;31, 2011: 1,547,581,805  </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> DOCUMENTS INCORPORATED BY REFERENCE  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b>Portions of the 2011 Abbott Laboratories Proxy Statement are incorporated by reference into Part&nbsp;III. The Proxy Statement will be filed on or about
March&nbsp;15, 2011.  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> </b></font></p><div style="width:100%;border-top:solid #000000 1.0pt;padding:0in 0in 0in 0in;font-size:3.0pt;"></div><font size="2"><b>
<div style="width:100%;border-top:solid #000000 3.0pt;padding:0in 0in 0in 0in;font-size:4.0pt;"></div>  </b></font><p></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=1,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=399423,FOLIO='blank',FILE='DISK114:[11ZAD1.11ZAD42901]BA42901A.;7',USER='MBLOUNT',CD='15-FEB-2011;17:07' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_de42901_1_1"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="de42901_part_i"> </a>
<a name="toc_de42901_1"> </a>
<br></font><font size="2"><b>  PART&nbsp;I    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><a name="de42901_item_1._business"> </a>
<a name="toc_de42901_2"> </a></font> <font size="2"><b>  ITEM&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;BUSINESS    <br>    </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="de42901_general_development_of_business"> </a>
<a name="toc_de42901_3"> </a></font> <font size="2"><b>  GENERAL DEVELOPMENT OF BUSINESS    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott Laboratories is an Illinois corporation, incorporated in 1900. Abbott's* principal business is the discovery, development,
manufacture, and sale of a broad and diversified line of health care products. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="de42901_financial_information_relating__fin04050"> </a>
<a name="toc_de42901_4"> </a>
<br></font><font size="2"><b>  FINANCIAL INFORMATION RELATING TO INDUSTRY SEGMENTS, GEOGRAPHIC AREAS, AND<br>  CLASSES OF SIMILAR PRODUCTS    <br>    </b></font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated herein by reference is Note&nbsp;6 entitled "Segment and Geographic Area Information" of the Notes to Consolidated
Financial Statements included under Item&nbsp;8, "Financial Statements and Supplementary Data" and the sales information related to Humira® included in "Financial Review." </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="de42901_narrative_description_of_business"> </a>
<a name="toc_de42901_5"> </a>
<br></font><font size="2"><b>  NARRATIVE DESCRIPTION OF BUSINESS    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott has four reportable revenue segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
February&nbsp;15, 2010, Abbott completed its acquisition of the Solvay Group's pharmaceuticals business for approximately $6.1&nbsp;billion, in cash, plus additional payments of
up to EUR 100&nbsp;million per year if certain sales milestones are met in 2011, 2012, and 2013. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
September&nbsp;8, 2010, Abbott acquired Piramal Healthcare Limited's Healthcare Solutions business, a leader in the Indian branded generics market, for $2.2&nbsp;billion, in cash,
plus additional payments of $400&nbsp;million annually in 2011, 2012, 2013, and 2014. </font></p>


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<hr width="26%" size="1.0PT" noshade="" color="#000000" align="LEFT">


<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">*</font></dt><dd style="font-family:times;text-align:justify"><font size="2">As
used throughout the text of this report on Form&nbsp;10-K, the term "Abbott" refers to Abbott Laboratories, an Illinois corporation, or
Abbott Laboratories and its consolidated subsidiaries, as the context requires. </font></dd></dl>
<p style="font-family:times;" align="CENTER"><font size="2">1</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=2,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=1009671,FOLIO='1',FILE='DISK114:[11ZAD1.11ZAD42901]DE42901A.;17',USER='SLYUBOM',CD='18-FEB-2011;13:37' -->
<a name="page_de42901_1_2"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Pharmaceutical Products  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These products include a broad line of adult and pediatric pharmaceuticals manufactured, marketed, and sold worldwide and are generally
sold directly to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses.
Outside the United States, sales are made either directly to customers or through distributors, depending on the market served. Certain products are co-marketed or co-promoted
with other companies. In April 2010, Abbott acquired the outstanding shares of Facet Biotech Corporation for approximately $430&nbsp;million, in cash, net of cash held by Facet. The acquisition
enhances Abbott's early- and mid-stage pharmaceutical pipeline, including a biologic for multiple sclerosis and compounds that complement Abbott's oncology program. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
principal products included in the Pharmaceutical Products segment are: </font></p>

<ul>
<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Humira®, for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis,
and Crohn's disease;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">TriCor®, Trilipix®, Simcor®, and Niaspan®, for the treatment of
dyslipidemia;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Kaletra®, Aluvia™, and Norvir®, protease inhibitors for the treatment of HIV
infection;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Lupron®, also marketed as Lucrin®, and Lupron Depot®, used for the palliative
treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty, and for the preoperative treatment of patients with anemia caused by uterine fibroids; </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Synagis®, for the treatment and prevention of respiratory syncytial virus (RSV);  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">AndroGel®, for the treatment of adult males who have low or no testosterone;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">the anesthesia products sevoflurane (sold in the United States under the trademark Ultane® and outside of the
United States primarily under the trademark Sevorane® and in a few other markets as Ultane®), isoflurane, and enflurane;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Zemplar®, for the prevention and treatment of secondary hyperparathyroidism associated with chronic kidney
disease and Stage&nbsp;5 treatment;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Synthroid®, for the treatment of hypothyroidism;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">the anti-infective clarithromycin (sold under the trademarks Biaxin®, Klacid®, and
Klaricid®); and  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Creon®, for the treatment of pancreatic exocrine insufficiency associated with several underlying conditions,
including cystic fibrosis and chronic pancreatitis. </font></dd></dl>
</ul>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Pharmaceutical Products segment directs its primary marketing efforts toward securing the prescription, or recommendation of Abbott's brand of products by physicians. Managed care
providers (for example, health maintenance organizations and pharmacy benefit managers) and state and federal governments and agencies (for example, the United States Department of Veterans Affairs
and the United States Department of Defense) are also important customers. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Competition
in the Pharmaceutical Products segment is generally from other health care and pharmaceutical companies. The search for technological innovations in pharmaceutical products
is a significant aspect of competition in this segment. The introduction of new products by competitors and changes in medical practices and procedures can result in product obsolescence in the
Pharmaceutical Products segment. Price can also be a factor. In addition, the substitution of generic drugs for the brand prescribed has increased competitive pressures on pharmaceutical products that
are off-patent. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">2</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=2,SEQ=3,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=58474,FOLIO='2',FILE='DISK114:[11ZAD1.11ZAD42901]DE42901A.;17',USER='SLYUBOM',CD='18-FEB-2011;13:37' -->
<a name="page_de42901_1_3"> </a>


<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Diagnostic Products  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These products include a broad line of diagnostic systems and tests manufactured, marketed, and sold worldwide to blood banks,
hospitals, commercial laboratories, clinics, physicians' offices, government agencies, alternate-care testing sites, and plasma protein therapeutic companies. The segment's products are
generally marketed and sold directly from Abbott-owned distribution centers and public warehouses and third-party distributors. Outside the United States, sales are made either directly to customers
or through distributors, depending on the market served. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
principal products included in the Diagnostic Products segment are: </font></p>

<ul>
<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">immunoassay systems, including ARCHITECT®, AxSYM®, and ABBOTT PRISM®; </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">chemistry systems such as ARCHITECT® c4000®, c8000®, and c16000®; </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">assays used for screening and/or diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility,
physiological diseases, and infectious diseases such as hepatitis and HIV;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">the m2000™, an instrument that automates the extraction, purification, and preparation of DNA and RNA from
patient samples and detects and measures infectious agents including HIV, HBV, HCV, HPV, and CT/NG;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">the Vysis® product line of genomic-based tests, including the PathVysion® HER-2 DNA
probe kit and the UroVysion® bladder cancer recurrence kit;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">a full line of hematology systems and reagents known as the Cell-Dyn® series; and </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">the i-STAT® point-of-care diagnostic systems and tests for blood analysis. </font></dd></dl>
</ul>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, under a distribution agreement with Celera Group, the Diagnostic Products segment exclusively distributes certain Celera molecular diagnostic products, including the
ViroSeq® HIV genotyping system and products used for the detection of mutations in the CFTR gene, which causes cystic fibrosis. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Diagnostic Products segment's products are subject to competition in technological innovation, price, convenience of use, service, instrument warranty provisions, product
performance, long-term supply contracts, and product potential for overall cost-effectiveness and productivity gains. Some products in this segment can be subject to rapid
product obsolescence or regulatory changes. Although Abbott has benefited from technological advantages of certain of its current products, these advantages may be reduced or eliminated as competitors
introduce new products. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Nutritional Products  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These products include a broad line of pediatric and adult nutritional products manufactured, marketed, and sold worldwide. These
products are generally marketed and sold to institutions, wholesalers, retailers, health care facilities, government agencies, and third-party distributors from Abbott-owned distribution centers or
third-party distributors. Outside the United States, sales are made either directly to customers or through distributors, depending on the market served. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Principal
products in the Nutritional Products segment include: </font></p>

<ul>
<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">various forms of prepared infant formula and follow-on formula, including
Similac®Advance®, Similac Advance EarlyShield®, Similac®, Similac® with Iron, Similac Sensitive®, Similac Sensitive®
RS, Similac Go&amp;Grow®, Similac® NeoSure®, Similac® Organic, Similac® Special Care®, Isomil® Advance®,
Isomil®, Alimentum®, Gain™, and Grow™; </font></dd></dl>
</ul>
<p style="font-family:times;" align="CENTER"><font size="2">3</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=3,SEQ=4,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=626698,FOLIO='3',FILE='DISK114:[11ZAD1.11ZAD42901]DE42901A.;17',USER='SLYUBOM',CD='18-FEB-2011;13:37' -->
<a name="page_de42901_1_4"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<ul>
<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">adult and other pediatric nutritional products, including Ensure®, Ensure Plus®,
Ensure® Muscle Health, Glucerna®, ProSure™, PediaSure®, PediaSure Sidekicks®, EleCare®, Juven®, Abound™,
and Pedialyte®;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">nutritional products used in enteral feeding in health care institutions, including Jevity®,
Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Osmolite®, Oxepa®, and Nepro®; and  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Zone Perfect® bars and the EAS® family of nutritional brands, including Myoplex® and
AdvantEdge®. </font></dd></dl>
</ul>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primary
marketing efforts for nutritional products are directed toward securing the recommendation of Abbott's brand of products by physicians or other health care professionals. In
addition, certain nutritional products sold as Gain™, Grow™, PediaSure®, PediaSure Sidekicks®, Pedialyte®, Ensure®, Zone
Perfect®, EAS®/Myoplex®, and Glucerna® are also promoted directly to the public by consumer marketing efforts in select markets. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Competition
for nutritional products in the segment is generally from other diversified consumer and health care manufacturers. Competitive factors include consumer advertising,
formulation, packaging, scientific innovation, intellectual property, price, and availability of product forms. A significant aspect of competition is the search for ingredient innovations. The
introduction of new products by competitors, changes in medical practices and procedures, and regulatory changes can result in product obsolescence. In addition, private label and local manufacturers'
products may increase competitive pressure. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Vascular Products  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These products include a broad line of coronary, endovascular, vessel closure, and structural heart devices for the treatment of
vascular disease manufactured, marketed and sold worldwide. The segment's products are generally marketed and sold directly to hospitals from
Abbott-owned distribution centers and public warehouses. Outside the United States, sales are made either directly to customers or through distributors, depending on the market served. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
principal products included in the Vascular Products segment are: </font></p>

<ul>
<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Xience Prime™ and Xience V® drug-eluting stent systems developed on the
Multi-Link Vision® platform;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Multi-Link 8™, Multi-Link Vision® and Multi-Link Mini
Vision® coronary metallic stents;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">TREK® and Voyager® balloon dilatation products;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Hi-Torque Balance Middleweight Elite™ and Asahi® coronary guidewires; </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">StarClose® and Perclose® vessel closure devices;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Acculink®/Accunet® and Xact®/Emboshield NAV<sup>6</sup>® carotid stent
systems;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">MitraClip®, a percutaneous valve repair system; and  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">ABSORB™, a drug eluting bioresorbable vascular scaffold. </font></dd></dl>
</ul>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Vascular Products segment's products are subject to competition in technological innovation, price, convenience of use, service, product performance, long-term supply
contracts, and product potential for overall cost-effectiveness and productivity gains. Some products in this segment can be subject to rapid product obsolescence or regulatory changes.
Although Abbott has benefited from technological advantages of certain of its current products, these advantages may be reduced or eliminated as competitors introduce new products. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">4</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=4,SEQ=5,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=775967,FOLIO='4',FILE='DISK114:[11ZAD1.11ZAD42901]DE42901A.;17',USER='SLYUBOM',CD='18-FEB-2011;13:37' -->
<a name="page_de42901_1_5"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Other Products  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The principal products in Abbott's other businesses include blood glucose monitoring meters, test strips, data management software and
accessories for people with diabetes, including the FreeStyle® product line, and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry
eye products. These products are mostly marketed worldwide and generally sold directly to wholesalers, government agencies, health care facilities, mail order pharmacies, and independent retailers
from Abbott-owned distribution centers and public warehouses. Some of these products are marketed and distributed through distributors. Blood glucose monitoring meters, contact lens care products, and
dry eye products are also marketed and sold over-the-counter to consumers. These products are subject to competition in technological innovation, price, convenience of use,
service, and product performance. Medical devices for the eye also can be subject to rapid product obsolescence or regulatory changes. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="de42901_information_with_respe__de402347"> </a>
<a name="toc_de42901_6"> </a>
<br></font><font size="2"><b>  INFORMATION WITH RESPECT TO ABBOTT'S BUSINESS IN GENERAL    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Sources and Availability of Raw Materials  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott purchases, in the ordinary course of business, raw materials and supplies essential to Abbott's operations from numerous
suppliers in the United States and abroad. There have been no recent significant availability problems or supply shortages. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Patents, Trademarks, and Licenses  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott is aware of the desirability for patent and trademark protection for its products. Accordingly, where possible, patents and
trademarks are sought and obtained for Abbott's products in the United States and all countries of major marketing interest to Abbott. Abbott owns and is licensed under a substantial number of patents
and patent applications. Principal trademarks and the products they cover are discussed in the Narrative Description of Business on pages&nbsp;1 through&nbsp;5. These, and various patents which
expire during the period 2011 to 2030, in the aggregate are believed to be of material importance in the operation of Abbott's business. Abbott believes that no single patent, license, trademark (or
related group of patents, licenses, or trademarks), except for those related to adalimumab (which is sold under the trademark Humira®), are material in relation to Abbott's business as a
whole. The United States composition of matter (that is, compound) patents covering adalimumab will expire in December 2016. In addition, the following patents, licenses, and trademarks are
significant for Abbott's Pharmaceutical Products segment: those related to lopinavir/ritonavir (which is sold under the trademarks Kaletra® and Aluvia™), those related to
fenofibrate (which is sold under the trademarks TriCor® and Trilipix®), and those related to niacin (which is sold under the trademarks Niaspan® and
Simcor®). The United States composition of matter patent covering lopinavir will expire in 2016. The United States non-composition of matter patent covering lopinavir/ritonavir
will expire in 2016. The principal United States non-composition of matter patents covering the fenofibrate products will expire in 2011, 2018, 2020, 2023, and 2025. The principal United
States non-composition of matter patents covering the niacin products will expire in 2013, 2017, and 2018. Litigation related to the products listed above is discussed in Legal Proceedings
on pages&nbsp;16 through&nbsp;20. Agreements that may affect exclusivity are discussed in Item&nbsp;7, "Management's Discussion and Analysis of Financial Condition and Results of
Operations&nbsp;— Results of Operations" on pages&nbsp;34 through 35. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although
the expiration of a composition of matter patent may lead to increased competition, in most cases Abbott owns or has a license to other patents that expire after the composition
of matter patent related to particular formulations, uses, or processes for manufacturing the pharmaceutical. These non-composition of matter patents and Abbott's other intellectual
property, along with such other factors as a competitor's need to obtain regulatory approvals prior to marketing a competitive product and the nature of the market, may allow Abbott to continue to
have commercial advantages after the expiration of the composition of matter patent, including in some instances exclusivity. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">5</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=5,SEQ=6,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=292470,FOLIO='5',FILE='DISK114:[11ZAD1.11ZAD42901]DE42901A.;17',USER='SLYUBOM',CD='18-FEB-2011;13:37' -->
<a name="page_de42901_1_6"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Seasonal Aspects, Customers, Backlog, and Renegotiation  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There are no significant seasonal aspects to Abbott's business. Abbott has no single customer that, if the customer were lost, would
have a material adverse effect on Abbott. Orders for Abbott's products are generally filled on a current basis, and order backlog is not material to Abbott's business. No material portion of Abbott's
business is subject to renegotiation of profits or termination of contracts at the election of the government. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Research and Development  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott spent $3,724,424,000 in 2010, $2,743,733,000 in 2009, and $2,688,811,000 in 2008, on research to discover and develop new
products and processes and to improve existing products and processes. The majority of research and development expenditures is concentrated on pharmaceutical products. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Environmental Matters  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott believes that its operations comply in all material respects with applicable laws and regulations concerning environmental
protection. Regulations under federal and state environmental laws impose stringent limitations on emissions and discharges to the environment from various manufacturing operations. Abbott's capital
and operating expenditures for pollution control in 2010 were approximately $9&nbsp;million and $65&nbsp;million, respectively. Capital and operating expenditures for pollution control in 2011 are
estimated to be $15&nbsp;million and $67&nbsp;million, respectively. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott
has been identified as one of many potentially responsible parties in investigations and/or remediations at several locations in the United States, including Puerto Rico, under
the Comprehensive Environmental Response, Compensation, and Liability Act, commonly known as Superfund. Abbott is also engaged in remediation at several other sites, some of which are owned by Abbott,
in cooperation
with the Environmental Protection Agency (EPA) or similar agencies. While it is not feasible to predict with certainty the final costs related to those investigations and remediation activities,
Abbott believes that such costs, together with other expenditures to maintain compliance with applicable laws and regulations concerning environmental protection, should not have a material adverse
effect on Abbott's financial position, cash flows, or results of operations. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Employees  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott employed approximately 90,000 persons as of December&nbsp;31, 2010. </font></p>


<p style="font-family:times;text-align:justify"><font size="2"><b> Regulation  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The development, manufacture, sale, and distribution of Abbott's products are subject to comprehensive government regulation.
Government regulation by various federal, state, and local agencies, both domestic and international, which includes detailed inspection of, and controls over, research and laboratory procedures,
clinical investigations, product approvals and manufacturing, marketing and promotion, sampling, distribution, record keeping, storage, and disposal practices, and achieving compliance with these
regulations, substantially increases the time, difficulty, and costs incurred in obtaining and maintaining the approval to market newly developed and existing products. Government regulatory actions
can result in delay in the release of products, seizure or recall of products, suspension or revocation of the authority necessary for their production and sale, and other civil or criminal sanctions,
including fines and penalties. Governmental administrative agencies also can invalidate intellectual property rights and control the entrance of multi-source drugs for small molecule and biologic
generic medicines. In addition, governmental regulatory agencies require prescription drug, nutrition, and medical device manufacturers to pay fees, such as application, product, user, and
establishment fees or taxes. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott
is a party to a consent decree entered in 1999 that requires Abbott to ensure its diagnostics manufacturing processes in Lake County, Illinois conform to the U.S. Food and Drug
Administration's </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">6</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=6,SEQ=7,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=849201,FOLIO='6',FILE='DISK114:[11ZAD1.11ZAD42901]DE42901A.;17',USER='SLYUBOM',CD='18-FEB-2011;13:37' -->
<a name="page_de42901_1_7"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">(FDA)
Quality System Regulation and restricts the sale in the United States of certain products in the Diagnostic Products segment. In 2003, the FDA concluded that those operations were in substantial
conformity with the Quality System Regulation. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;International
operations are also subject to a significant degree of government regulation and country-specific rules and regulations. Many countries, directly or indirectly, through
reimbursement, payment, pricing, or coverage limitations, control the selling price of most health care products. Furthermore, many countries limit the importation of raw materials and finished
products. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing
studies of the utilization, safety, efficacy, and outcomes of health care products and their components are being conducted by industry, government agencies, and others. Such
studies, which employ increasingly sophisticated methods and techniques, can call into question the utilization, safety, and efficacy of previously marketed products and in some cases have resulted,
and may in the future result, in the discontinuance of marketing of such products and may give rise to claims for damages from persons who believe they have been injured as a result of their use. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Access
to and the cost of human health care products continues to be a subject of investigation and action by governmental agencies, legislative bodies, and private organizations in the
United States and other countries. In the United States, most states have generic substitution legislation requiring or permitting a dispensing pharmacist to substitute a different manufacturer's
version of a pharmaceutical product for the one prescribed. In addition, the federal government follows a diagnosis-related group (DRG) payment system for certain institutional services provided under
Medicare or Medicaid and has implemented a prospective payment system (PPS) for services delivered in hospital outpatient, nursing home, and home health settings. DRG and PPS entitle a health care
facility to a fixed reimbursement based on the diagnosis and/or procedure rather than actual costs incurred in patient treatment, thereby increasing the incentive for the facility to limit or control
expenditures for many health care products. Medicare enters into contracts with private plans to negotiate prices for medicine delivered under Part&nbsp;D and beginning in 2011 companies must
provide a discount of 50&nbsp;percent for branded prescription drugs sold to patients who fall into the Medicare Part&nbsp;D coverage gap. Medicare is implementing a competitive bidding system for
durable medical equipment, enteral nutrition products, and supplies. Under federal law, manufacturers must pay certain statutorily-prescribed rebates to state Medicaid programs on prescription drugs
reimbursed under state Medicaid plans. In addition, a majority of states are seeking additional rebates. The Veterans Health Care Act of 1992 requires manufacturers to extend additional discounts on
pharmaceutical products to various federal agencies, including the Department of Veterans Affairs, Department of Defense, Public Health Service entities and institutions, as well as certain other
covered entities. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the United States, governmental cost containment efforts have extended to the federally funded Special Supplemental Nutrition Program for Women, Infants, and Children (WIC). All
states are mandated to have in place a cost containment program for infant formula. As a result, states obtain rebates from manufacturers of infant formula whose products are used in the program
through competitive bidding. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott
expects debate to continue during 2011 at all government levels over marketing, availability, method of delivery, and payment for health care products and services. Abbott
believes that legislation could change access to health care products and services, increase rebates, reduce prices or the rate of price increases for health care products and services, make changes
to health care delivery systems, create new fees and obligations for the pharmaceutical, nutrition, and medical device industries, or require additional reporting and disclosure. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Efforts
to reduce health care costs are also being made in the private sector. Health care providers have responded by instituting various cost reduction and containment measures. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It
is not possible to predict the extent to which Abbott or the health care industry in general might be affected by the matters discussed above. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">7</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=7,SEQ=8,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=108855,FOLIO='7',FILE='DISK114:[11ZAD1.11ZAD42901]DE42901A.;17',USER='SLYUBOM',CD='18-FEB-2011;13:37' -->
<a name="page_de42901_1_8"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="de42901_international_operations"> </a>
<a name="toc_de42901_7"> </a>
<br></font><font size="2"><b>  INTERNATIONAL OPERATIONS    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott markets products worldwide through affiliates and distributors. Most of the products discussed in the preceding sections of this
report are also sold outside the United States. In addition, certain products of a local nature and variations of product lines to meet local regulatory requirements and marketing preferences are
manufactured and marketed to customers outside the United States. International operations are subject to certain additional risks inherent in conducting business outside the United States, including
price and currency exchange controls, changes in currency exchange rates, limitations on foreign participation in local enterprises, expropriation, nationalization, and other governmental action. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="de42901_internet_information"> </a>
<a name="toc_de42901_8"> </a>
<br></font><font size="2"><b>  INTERNET INFORMATION    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Copies of Abbott's Annual Report on Form&nbsp;10-K, Quarterly Reports on Form&nbsp;10-Q, Current Reports on
Form&nbsp;8-K, and amendments to those reports filed or furnished pursuant to Section&nbsp;13(a) or 15(d) of the Securities Exchange Act of 1934 are available free of charge through
Abbott's investor relations website </font><font size="2"><i>(www.abbottinvestor.com)</i></font><font size="2"> as soon as reasonably practicable after Abbott electronically files the material with, or
furnishes it to, the Securities and Exchange Commission. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott's
corporate governance guidelines, outline of directorship qualifications, code of business conduct and the charters of Abbott's audit committee, compensation committee,
nominations and
governance committee, and public policy committee are all available on Abbott's investor relations website </font><font size="2"><i>(www.abbottinvestor.com)</i></font><font size="2">. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">8</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=8,SEQ=9,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=667514,FOLIO='8',FILE='DISK114:[11ZAD1.11ZAD42901]DE42901A.;17',USER='SLYUBOM',CD='18-FEB-2011;13:37' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_dg42901_1_9"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->



<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><a name="dg42901_item_1a._risk_factors"> </a>
<a name="toc_dg42901_1"> </a></font> <font size="2"><b>  ITEM 1A.&nbsp;&nbsp;&nbsp;&nbsp;RISK FACTORS    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition to the other information in this report, the following risk factors should be considered before deciding to invest in any
of Abbott's securities. Additional risks and uncertainties not presently known to Abbott, or risks Abbott currently considers immaterial, could also affect Abbott's actual results. Abbott's business,
financial condition, results of operations, or prospects could be materially adversely affected by any of these risks. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b>Abbott may acquire other businesses, license rights to technologies or products, form alliances, or dispose of or spin-off businesses,
which could cause it to incur significant expenses and could negatively affect profitability.  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott may pursue acquisitions, technology licensing arrangements, and strategic alliances, or dispose of or spin-off some
of its businesses, as part of its business strategy. Abbott may not complete these transactions in a timely manner, on a cost-effective basis, or at all, and may not realize the expected
benefits. If Abbott is successful in making an acquisition, the products and technologies that are acquired may not be successful or may require significantly greater resources and investments than
originally anticipated. Abbott may not be able to integrate acquisitions successfully into its existing business and could incur or assume significant debt and unknown or contingent liabilities.
Abbott could also experience negative effects on its reported results of operations from acquisition or disposition-related charges, amortization of expenses related to intangibles and charges for
impairment of long-term assets. These effects could cause a deterioration of Abbott's credit rating and result in increased borrowing costs and interest expense. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b>The expiration or loss of patent protection and licenses may affect Abbott's future revenues and operating income.  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Many of Abbott's businesses rely on patent and trademark and other intellectual property protection. Although most of the challenges to
Abbott's intellectual property have come from other businesses, governments may also challenge intellectual property protections. To the extent Abbott's intellectual property is successfully
challenged, invalidated, or circumvented or to the extent it does not allow Abbott to compete effectively, Abbott's business will suffer. To the extent that countries do not enforce Abbott's
intellectual property rights or to the extent that countries require compulsory licensing of its intellectual property, Abbott's future revenues and operating income will be reduced. Abbott's
principal patents and trademarks are described in greater detail in the sections captioned, "Patents, Trademarks, and Licenses" and "Financial Review," and litigation regarding these patents is
described in the section captioned "Legal Proceedings." </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott
faces increasing competition from lower-cost generic products. The expiration or loss of patent protection for a product typically is followed promptly by generic
substitutes that may significantly reduce Abbott's sales for that product in a short amount of time. If Abbott's competitive position is compromised because of generics or otherwise, it could have a
material adverse effect on its revenues, margins, business, and results of operations. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b>Competitors' intellectual property may prevent Abbott from selling its products or have a material adverse effect on Abbott's future profitability
and financial condition.  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Competitors may claim that an Abbott product infringes upon their intellectual property. Resolving an intellectual property
infringement claim can be costly and time consuming and may require Abbott to enter into license agreements. Abbott cannot guarantee that it would be able to obtain license agreements on commercially
reasonable terms. A successful claim of patent or other intellectual property infringement could subject Abbott to significant damages or an injunction preventing the manufacture, sale or use of </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">9</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=10,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=693272,FOLIO='9',FILE='DISK114:[11ZAD1.11ZAD42901]DG42901A.;11',USER='VSTEFAN',CD='14-FEB-2011;04:11' -->
<a name="page_dg42901_1_10"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">affected
Abbott products. Any of these events could have a material adverse effect on Abbott's profitability and financial condition. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b>Abbott is subject to cost-containment efforts that could cause a reduction in future revenues and operating income.  </b></font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the United States and other countries, Abbott's businesses have experienced downward pressure on product pricing.
Cost-containment efforts by governments and private organizations are described in greater detail in the section captioned "Regulation." To the extent these cost containment efforts are
not offset by greater patient access to healthcare or other factors, Abbott's future revenues and operating income will be reduced. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b>Abbott is subject to numerous governmental regulations and it can be costly to comply with these regulations and to develop compliant products and
processes.  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott's products are subject to rigorous regulation by the U.S. Food and Drug Administration, and numerous international,
supranational, federal, and state authorities. The process of obtaining regulatory approvals to market a drug or medical device can be costly and time-consuming, and approvals might not be
granted for future products, or additional indications or uses of existing products, on a timely basis, if at all. Delays in the receipt of, or failure to obtain approvals for, future products, or new
indications and uses, could result in delayed realization of product revenues, reduction in revenues, and in substantial additional costs. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, no assurance can be given that Abbott will remain in compliance with applicable FDA and other regulatory requirements once clearance or approval has been obtained for a
product. These
requirements include, among other things, regulations regarding manufacturing practices, product labeling, and advertising and postmarketing reporting, including adverse event reports and field alerts
due to manufacturing quality concerns. Many of Abbott's facilities and procedures and those of Abbott's suppliers are subject to ongoing regulation, including periodic inspection by the FDA and other
regulatory authorities. Abbott must incur expense and spend time and effort to ensure compliance with these complex regulations. Possible regulatory actions could include warning letters, fines,
damages, injunctions, civil penalties, recalls, seizures of Abbott's products, and criminal prosecution. These actions could result in, among other things, substantial modifications to Abbott's
business practices and operations; refunds, recalls, or seizures of Abbott's products; a total or partial shutdown of production in one or more of Abbott's facilities while Abbott or Abbott's
suppliers remedy the alleged violation; the inability to obtain future pre-market clearances or approvals; and withdrawals or suspensions of current products from the market. Any of these
events could disrupt Abbott's business and have a material adverse effect on Abbott's revenues, profitability and financial condition. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b>Laws and regulations affecting government benefit programs could impose new obligations on Abbott, require Abbott to change its business practices,
and restrict its operations in the future.  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott's industry is also subject to various federal, state, and international laws and regulations pertaining to government benefit
program reimbursement, price reporting and regulation, and health care fraud and abuse, including anti-kickback and false claims laws, the Medicaid Rebate Statute, the Veterans Health Care
Act, and individual state laws relating to pricing and sales and marketing practices. Violations of these laws may be punishable by criminal and/or civil sanctions, including, in some instances,
substantial fines, imprisonment, and exclusion from participation in federal and state health care programs, including Medicare, Medicaid, and Veterans Administration health programs. These laws and
regulations are broad in scope and they are subject to evolving interpretations, which could require Abbott to incur substantial costs associated with compliance or to alter one or more of its sales
or marketing practices. In addition, violations of these laws, or allegations of such violations, could disrupt Abbott's business and result in a material adverse effect on Abbott's revenues,
profitability, and financial condition. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">10</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=2,SEQ=11,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=432081,FOLIO='10',FILE='DISK114:[11ZAD1.11ZAD42901]DG42901A.;11',USER='VSTEFAN',CD='14-FEB-2011;04:11' -->
<a name="page_dg42901_1_11"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2"><b>Changes in the health care regulatory environment may adversely affect Abbott's business.  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 were signed into law on
March&nbsp;23, 2010 and March&nbsp;30, 2010, respectively. A number of the provisions of those laws require further rulemaking action by governmental agencies to implement. The laws change access
to health care products and services and
create new fees for the pharmaceutical and medical device industries. Future rulemaking could increase rebates, reduce prices or the rate of price increases for health care products and services, or
require additional reporting and disclosure. Abbott cannot predict the timing or impact of any future rulemaking. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b>Abbott's research and development efforts may not succeed in developing commercially successful products and technologies, which may cause Abbott's
revenue and profitability to decline.  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To remain competitive, Abbott must continue to launch new products and technologies. To accomplish this, Abbott commits substantial
efforts, funds, and other resources to research and development. A high rate of failure is inherent in the research and development of new products and technologies. Abbott must make ongoing
substantial expenditures without any assurance that its efforts will be commercially successful. Failure can occur at any point in the process, including after significant funds have been invested. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Promising
new product candidates may fail to reach the market or may only have limited commercial success because of efficacy or safety concerns, failure to achieve positive clinical
outcomes, inability to obtain necessary regulatory approvals, limited scope of approved uses, excessive costs to manufacture, the failure to establish or maintain intellectual property rights, or
infringement of the intellectual property rights of others. Even if Abbott successfully develops new products or enhancements or new generations of Abbott's existing products, they may be quickly
rendered obsolete by changing customer preferences, changing industry standards, or competitors' innovations. Innovations may not be accepted quickly in the marketplace because of, among other things,
entrenched patterns of clinical practice or uncertainty over third-party reimbursement. Abbott cannot state with certainty when or whether any of its products under development will be launched,
whether it will be able to develop, license, or otherwise acquire compounds or products, or whether any products will be commercially successful. Failure to launch successful new products or new
indications for existing products may cause Abbott's products to become obsolete, causing Abbott's revenues and operating results to suffer. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b>New products and technological advances by Abbott's competitors may negatively affect Abbott's results of operations.  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott's products face intense competition from its competitors' products. Competitors' products may be safer, more effective, more
effectively marketed or sold, or have lower prices or superior performance features than Abbott's products. Abbott cannot predict with certainty the timing or impact of the introduction of
competitors' products. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b>The manufacture of many of Abbott's products is a highly exacting and complex process, and if Abbott or one of its suppliers encounters problems
manufacturing products, Abbott's business could suffer.  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The manufacture of many of Abbott's products is a highly exacting and complex process, due in part to strict regulatory requirements.
Problems may arise during manufacturing for a variety of reasons, including equipment malfunction, failure to follow specific protocols and procedures, problems with raw materials, natural disasters,
and environmental factors. In addition, single suppliers are currently used for certain products and materials. If problems arise during the production of a batch of product, that batch of product may
have to be discarded. This could, among other things, lead to increased costs, lost revenue, damage to customer relations, time and expense spent investigating the cause and, depending on the cause,
similar losses with respect to other batches or products. If problems are not discovered before the product </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">11</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=3,SEQ=12,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=832911,FOLIO='11',FILE='DISK114:[11ZAD1.11ZAD42901]DG42901A.;11',USER='VSTEFAN',CD='14-FEB-2011;04:11' -->
<a name="page_dg42901_1_12"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">is
released to the market, recall and product liability costs may also be incurred. To the extent Abbott or one of its suppliers experiences significant manufacturing problems, this could have a
material adverse effect on Abbott's revenues and profitability. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b>Significant safety issues could arise for Abbott's products, which could have a material adverse effect on Abbott's revenues and financial condition.  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All health care products receive regulatory approval based on data obtained in controlled clinical trials of limited duration.
Following regulatory approval, these products will be used over longer periods of time in many patients. Investigators may also conduct additional, and perhaps more extensive, studies. If new safety
issues are reported, Abbott may be required to amend the conditions of use for a product. For example, Abbott may be required to provide additional warnings on a product's label or narrow its approved
indication, either of which could reduce the product's market acceptance. If serious safety issues with an Abbott product arise, sales of the product could be halted by Abbott or by regulatory
authorities. Safety issues affecting suppliers' or competitors' products also may reduce the market acceptance of Abbott's products. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, in the ordinary course of business, Abbott is the subject of product liability claims and lawsuits alleging that its products or the products of other companies that Abbott
promotes have resulted or could result in an unsafe condition for or injury to patients. Product liability claims and lawsuits and safety alerts or product recalls, regardless of their ultimate
outcome, may have a material adverse effect on Abbott's business and reputation and on Abbott's ability to attract and retain customers. Consequences may also include additional costs, a decrease in
market share for the products, lower income or exposure to other claims. Product liability losses are generally self-insured. Product liability claims could have a material adverse effect
on Abbott's profitability and financial condition. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b>The international nature of Abbott's business subjects it to additional business risks that may cause its revenue and profitability to decline.  </b></font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott's business is subject to risks associated with doing business internationally. Sales outside of the United States make up
approximately 55% of Abbott's net sales. The risks associated with Abbott's operations outside the United States include: </font></p>

<ul>
<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">changes in foreign medical reimbursement policies and programs;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">multiple foreign regulatory requirements that are subject to change and that could restrict Abbott's ability to
manufacture, market, and sell its products;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">differing local product preferences and product requirements;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">trade protection measures and import or export licensing requirements;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">difficulty in establishing, staffing, and managing foreign operations;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">differing labor regulations;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">potentially negative consequences from changes in or interpretations of tax laws;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">political and economic instability;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">price and currency exchange controls, limitations on foreign participation in local enterprises, expropriation,
nationalization, and other governmental action;  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">inflation, recession and fluctuations in foreign currency exchange and interest rates; and  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">compulsory licensing or diminished protection of intellectual property. </font></dd></dl>
</ul>
<p style="font-family:times;" align="CENTER"><font size="2">12</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=4,SEQ=13,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=589927,FOLIO='12',FILE='DISK114:[11ZAD1.11ZAD42901]DG42901A.;11',USER='VSTEFAN',CD='14-FEB-2011;04:11' -->
<a name="page_dg42901_1_13"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>


<p style="font-family:times;text-align:justify"><font size="2">These
risks may, individually or in the aggregate, have a material adverse effect on Abbott's revenues and profitability. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b>Other factors can have a material adverse effect on Abbott's future profitability and financial condition.  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Many other factors can affect Abbott's profitability and its financial condition, including: </font></p>

<ul>
<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Differences between the fair value measurement of assets and liabilities and their actual value, particularly for
pensions, retiree health care, stock compensation, intangibles, and goodwill; and for contingent liabilities such as litigation, the absence of a recorded amount, or an amount recorded at the minimum,
compared to the actual amount.  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Changes in or interpretations of laws and regulations including changes in accounting standards, taxation requirements,
product marketing application standards, and environmental laws in domestic or foreign jurisdictions.  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Changes in the rate of inflation (including the cost of raw materials, commodities, and supplies), interest rates, market
value of Abbott's equity investments, and the performance of investments held by Abbott or Abbott's employee benefit trusts.  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Changes in the creditworthiness of counterparties that transact business with or provide services to Abbott or Abbott's
employee benefit trusts.  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Changes in business, economic, and political conditions, including: war, political instability, terrorist attacks in the
U.S. and other parts of the world, the threat of future terrorist activity in the U.S. and other parts of the world and related military action; natural disasters; the cost and availability of
insurance due to any of the foregoing events; labor disputes, strikes, slow-downs, or other forms of labor or union activity; and pressure from third-party interest groups. </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Changes in Abbott's business units and investments and changes in the relative and absolute contribution of each to
earnings and cash flow resulting from evolving business strategies, changing product mix, changes in tax laws or tax rates both in the U.S. and abroad and opportunities existing now or in the future. </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Changes in the buying patterns of a major distributor, retailer, or wholesale customer resulting from buyer purchasing
decisions, pricing, seasonality, or other factors, or other problems with licensors, suppliers, distributors, and business partners.  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Difficulties related to Abbott's information technology systems, any of which could adversely affect business operations,
including any significant breakdown, invasion, destruction, loss of data privacy, or interruption of these systems.  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Changes in credit markets impacting Abbott's ability to obtain financing for its business operations. </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Legal difficulties, any of which could preclude or delay commercialization of products or adversely affect profitability,
including claims asserting statutory or regulatory violations, adverse litigation decisions, and issues regarding compliance with any governmental consent decree. </font></dd></dl>
</ul>
<p style="font-family:times;" align="CENTER"><font size="2"><a name="dg42901_cautionary_statement_r__dg402377"> </a>
<a name="toc_dg42901_2"> </a>
<br></font><font size="2"><b>  CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Form&nbsp;10-K contains forward-looking statements that are based on management's current expectations, estimates,
and projections. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "forecasts," variations of these words, and similar expressions are intended to identify
these forward-looking statements. Certain factors, including but not limited to those identified under "Item&nbsp;1A. Risk Factors" of this Form&nbsp;10-K, may cause actual results to
differ materially from current expectations, estimates, projections, forecasts, and from past results. No assurance can be made that any expectation, estimate, or projection contained in a
forward-looking statement will be </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">13</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=5,SEQ=14,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=486339,FOLIO='13',FILE='DISK114:[11ZAD1.11ZAD42901]DG42901A.;11',USER='VSTEFAN',CD='14-FEB-2011;04:11' -->
<a name="page_dg42901_1_14"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">achieved
or will not be affected by the factors cited above or other future events. Abbott undertakes no obligation to release publicly any revisions to forward-looking statements as the result of
subsequent events or developments.  </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><a name="dg42901_item_1b._unresolved_staff_comments"> </a>
<a name="toc_dg42901_3"> </a></font> <font size="2"><b>  ITEM 1B.&nbsp;&nbsp;&nbsp;&nbsp;UNRESOLVED STAFF COMMENTS    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">14</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=6,SEQ=15,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=596799,FOLIO='14',FILE='DISK114:[11ZAD1.11ZAD42901]DG42901A.;11',USER='VSTEFAN',CD='14-FEB-2011;04:11' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_di42901_1_15"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><a name="di42901_item_2._properties"> </a>
<a name="toc_di42901_1"> </a></font> <font size="2"><b>  ITEM 2.&nbsp;&nbsp;&nbsp;&nbsp;PROPERTIES    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott's corporate offices are located at 100 Abbott Park Road, Abbott Park, Illinois 60064-6400. The locations of Abbott's
principal plants, as of December&nbsp;31, 2010, are listed below. </font></p>
 <div style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="48%"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="48%"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;border-bottom:solid #000000 1.0pt;" align="LEFT"><font size="1"><b>Location </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th style="font-family:times;border-bottom:solid #000000 1.0pt;" align="LEFT"><font size="1"><b>Segments of Products Produced </b></font></th>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Abbott Park, Illinois</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Pharmaceutical and Diagnostic Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Alameda, California*</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Non-Reportable</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Alcobendas, Spain</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Non-Reportable</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Altavista, Virginia</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Nutritional Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Anasco, Puerto Rico</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Non-Reportable</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Barceloneta, Puerto Rico</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Pharmaceutical, Diagnostic, and Vascular Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Brockville, Canada</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Nutritional Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Buenos Aires, Argentina</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Pharmaceutical Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Campoverde di Aprilia, Italy</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Pharmaceutical Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Casa Grande, Arizona</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Nutritional Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Chatillon, France</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Pharmaceutical Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Clonmel, Ireland</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Vascular Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Columbus, Ohio</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Nutritional Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Cootehill, Ireland</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Nutritional Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Dartford, England*</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Diagnostic Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Des Plaines, Illinois</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Diagnostic Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Fairfield, California*</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Nutritional Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Granada, Spain</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Nutritional Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Irving, Texas</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Diagnostic Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Jayuya, Puerto Rico</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Pharmaceutical Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Kanata, Ontario, Canada</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Diagnostic Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Karachi, Pakistan</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Pharmaceutical Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Katsuyama, Japan</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Pharmaceutical Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Longford, Ireland</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Diagnostic Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Ludwigshafen, Germany</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Pharmaceutical Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Milpitas, California*</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Non-Reportable</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Murrieta, California</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Vascular Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Neustadt, Germany</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Pharmaceutical Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">North Chicago, Illinois</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Pharmaceutical Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Olst, Netherlands</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Pharmaceutical Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Ottawa, Ontario, Canada*</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Diagnostic Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Redwood City, California*</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Vascular Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Rio de Janeiro, Brazil</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Pharmaceutical Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Santa Clara, California</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Diagnostic Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Singapore</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Nutritional Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Sligo, Ireland</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Nutritional and Diagnostic Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Sturgis, Michigan</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Nutritional Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Temecula, California</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Vascular Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Tlalpan, Mexico</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Pharmaceutical Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Uppsala, Sweden</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Non-Reportable</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Weesp, Netherlands</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Pharmaceutical Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Wiesbaden, Delkenheim, Germany</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Diagnostic Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Witney, Oxon, England</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Non-Reportable</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Worcester, Massachusetts</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Pharmaceutical Products</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">Zwolle, the Netherlands</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">Nutritional Products</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
<div style="padding:0pt;position:relative;text-align:left;margin-left:0%;">
 <!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<hr width="26%" size="1.0PT" noshade="" color="#000000" align="LEFT">


<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">*</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Leased
property </font></dd></dl>
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition to the above, Abbott has manufacturing facilities in seven other locations in the United States, including Puerto Rico, and in five
other countries outside the United States. Abbott's facilities are deemed suitable and provide adequate productive capacity. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">15</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=16,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=154237,FOLIO='15',FILE='DISK114:[11ZAD1.11ZAD42901]DI42901A.;17',USER='EYOUNG',CD='16-FEB-2011;11:29' -->
<a name="page_di42901_1_16"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the United States, including Puerto Rico, Abbott owns nine distribution centers. Outside the United States, Abbott owns ten distribution centers. Abbott also has
twenty-two United States research and development facilities located at: Abbott Park, Illinois; Alameda, California; Albuquerque, New Mexico; Carlsbad, California; Columbus, Ohio (two
locations); Des Plaines, Illinois; Fairfield, California; Irving, Texas; Long Grove, Illinois; Menlo Park, California; Milpitas, California; Mountain View, California; North Chicago, Illinois;
Princeton, New Jersey; Redwood City, California (two locations); Santa Ana, California; Santa Clara, California; South Irvine, California; Temecula, California; and Worcester, Massachusetts. Outside
the United States, Abbott has research and development facilities in Canada, China, France, Germany, Ireland, Israel, Japan, the Netherlands, Singapore, South Africa, Spain, Sweden, Switzerland, and
the United Kingdom. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as noted, the corporate offices, and those principal plants in the United States listed above, are owned by Abbott or subsidiaries of Abbott. The remaining manufacturing plants
and all other facilities are owned or leased by Abbott or subsidiaries of Abbott. There are no material encumbrances on the properties.  </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><a name="di42901_item_3._legal_proceedings"> </a>
<a name="toc_di42901_2"> </a></font> <font size="2"><b>  ITEM 3.&nbsp;&nbsp;&nbsp;&nbsp;LEGAL PROCEEDINGS    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott is involved in various claims, legal proceedings and investigations, including (as of January&nbsp;31, 2011, except where
noted below) those described below. While it is not feasible to predict the outcome of such pending claims, proceedings and investigations with certainty, management is of the opinion that their
ultimate resolution should not have a material adverse effect on Abbott's financial position, cash flows, or results of operations, except where noted below. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
case is pending against Abbott in which New York University (NYU) and Centocor,&nbsp;Inc. assert that adalimumab (a drug Abbott sells under the trademark Humira®)
infringes a patent co-owned by NYU and Centocor and exclusively licensed to Centocor. In June 2009, a jury found that Abbott had willfully infringed the patent and awarded NYU and Centocor
approximately $1.67&nbsp;billion in past compensatory damages. In October 2009, the United States District Court for the Eastern District of Texas overturned the jury's finding that Abbott's
infringement was willful, but denied Abbott's request to overturn the jury's verdict on validity, infringement, and damages. In December 2009, the district court issued a final judgment and awarded
the plaintiffs an additional $175&nbsp;million in prejudgment interest. In December 2009, NYU and Centocor filed a separate action seeking enhanced damages and interest for the continuing sale of
Humira® after the jury verdict through July&nbsp;11, 2011 when their patent expires. In December 2009, Abbott filed a
notice of appeal with the United States Court of Appeals for the Federal Circuit and oral argument in Abbott's appeal took place in November 2010. Abbott is confident in the merits of its case and
believes that it will prevail on appeal. While it is not feasible to predict with certainty the outcome of this litigation, its ultimate resolution could be material to cash flows or results of
operations. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
response to a patent infringement action filed in December 2008 by Bayer HealthCare&nbsp;LLC (Bayer) in the United States District Court for the Eastern District of Texas, in
January 2009 Abbott filed an action against Bayer in the United States District Court for the District of Massachusetts seeking a declaration that Bayer's patent is invalid, unenforceable, and not
infringed by Humira®. The Massachusetts court consolidated the Texas case with the Massachusetts proceeding. Bayer seeks damages, including treble damages, but does not seek injunctive
relief. In January 2011, a Stipulation for Entry of Final Judgment was filed under which Bayer stipulated that Humira® does not infringe its patent in view of the District Court's modified
claims construction order, which was issued in December 2010. In February 2011, Bayer filed an appeal with the United States Court of Appeals for the Federal Circuit challenging the claims
construction order. Separately, in November 2009, Bayer filed infringement actions in the District Court of The Hague, The Netherlands and in the Regional Court in Dusseldorf, Germany, asserting that
Humira® infringes Bayer's European patent. In both European cases, Bayer seeks damages, but not injunctions. In March 2010, Abbott filed an action in the German Federal Patent Court asking
that Bayer's patent be revoked. In October 2010, the District Court of The Hague issued a decision invalidating Bayer's </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">16</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=2,SEQ=17,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=576711,FOLIO='16',FILE='DISK114:[11ZAD1.11ZAD42901]DI42901A.;17',USER='EYOUNG',CD='16-FEB-2011;11:29' -->
<a name="page_di42901_1_17"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">European
patent in the Netherlands. In November 2010, Bayer appealed that decision to the Court of Appeal in The Hague. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Several
cases, brought as purported class actions or representative actions on behalf of individuals or entities, are pending against Abbott that allege generally that Abbott and
numerous other pharmaceutical companies reported false pricing information in connection with certain drugs that are reimbursable under Medicare and Medicaid and by private payors. These cases,
brought by private plaintiffs, state Attorneys General, and other state government entities, generally seek monetary damages and/or injunctive relief and attorneys' fees. The federal court cases have
been consolidated for pre-trial purposes in the United States District Court for the District of Massachusetts under the Multi District Litigation Rules as </font><font size="2"><i>In re:
Pharmaceutical Industry Average Wholesale Price Litigation, MDL 1456</i></font><font size="2">. MDL 1456 includes: (a)&nbsp;two state Attorneys General suits, filed in August 2006
(</font><font size="2"><i>State of South Carolina)</i></font><font size="2"> and July 2009 (</font><font size="2"><i>State of Mississippi</i></font><font size="2"> on behalf of its state health plan); and
(b)&nbsp;a purported class action case in which the plaintiffs seek to certify nationwide classes of Medicare Part&nbsp;B consumers and third party payors and other consumers, filed in June 2003.
Eighteen named defendants, including Abbott, collectively settled this case, subject to final approval of the district court. In addition, several cases are pending against Abbott in state courts: </font> <font size="2"><i>Commonwealth of
Kentucky</i></font><font size="2">, filed in September 2003 in the Circuit Court of Franklin County, Kentucky; </font><font size="2"><i>State of
Wisconsin</i></font><font size="2">, filed in June 2004 in the Circuit Court of Dane County, Wisconsin; </font><font size="2"><i>State of Illinois</i></font><font size="2">, filed in February 2005 in the
Circuit Court of Cook County, Illinois; </font><font size="2"><i>State of South Carolina</i></font><font size="2"> (on behalf of its state health plan), filed in August 2006 in the Court of Common Pleas,
Fifth Judicial Circuit of Richland County, South Carolina; </font><font size="2"><i>State of Alaska</i></font><font size="2">, filed in October 2006 in the Superior Court for the Third Judicial District
in Anchorage, Alaska; </font><font size="2"><i>State of Idaho</i></font><font size="2">, filed in January 2007 in the District Court of the Fourth Judicial District in Ada County, Idaho; </font> <font size="2"><i>State of Utah</i></font><font size="2">,
filed in November 2007 in the Third Judicial District in Salt Lake County, Utah; </font><font size="2"><i>State of
Louisiana</i></font><font size="2">, filed in October 2010 in the Nineteenth Judicial District, Parish of Baton
Rouge, Louisiana and </font><font size="2"><i>State of Oklahoma</i></font><font size="2">, filed in September 2010 in the District Court of Pottawatomie County, Oklahoma. In 2010, Abbott settled the
civil whistle-blower suit brought by the United States Department of Justice, filed in May 2006 in the United States District Court for the Southern District of Florida; the civil whistle-blower suit
brought by Ven-A-Care of the Florida Keys,&nbsp;Inc., unsealed against Abbott in August 2007 and in which the United States declined to intervene; </font> <font size="2"><i>County of Erie</i></font><font size="2">, filed in March 2005 in the Supreme
Court of Erie County, New York; </font><font size="2"><i>State of Mississippi</i></font><font size="2">,
filed in October 2005 in the Circuit Court of Rankin County, Mississippi; </font><font size="2"><i>State of Hawaii</i></font><font size="2">, filed in April 2006 in the First Circuit Court of Hawaii; </font> <font size="2"><i>County of
Oswego</i></font><font size="2">, filed in August 2006 in the Supreme Court of Oswego County, New York; </font><font size="2"><i>County of
Schenectady</i></font><font size="2">, filed in August 2006 in the Supreme Court of Schenectady County, New York; and </font><font size="2"><i>State of Kansas</i></font><font size="2">, filed in October
2008 in the District Court of Wyandotte County, Kansas. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Several
lawsuits filed against Unimed Pharmaceuticals,&nbsp;Inc., Solvay Pharmaceuticals,&nbsp;Inc. (a company Abbott acquired in February 2010) et al. have been consolidated for
pre-trial purposes in the United States District Court for the Northern District of Georgia under the Multi District Litigation Rules as </font><font size="2"><i>In re AndroGel Antitrust
Litigation</i></font><font size="2">, MDL No.&nbsp;2084. These cases, brought by private plaintiffs and the Federal Trade Commission ("FTC"), generally allege Solvay's 2006 patent litigation involving
AndroGel was sham litigation and the patent litigation settlement agreement and related agreements with three generic companies violate federal and state antitrust laws and state consumer protection
and unjust enrichment laws. Plaintiffs generally seek monetary damages and/or injunctive relief and attorneys' fees. MDL 2084 includes: (a)&nbsp;3 individual plaintiff lawsuits: </font> <font size="2"><i>Supervalu,&nbsp;Inc. v. Unimed Pharmaceuticals,
&nbsp;Inc. et al.</i></font><font size="2">, was filed in April 2010 in the Northern District of Georgia; and </font> <font size="2"><i>Rite Aid Corp. et al. v. Unimed Pharmaceuticals,&nbsp;Inc. et al.</i></font><font size="2"> and </font><font size="2"><i>Walgreen&nbsp;Co. et al. v. Unimed
Pharmaceuticals,&nbsp;Inc. et al.,</i></font><font size="2"> both of which were filed in February 2009 in the United States District Court for the Middle District of Pennsylvania; (b)&nbsp;7
purported class actions: </font><font size="2"><i>Meijer,&nbsp;Inc. et al. v. Unimed Pharmaceuticals,&nbsp;Inc. et al., Rochester Drug Co-Operative,&nbsp;Inc. et al. v. Unimed
Pharmaceuticals,&nbsp;Inc. et al.,</i></font><font size="2"> and </font><font size="2"><i>Louisiana Wholesale Drug&nbsp;Co.,&nbsp;Inc. et al. v. Unimed Pharmaceuticals,&nbsp;Inc. et
al.,</i></font><font size="2"> all of which were filed in May 2009 in the United States District Court for the Northern District of Georgia; </font><font size="2"><i>Stephen L. LaFrance
Pharmacy,&nbsp;Inc. et al. v. Unimed Pharmaceuticals,&nbsp;Inc.  </i></font></p>

<p style="font-family:times;" align="CENTER"><font size="2">17</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=3,SEQ=18,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=327526,FOLIO='17',FILE='DISK114:[11ZAD1.11ZAD42901]DI42901A.;17',USER='EYOUNG',CD='16-FEB-2011;11:29' -->
<a name="page_di42901_1_18"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2"><i> et&nbsp;al.,</i></font><font size="2"> filed in March 2009 in the United States District Court for the District of New Jersey; </font><font size="2"><i>Fraternal Order of Police v. Unimed
Pharmaceuticals,&nbsp;Inc. et al.,</i></font><font size="2"> filed in September 2009 in the United States District Court for the Northern District of Georgia; </font><font size="2"><i>Jabo's
Pharmacy,&nbsp;Inc. v. Solvay Pharmaceuticals,&nbsp;Inc. et al.,</i></font><font size="2"> filed in October 2009 in the United States District Court for the Eastern District of Tennessee; and </font> <font size="2"><i>LeGrand v. Unimed Pharmaceuticals,
&nbsp;Inc. et al.,</i></font><font size="2"> filed in September 2010 in the United States District Court for the Northern District of Georgia;
and (c)&nbsp;a lawsuit brought by the FTC, </font><font size="2"><i>Federal Trade Commission v. Watson Pharmaceuticals,&nbsp;Inc. et al.</i></font><font size="2">, filed in May 2009 in the United
States District Court for the Northern District of Georgia. In February 2010, Solvay's motion to dismiss the cases was partially granted and all of the FTC's claims and all of the plaintiffs' claims
except those alleging sham litigation were dismissed. In June 2010, the FTC appealed the decision to the United States Court of Appeals for the Eleventh Circuit, and this appeal is pending. In
February 2010, two cases, </font><font size="2"><i>Scurto et al. v. Unimed Pharmaceuticals,&nbsp;Inc. et al.,</i></font><font size="2"> filed in March 2009 in the United States District Court for the
District of New Jersey, and </font><font size="2"><i>United Food&nbsp;&amp; Com. Workers Unions&nbsp;&amp; Employ. Midwest Health Benefits Fund et al. v. Unimed Pharmaceuticals,&nbsp;Inc. et
al.,</i></font><font size="2"> filed in May 2009 in the United States District Court for the District of Minnesota, were dismissed. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Four
cases are pending against Abbott in the United States District Court for the Northern District of California that allege antitrust violations in connection with the 2003 Norvir
re-pricing: (a)&nbsp;a consolidated class action filed on behalf of all direct purchasers by three individual plaintiffs, </font><font size="2"><i>Meijer,&nbsp;Inc.,  </i></font><font size="2">filed in November 2007, </font><font size="2"><i>Louisiana
Wholesale Drug Company,&nbsp;Inc.</i></font><font size="2">, filed in December 2007, and </font> <font size="2"><i>Rochester Drug Co-Operative,&nbsp;Inc.</i></font><font size="2">, filed in November 2007; (b)&nbsp;two cases filed on behalf of director
purchaser class
opt-outs, </font><font size="2"><i>Rite Aid,&nbsp;Inc.</i></font><font size="2">, filed in December 2007 and </font><font size="2"><i>Safeway,&nbsp;Inc.</i></font><font size="2">, filed in
October 2007; and (c)&nbsp;one case filed by a competitor, </font><font size="2"><i>GlaxoSmithKline</i></font><font size="2">, filed in November 2007. All of the cases have been consolidated for
discovery and trial. The plaintiffs seek damages, injunctive relief, and costs. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
case is pending against Abbott under the name </font><font size="2"><i>Myla Nauman, Jane Roller and Michael Loughery v. Abbott Laboratories and
Hospira,&nbsp;Inc.</i></font><font size="2"> in which former Abbott employees alleged that (i)&nbsp;their transfer to Hospira,&nbsp;Inc., as part of Abbott's spin-off of Hospira,
adversely affected their employee benefits in violation of the Employee Retirement Income Security Act and (ii)&nbsp;Abbott's conduct in connection with their transfer breached a fiduciary duty to
plaintiffs involving employee benefits. The plaintiffs generally sought reinstatement as Abbott employees, or reinstatement as participants in Abbott's employee benefit plans, and an award of the
employee benefits they have allegedly lost. In April 2010, the United States District Court for the Northern District of Illinois entered judgment in favor of Abbott on all counts. The plaintiffs have
appealed to the United States Court of Appeals for the Seventh Circuit. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
December 2010, Kos Pharmaceuticals&nbsp;Inc. settled an investigation of its sales and marketing practices initiated by the Office of the Inspector General of the United States
Department of Health and Human Services in conjunction with the United States Department of Justice, and the United States Attorneys for the Eastern District of Wisconsin, the Western District of
Louisiana, and the Middle District of Louisiana. The settlement related to conduct that occurred prior to Abbott's December 2006 acquisition of Kos. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
United States Department of Justice, through the United States Attorney for Maryland, is investigating the sales and marketing practices of Abbott for Micardis®, a drug
co-promoted for (until March&nbsp;31, 2006) and manufactured by Boehringer Ingelheim. The government is seeking to determine whether any of these practices resulted in any violations of
civil and/or criminal laws, including the Federal False Claims Act and the Anti-Kickback Statute, in connection with the Medicare and/or Medicaid reimbursement paid to third parties. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
United States Department of Justice, through the Unites States Attorney for the Western District of Virginia, is investigating Abbott's sales and marketing activities for Depakote.
The government is seeking to determine whether any of these activities violated civil and/or criminal laws, including the Federal False Claims Act, the Food and Drug Cosmetic Act, and the
Anti-Kickback Statute in connection with Medicare and/or Medicaid reimbursement to third parties. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">18</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=4,SEQ=19,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=654758,FOLIO='18',FILE='DISK114:[11ZAD1.11ZAD42901]DI42901A.;17',USER='EYOUNG',CD='16-FEB-2011;11:29' -->
<a name="page_di42901_1_19"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
United States Department of Justice, through the United States Attorney for the District of Massachusetts, is investigating the sales and marketing activities of Abbott's and other
companies' biliary stent products. The government is seeking to determine whether any of these activities violated civil and/or criminal laws, including the Federal False Claims Act, the Food and Drug
Cosmetic Act, and the Anti-Kickback Statute in connection with Medicare and/or Medicaid reimbursement paid to third parties. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2007, Johnson&nbsp;&amp; Johnson,&nbsp;Inc. and Cordis Corporation, a wholly-owned subsidiary of Johnson&nbsp;&amp; Johnson (collectively Johnson&nbsp;&amp; Johnson), filed suits against
Abbott in the United States District Court for the District of New Jersey asserting infringement of four Johnson&nbsp;&amp; Johnson patents by Abbott's Xience V stent and seeking an injunction, damages,
and a determination of willful infringement. In January 2010, the New Jersey court issued an Order of Judgment finding the four patents invalid and dismissing the suits against Abbott. In January
2008, Cordis Corporation and Wyeth filed suit against Abbott in the United States District Court for the District of New Jersey alleging the Xience V stent infringes three additional patents and
seeking an injunction, damages, and a determination of willful infringement. In September 2009, Wyeth, Cordis Corporation, and Cordis&nbsp;LLC filed suit against Abbott in the United States District
Court for the District of New Jersey alleging the Xience V stent infringes an additional patent, and in August 2010 the plaintiffs amended their lawsuit to add a second related patent to this case.
The plaintiffs in this case also seek an injunction and damages. Abbott denies all substantive allegations in each case. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
case brought by Wall Cardiovascular Technologies,&nbsp;LLC (Wall) in July 2008 was pending against Abbott in the United States District Court for the Eastern District of Texas in
which Wall asserted that Abbott's Xience V stent infringes a patent. In December 2010, the parties settled the case and it was dismissed with prejudice. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
December 2008, Medinol Limited (Medinol) sued Abbott in the High Court of Ireland, the District Court of The Hague, The Netherlands, and the Regional Court in Dusseldorf, Germany
asserting that Abbott's Vision and Xience V stents infringe one of Medinol's European stent design patents. Medinol has since accused Abbott's Multi-Link 8 and Xience Prime stents of
infringement. In Germany, Medinol further asserts that Abbott's Vision, Xience V, Penta, Xience Prime, Multi-Link 8, and Zeta stents infringe two Medinol German stent design patents and
one Medinol German stent design utility model. Medinol seeks damages and injunctions in Ireland and The Netherlands and seeks damages in Germany. Abbott initiated an action in the German Federal
Patent Court seeking a declaration that Medinol's patents are invalid. Abbott also initiated an action in the High Court of Justice in the United Kingdom asserting that Abbott's stents do not infringe
Medinol's European patent and two other Medinol patents which were previously revoked at the European Patent Office and seeking a declaration that all three Medinol patents are invalid. In Ireland,
Abbott asserts that Medinol's European patent is invalid and not infringed. In December 2009, the Dutch court found that Abbott's stents do not infringe Medinol's European patent but did not rule on
the patent's validity. Medinol has filed a notice of appeal of the Dutch court's finding that Abbott's stents do not infringe Medinol's patent. In March 2010, the Dusseldorf court, which does not
assess the validity of patents, found that Abbott's stents do not infringe Medinol's European patent, but that they do infringe two of Medinol's German stent design patents. Medinol has appealed the
non-infringement decision and Abbott has appealed the infringement decisions. In November and December 2010, the German Federal Patent Court held two invalidity hearings on the three
patents being asserted by Medinol in Germany. In January 2011, the German Federal Patent Court found all three Medinol patents invalid. However, after allowing Medinol to modify the claims for one of
its German patents, the court concluded that the modified claims of that patent were valid. In October 2010, the United Kingdom court found that Abbott's products do not infringe any of the three
Medinol patents and that one of the two previously revoked patents is invalid. Abbott denies all substantive allegations in each remaining case. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott
is seeking to enforce its patent rights relating to fenofibrate tablets (a drug Abbott sells under the trademark Tricor®). In a case filed in the United States
District Court for the Northern District of Illinois in February 2008, Abbott and the patent owner, Laboratories Fournier,&nbsp;S.A. (Fournier), allege </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">19</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=5,SEQ=20,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=671195,FOLIO='19',FILE='DISK114:[11ZAD1.11ZAD42901]DI42901A.;17',USER='EYOUNG',CD='16-FEB-2011;11:29' -->
<a name="page_di42901_1_20"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">infringement
of three patents and seek injunctive relief against Teva Pharmaceuticals USA&nbsp;Inc. In November 2009, the parties reached a settlement and this case was dismissed. In a second case
filed in the Northern District of Illinois in November 2008, Abbott and Fournier allege infringement of the three patents and seek injunctive relief against Biovail Laboratories International SRL.
This case has been transferred to the United States District Court for the District of New Jersey. In a third case filed in the United States District Court for the District of New Jersey in March
2009, Abbott and Fournier allege infringement of the three patents and seek injunctive relief against Lupin Pharmaceuticals and Lupin Limited. In a fourth case filed in the United States District
Court for the District of New Jersey in October 2009, Abbott and Fournier allege infringement of the three patents and seek injunctive relief against Impax Laboratories. In a case filed in June 2010
in the United States District Court for the District of New Jersey, Abbott and Fournier allege infringement of three patents and seek injunctive relief against Ranbaxy Laboratories&nbsp;Ltd.,
Ranbaxy Pharmaceuticals&nbsp;Inc. and Ranbaxy&nbsp;Inc. In a case filed in the United States District Court for the District of New Jersey in July 2010, Abbott and Fournier allege infringement of
three patents and seek injunctive relief against Teva Pharmaceuticals USA&nbsp;Inc. (Teva). In related cases where Abbott became involved through its acquisition of Fournier Laboratoires
Ireland&nbsp;Ltd. (Fournier Ireland), Abbott is seeking to enforce additional rights relating to fenofibrate tablets. These cases were filed in the United States District Court for the District of
New Jersey by joint patent owners Elan Pharma International&nbsp;Ltd. (Elan) and Fournier Ireland against Biovail Laboratories International SRL and Biovail Corporation in November 2008, Lupin
Pharmaceuticals,&nbsp;Inc. and Lupin Limited in March 2009, Impax Laboratories,&nbsp;Inc. in October 2009, Ranbaxy Laboratories&nbsp;Ltd., Ranbaxy Pharmaceuticals&nbsp;Inc. and
Ranbaxy&nbsp;Inc. in June 2010, and Teva Pharmaceuticals USA&nbsp;Inc. in July 2010. Elan and Fournier Ireland allege infringement of two jointly-owned patents and one Elan patent and seek
injunctive relief. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott
is seeking to enforce its patent rights relating to ritonavir/lopinavir tablets (a drug Abbott sells under the trademark Kaletra®). In cases filed in the United States
District Courts for the Northern District of Illinois and for the District of Delaware in March 2009, Abbott alleges that Matrix Laboratories,&nbsp;Inc., Matrix Laboratories,&nbsp;Ltd., and
Mylan,&nbsp;Inc.'s proposed generic products infringe
Abbott's patents and seeks declaratory and injunctive relief. The case in Delaware was dismissed in April 2009. Upon Matrix's motion in November 2009, the United States District Court for the Northern
District of Illinois granted a five-year stay of the litigation unless good cause to lift the stay is shown. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott
is seeking to enforce its patent rights relating to niacin extended release tablets (a drug Abbott sells under the trademark Niaspan®). In a case filed in the United
States District Court for the District of Delaware in March 2009, Abbott alleges that Lupin Pharmaceuticals and Lupin Limited's proposed generic products infringe Abbott's patents and seeks
declaratory and injunctive relief. In February 2010, Abbott filed a case in the United States District Court for the District of Delaware alleging that Sun Pharmaceutical Industries Limited's and Sun
Pharma Global FZE's generic product infringes Abbott's patents and seeks declaratory and injunctive relief. In a case filed in June 2010 in the United States District Court for the District of
Delaware, Abbott alleges Sandoz,&nbsp;Inc.'s proposed generic product infringes Abbott's patents and seeks declaratory and injunctive relief. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott
is seeking to enforce certain patent rights that cover the use of fully human anti-TNF alpha antibodies with methotrexate to treat rheumatoid arthritis. In a case
filed in the United States District Court for the District of Massachusetts in May 2009, Abbott alleges Centocor&nbsp;Inc.'s product Simponi® infringes Abbott's patents and seeks damages
and injunctive relief. The case was stayed at Centocor's request while the parties arbitrated issues related to Centocor's license defenses. In June 2010 the arbitrator ruled, the Court lifted the
stay, and the patent infringement case is proceeding.  </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><a name="di42901_item_4._(removed_and_reserved)"> </a>
<a name="toc_di42901_3"> </a></font> <font size="2"><b>  ITEM 4.&nbsp;&nbsp;&nbsp;&nbsp;(REMOVED AND RESERVED)    <br>    </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2">20</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=6,SEQ=21,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=607334,FOLIO='20',FILE='DISK114:[11ZAD1.11ZAD42901]DI42901A.;17',USER='EYOUNG',CD='16-FEB-2011;11:29' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_dk42901_1_21"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="dk42901_executive_officers_of_the_registrant"> </a>
<a name="toc_dk42901_1"> </a>
<br></font><font size="2"><b>  EXECUTIVE OFFICERS OF THE REGISTRANT    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Executive officers of Abbott are elected annually by the board of directors. All other officers are elected by the board or appointed
by the chairman of the board. All officers are either elected at the first meeting of the board of directors held after the annual shareholder meeting or appointed by the chairman after that board
meeting. Each officer holds office until a successor has been duly elected or appointed and qualified or until the officer's death, resignation, or removal. Vacancies may be filled at any time by the
board. Any officer may be removed by the board of directors when, in its judgment, removal would serve the best interests of Abbott. Any officer appointed by the chairman of the board may be removed
by the chairman whenever, in the chairman's judgment, removal would serve the best interests of Abbott. A vacancy in any office appointed by the chairman of the board may be filled by the chairman. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott's
executive officers, their ages as of February&nbsp;18, 2011, and the dates of their first election as officers of Abbott are listed below. The executive officers' principal
occupations and employment for the past five years and the year of appointment to the earliest reported office are also shown. Unless otherwise stated, employment was by Abbott. There are no family
relationships between any corporate officers or directors. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Miles D. White, 55  </b></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">1999
to present&nbsp;— Chairman of the Board and Chief Executive Officer, and Director. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">Elected
Corporate Officer&nbsp;— 1993. </font></p>

</ul>

<p style="font-family:times;text-align:justify"><font size="2"><b> Richard W. Ashley, 67  </b></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">2004
to present&nbsp;— Executive Vice President, Corporate Development. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Elected
Corporate Officer&nbsp;— 2004. </font></p>

</ul>

<p style="font-family:times;text-align:justify"><font size="2"><b> John M. Capek, 49  </b></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">2007
to present&nbsp;— Executive Vice President, Medical Devices. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">2006
to 2007&nbsp;— Senior Vice President, Abbott Vascular. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2006&nbsp;—
Vice President and President, Cardiac Therapies. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2005
to 2006&nbsp;— President, Guidant Vascular Intervention. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Elected
Corporate Officer&nbsp;— 2006. </font></p>

</ul>

<p style="font-family:times;text-align:justify"><font size="2"><b> Thomas C. Freyman, 56  </b></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">2004
to present&nbsp;— Executive Vice President, Finance and Chief Financial Officer. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Elected
Corporate Officer&nbsp;— 1991. </font></p>

</ul>

<p style="font-family:times;text-align:justify"><font size="2"><b> Richard A. Gonzalez, 57  </b></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">2010
to present&nbsp;— Executive Vice President, Pharmaceutical Products Group. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2009
to present&nbsp;— President, Abbott Ventures&nbsp;Inc. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2007
to 2009&nbsp;— Retired. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2006
to 2007&nbsp;— President and Chief Operating Officer, and Director. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">2002
to 2006&nbsp;— President and Chief Operating Officer, Medical Products Group, and Director. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Elected
Corporate Officer&nbsp;— 2010. </font></p>

</ul>
<p style="font-family:times;" align="CENTER"><font size="2">21</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=22,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=97686,FOLIO='21',FILE='DISK114:[11ZAD1.11ZAD42901]DK42901A.;24',USER='SLYUBOM',CD='15-FEB-2011;18:15' -->
<a name="page_dk42901_1_22"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>


<p style="font-family:times;text-align:justify"><font size="2"><b> John C. Landgraf, 58  </b></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">2011
to present&nbsp;— Executive Vice President, Nutritional Products. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2008
to 2010&nbsp;— Senior Vice President, Pharmaceuticals, Manufacturing and Supply. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2004
to 2008&nbsp;— Senior Vice President, Global Pharmaceutical Manufacturing and Supply. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Elected
Corporate Officer&nbsp;— 2000. </font></p>

</ul>

<p style="font-family:times;text-align:justify"><font size="2"><b> Edward L. Michael, 54  </b></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">2008
to present&nbsp;— Executive Vice President, Diagnostic Products. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2007
to 2008&nbsp;— Executive Vice President, Diagnostics. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2007&nbsp;—
Senior Vice President, Medical Products. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2003
to 2007&nbsp;— Vice President and President, Molecular Diagnostics. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Elected
Corporate Officer&nbsp;— 1997. </font></p>

</ul>

<p style="font-family:times;text-align:justify"><font size="2"><b> Laura J. Schumacher, 47  </b></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">2007
to present&nbsp;— Executive Vice President, General Counsel and Secretary. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2005
to 2007&nbsp;— Senior Vice President, Secretary and General Counsel. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Elected
Corporate Officer&nbsp;— 2003. </font></p>

</ul>

<p style="font-family:times;text-align:justify"><font size="2"><b> Carlos Alban, 48  </b></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">2009
to present&nbsp;— Senior Vice President, International Pharmaceuticals. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">2008
to 2009&nbsp;— Vice President, Pharmaceuticals, Western Europe and Canada. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2007
to 2008&nbsp;— Vice President, Western Europe and Canada. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2006
to 2007&nbsp;— Vice President, Pharmaceutical European Operations. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2004
to 2006&nbsp;— Regional Director, North Europe. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Elected
Corporate Officer&nbsp;— 2006. </font></p>

</ul>

<p style="font-family:times;text-align:justify"><font size="2"><b> Brian J. Blaser, 46  </b></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">2010
to present&nbsp;— Senior Vice President, Diagnostics. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2008
to 2010&nbsp;— Vice President, Diagnostics, Operations. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2008&nbsp;—
Divisional Vice President, Global Operations. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2007
to 2008&nbsp;— Divisional Vice President, Manufacturing. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2004
to 2007&nbsp;— Divisional Vice President, Strategic Operations Improvement. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Elected
Corporate Officer&nbsp;— 2008. </font></p>

</ul>

<p style="font-family:times;text-align:justify"><font size="2"><b> A. David Forrest, 49  </b></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">2010
to present&nbsp;— Senior Vice President, International Nutrition. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2007
to 2010&nbsp;— Divisional Vice President, Europe&nbsp;&amp; Canada. </font></p>

</ul>
<p style="font-family:times;" align="CENTER"><font size="2">22</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=2,SEQ=23,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=374465,FOLIO='22',FILE='DISK114:[11ZAD1.11ZAD42901]DK42901A.;24',USER='SLYUBOM',CD='15-FEB-2011;18:15' -->
<a name="page_dk42901_1_23"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">2004
to 2007&nbsp;— General Manager, United Kingdom. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Elected
Corporate Officer&nbsp;— 2010. </font></p>

</ul>

<p style="font-family:times;text-align:justify"><font size="2"><b> Stephen R. Fussell, 53  </b></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">2005
to present&nbsp;— Senior Vice President, Human Resources. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">Elected
Corporate Officer&nbsp;— 1999. </font></p>

</ul>

<p style="font-family:times;text-align:justify"><font size="2"><b> Robert B. Hance, 51  </b></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">2008
to present&nbsp;— Senior Vice President, Vascular. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2006
to 2008&nbsp;— Senior Vice President, Diabetes Care Operations. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2006&nbsp;—
Vice President and President, Vascular Solutions. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2003
to 2006&nbsp;— Vice President and President, Abbott Vascular Devices. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">Elected
Corporate Officer&nbsp;— 1999. </font></p>

</ul>

<p style="font-family:times;text-align:justify"><font size="2"><b> Heather L. Mason, 50  </b></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">2008
to present&nbsp;— Senior Vice President, Diabetes Care. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2007
to 2008&nbsp;— Vice President, Latin America Pharmaceuticals. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2005
to 2007&nbsp;— Vice President, International Marketing. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Elected
Corporate Officer&nbsp;— 2001. </font></p>

</ul>

<p style="font-family:times;text-align:justify"><font size="2"><b> James V. Mazzo, 53  </b></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">2009
to present&nbsp;— Senior Vice President, Abbott Medical Optics. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2006
to 2009&nbsp;—&nbsp;Chairman of the Board of Directors, Advanced Medical Optics, Inc. (a global leader in the<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;development, manufacture, and marketing of medical devices for the eye). </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2004
to 2009&nbsp;— Chief Executive Officer, Advanced Medical Optics,&nbsp;Inc. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">2004
to 2007&nbsp;— President, Advanced Medical Optics,&nbsp;Inc. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Elected
Corporate Officer&nbsp;— 2009. </font></p>

</ul>

<p style="font-family:times;text-align:justify"><font size="2"><b> Donald V. Patton Jr., 58  </b></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">2010
to present&nbsp;— Senior Vice President, U.S. Pharmaceuticals. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2007
to 2009&nbsp;— Senior Vice President, U.S. Nutrition. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2007&nbsp;—
Senior Vice President, Abbott Nutrition Products Division. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">2006
to 2007&nbsp;— Vice President, Diagnostic Global Commercial Operations. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2005
to 2006&nbsp;— Vice President, International Marketing. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Elected
Corporate Officer&nbsp;— 2004. </font></p>

</ul>
<p style="font-family:times;" align="CENTER"><font size="2">23</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=3,SEQ=24,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=418727,FOLIO='23',FILE='DISK114:[11ZAD1.11ZAD42901]DK42901A.;24',USER='SLYUBOM',CD='15-FEB-2011;18:15' -->
<a name="page_dk42901_1_24"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Mary T. Szela, 47  </b></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">2010
to present&nbsp;—&nbsp;Senior Vice President, Global Strategic Marketing and Services, Pharmaceutical Products Group. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2008
to 2009&nbsp;— Senior Vice President, U.S. Pharmaceuticals. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2007
to 2008&nbsp;— Senior Vice President, Pharmaceutical Operations. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2006&nbsp;—
Vice President, Commercial Pharmaceutical Operations. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">2001
to 2006&nbsp;— Vice President, Pharmaceutical Products, Primary Care Operations. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Elected
Corporate Officer&nbsp;— 2001. </font></p>

</ul>

<p style="font-family:times;text-align:justify"><font size="2"><b> Michael J. Warmuth, 48  </b></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">2010
to present&nbsp;— Senior Vice President, Established Products, Pharmaceutical Products Group. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2008
to 2010&nbsp;— Senior Vice President, Diagnostics. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2008&nbsp;—
Vice President, Hematology Diagnostics. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2007
to 2008&nbsp;— Vice President, Global Engineering Services. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2006
to 2007&nbsp;— Divisional Vice President, Global Engineering Services. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2004
to 2006&nbsp;— Divisional Vice President of Quality, Global Pharmaceutical Operations. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Elected
Corporate Officer&nbsp;— 2007. </font></p>

</ul>

<p style="font-family:times;text-align:justify"><font size="2"><b> J. Scott White, 42  </b></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">2010
to present&nbsp;— Senior Vice President, U.S. Nutrition. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">2007
to 2009&nbsp;—&nbsp;Division Vice President and Regional Director for Latin America, Abbott Nutrition International. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">2005
to 2007&nbsp;—&nbsp;Division Vice President and General Manager for Pediatric Nutrition, U.S. Nutrition. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Elected
Corporate Officer&nbsp;— 2009. </font></p>

</ul>

<p style="font-family:times;text-align:justify"><font size="2"><b> Greg W. Linder, 54  </b></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">2001
to present&nbsp;— Vice President and Controller. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Elected
Corporate Officer&nbsp;— 1999. </font></p>

</ul>
<p style="font-family:times;" align="CENTER"><font size="2">24</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=4,SEQ=25,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=127233,FOLIO='24',FILE='DISK114:[11ZAD1.11ZAD42901]DK42901A.;24',USER='SLYUBOM',CD='15-FEB-2011;18:15' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_dm42901_1_25"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->



<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="dm42901_part_ii"> </a>
<a name="toc_dm42901_1"> </a>
<br></font><font size="2"><b>  PART II    <br>    </b></font></p>


<p style="font-family:times;text-align:justify"><font size="2"><a name="dm42901_item_5._market_for_registrant___ite04666"> </a>
<a name="toc_dm42901_2"> </a></font> <font size="2"><b>  ITEM 5.&nbsp;&nbsp;&nbsp;&nbsp;MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Principal Market  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The principal market for Abbott's common shares is the New York Stock Exchange. Shares are also listed on the Chicago Stock Exchange
and traded on various regional and electronic exchanges. Outside the United States, Abbott's shares are listed on the London Stock Exchange and the Swiss Stock Exchange. </font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="11" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Market Price Per Share </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="5" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="5" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>high </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>low </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>high </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>low </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">First Quarter</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">56.79</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">52.21</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">57.39</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">44.10</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Second Quarter</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">53.25</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">45.26</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">48.37</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">41.27</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Third Quarter</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">52.86</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">44.59</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">49.69</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">43.45</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Fourth Quarter</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">53.75</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">46.03</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">54.97</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">48.41</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2"><b> Shareholders  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There were 64,413 shareholders of record of Abbott common shares as of December&nbsp;31, 2010. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Dividends  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Quarterly dividends of $.44 and $.40 per share were declared on common shares in 2010 and 2009, respectively. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott
Laboratories is an Illinois High Impact Business (HIB) and is located in a federal Foreign Trade Sub-Zone (Sub-Zone 22F). Dividends may be eligible for a
subtraction from base income for Illinois income tax purposes. If you have questions, please contact your tax advisor. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">25</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>

<!-- ZEQ.=1,SEQ=26,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=610685,FOLIO='25',FILE='DISK114:[11ZAD1.11ZAD42901]DM42901A.;10',USER='ANEETZ',CD='15-FEB-2011;17:48' -->
<a name="page_dm42901_1_26"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Issuer Purchases of Equity Securities  </b></font></p>
 <div style="padding:0pt;position:relative;width:54%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="150%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="82pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="82pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="98pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="135pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" nowrap="" align="LEFT"><div style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:23pt;"><font size="1"><b>Period

<!-- COMMAND=ADD_SCROPPEDRULE,23pt -->

 </b></font></div></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>(a) Total Number<br>
of Shares<br>
(or Units)<br>
Purchased </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>(b) Average Price<br>
Paid per Share<br>
(or Unit) </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>(c) Total Number of<br>
Shares (or Units)<br>
Purchased as Part of<br>
Publicly Announced<br>
Plans or Programs </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>(d) Maximum Number (or<br>
Approximate Dollar Value) of<br>
Shares (or Units) that May<br>
Yet Be Purchased Under the<br>
Plans or Programs </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">October&nbsp;1, 2010&nbsp;— October&nbsp;31, 2010</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">88,848</font></td>
<td style="font-family:times;"><font size="2"><sup>1</sup></font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">52.650</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">0</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3,392,180,505</font></td>
<td style="font-family:times;"><font size="2"><sup>2</sup></font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">November&nbsp;1, 2010&nbsp;— November&nbsp;30, 2010</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">79,068</font></td>
<td style="font-family:times;"><font size="2"><sup>1</sup></font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">49.915</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">0</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3,392,180,505</font></td>
<td style="font-family:times;"><font size="2"><sup>2</sup></font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">December&nbsp;1, 2010&nbsp;— December&nbsp;31, 2010</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">61,850</font></td>
<td style="font-family:times;"><font size="2"><sup>1</sup></font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">47.909</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">0</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3,392,180,505</font></td>
<td style="font-family:times;"><font size="2"><sup>2</sup></font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">229,766</font></td>
<td style="font-family:times;"><font size="2"><sup>1</sup></font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">50.433</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">0</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3,392,180,505</font></td>
<td style="font-family:times;"><font size="2"><sup>2</sup></font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
<div style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<hr width="26%" size="1.0PT" noshade="" color="#000000" align="LEFT">


<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">1.</font></dt><dd style="font-family:times;text-align:justify"><font size="2">These
shares represent:
<br><br></font>
<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(i)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">the
shares deemed surrendered to Abbott to pay the exercise price in connection with the exercise of employee stock options&nbsp;— 88,848 in
October; 56,568 in November; and 31,850 in December; and
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(ii)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">the
shares purchased on the open market for the benefit of participants in the Abbott Laboratories, Limited Employee Stock Purchase
Plan&nbsp;— 0 in October; 22,500 in November; and 30,000 in December. <br></font></dd></dl>
</dd></dl>
<ul>

<p style="font-family:times;text-align:justify"><font size="2">These
shares do not include the shares surrendered to Abbott to satisfy tax withholding obligations in connection with the vesting of restricted stock or restricted stock units. </font></p>

</ul>
<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">2.</font></dt><dd style="font-family:times;text-align:justify"><font size="2">On
October&nbsp;13, 2008, Abbott announced that its board of directors approved the purchase of up to $5&nbsp;billion of its common shares, from time to
time. </font></dd></dl>
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">26</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=2,SEQ=27,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=697296,FOLIO='26',FILE='DISK114:[11ZAD1.11ZAD42901]DM42901A.;10',USER='ANEETZ',CD='15-FEB-2011;17:48' -->
<a name="page_dm42901_1_27"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>


<p style="font-family:times;text-align:justify"><font size="2"><a name="dm42901_item_6._selected_financial_data"> </a>
<a name="toc_dm42901_3"> </a></font> <font size="2"><b>  ITEM 6.&nbsp;&nbsp;&nbsp;&nbsp;SELECTED FINANCIAL DATA    <br>    </b></font></p>
 <div style="padding:0pt;position:relative;width:73%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"110%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="110%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="55pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="55pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="55pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="55pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="55pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="14" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Year ended December&nbsp;31 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2007 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2006 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="14" style="font-family:times;" align="CENTER"><font size="1"><i>(dollars in millions, except per share data)</i></font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net sales</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">35,166.7</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">30,764.7</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">29,527.6</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">25,914.2</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">22,476.3</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Earnings from continuing operations</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,626.2</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,745.8</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,734.2</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3,606.3</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,716.8</font></td>
<td style="font-family:times;"><font size="2"><sup>1</sup></font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net earnings</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,626.2</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,745.8</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,880.7</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3,606.3</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,716.8</font></td>
<td style="font-family:times;"><font size="2"><sup>1</sup></font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Basic earnings per common share from continuing operations</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2.98</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3.71</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3.06</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2.34</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1.12</font></td>
<td style="font-family:times;"><font size="2"><sup>1</sup></font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Basic earnings per common share</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2.98</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3.71</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3.16</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2.34</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1.12</font></td>
<td style="font-family:times;"><font size="2"><sup>1</sup></font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Diluted earnings per common share from continuing operations</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2.96</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3.69</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3.03</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2.31</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1.12</font></td>
<td style="font-family:times;"><font size="2"><sup>1</sup></font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Diluted earnings per common share</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2.96</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3.69</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3.12</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2.31</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1.12</font></td>
<td style="font-family:times;"><font size="2"><sup>1</sup></font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total assets</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">59,462.3</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">52,416.6</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">42,419.2</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">39,713.9</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">36,178.2</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Long-term debt</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">12,523.5</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">11,266.3</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">8,713.3</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">9,487.8</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">7,009.7</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Cash dividends declared per common share</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1.76</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1.60</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1.44</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1.30</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1.18</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
<div style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<hr width="26%" size="1.0PT" noshade="" color="#000000" align="LEFT">


<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">1.</font></dt><dd style="font-family:times;text-align:justify"><font size="2">In
2006, Abbott recorded pre-tax charges of $2,014 for acquired in-process and collaborations research and development primarily
related to the acquisition of Guidant's vascular intervention and endovascular solutions businesses and Kos Pharmaceuticals&nbsp;Inc. </font></dd></dl>
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">27</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=3,SEQ=28,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=47987,FOLIO='27',FILE='DISK114:[11ZAD1.11ZAD42901]DM42901A.;10',USER='ANEETZ',CD='15-FEB-2011;17:48' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_do42901_1_28"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>


<p style="font-family:times;text-align:justify"><font size="2"><a name="do42901_item_7._management_s_discussio__ite03668"> </a>
<a name="toc_do42901_1"> </a></font> <font size="2"><b>  ITEM 7.&nbsp;&nbsp;&nbsp;&nbsp;MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS    <br>    </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="do42901_financial_review"> </a>
<a name="toc_do42901_2"> </a></font> <font size="2"><b>  Financial Review    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott's revenues are derived primarily from the sale of a broad line of health care products under short-term receivable
arrangements. Patent protection and licenses, technological and performance features, and inclusion of Abbott's products under a contract or by a pharmacy benefit manager most impact which products
are sold; price controls, competition and rebates most impact the net selling prices of products; and foreign currency translation impacts the measurement of net sales and costs. Abbott's primary
products are prescription pharmaceuticals, nutritional products, diagnostic testing products and vascular products. Sales in international markets are approximately 55&nbsp;percent of consolidated
net sales. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continued
robust growth of </font><font size="2"><i>HUMIRA</i></font><font size="2"> after the worldwide launch of additional indications, the acquisitions of Solvay's pharmaceuticals
business (Solvay Pharmaceuticals), Piramal Healthcare Limited's Healthcare Solutions business, and Advanced Medical Optics,&nbsp;Inc., the launch of the </font><font size="2"><i>Xience
V</i></font><font size="2"> drug eluting stent, the conclusion of the TAP Pharmaceutical Products&nbsp;Inc. joint venture, the loss of patent protection for some pharmaceutical products, and the
challenging economic environment in many countries around the world have impacted Abbott's sales, costs and financial position over the last three years. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pharmaceutical
research and development is focused on therapeutic areas that include immunology, oncology, neuroscience, pain management, hepatitis C (HCV), chronic kidney disease and
women's health. In 2003, Abbott began the worldwide launch of </font><font size="2"><i>HUMIRA</i></font><font size="2"> for rheumatoid arthritis, followed by launches for five additional indications,
which increased </font><font size="2"><i>HUMIRA's</i></font><font size="2"> worldwide sales to $6.5&nbsp;billion in 2010 compared to $5.5&nbsp;billion in 2009, and $4.5&nbsp;billion in 2008. Abbott
forecasts growth in the low teens for worldwide </font><font size="2"><i>HUMIRA</i></font><font size="2"> sales in 2011. Abbott is studying additional indications for </font> <font size="2"><i>HUMIRA</i></font><font size="2">. Substantial research and
development and selling support has been and continues to be dedicated to maximizing the worldwide potential of </font> <font size="2"><i>HUMIRA</i></font><font size="2">. Increased generic competition has resulted in U.S. </font><font size="2"><i>Depakote</i></font><font size="2"> sales declining from
$1.3&nbsp;billion in 2008 to $161&nbsp;million in 2010. Austerity measures implemented by several European countries reduced healthcare spending and affected pharmaceutical pricing in the second
half of 2010 and that impact is expected to continue for all of 2011. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
February 2010, Abbott acquired Solvay Pharmaceuticals which provided Abbott with a large and complementary portfolio of pharmaceutical products and expanded Abbott's presence in key
global emerging markets. The acquisition added approximately $3.1&nbsp;billion to Abbott's 2010 total sales, primarily outside the U.S. In 2010, Abbott recorded approximately $710&nbsp;million of
expense related to the integration of the Solvay business and a restructuring plan announced in September to streamline operations, improve efficiencies and reduce costs primarily in certain Solvay
sites and functions. The restructuring plan is further described below. In September 2010 Abbott completed the acquisition of Piramal's Healthcare Solutions business, propelling Abbott to market
leadership in the Indian pharmaceutical market and further accelerating the company's growth in emerging markets. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2007, Abbott's nutritional products businesses were reorganized into a worldwide business to better leverage the opportunities available for strong nutritional brands. Significant
efforts have been focused on capturing those opportunities, particularly in developing markets where growth has been strong. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2008, Abbott received FDA approval to market the </font><font size="2"><i>Xience V</i></font><font size="2"> drug eluting stent in the U.S. and in 2006 received European Union approval. </font> <font size="2"><i>Xience V</i></font><font size="2"> became the
market-leading drug eluting stent in the U.S. in the fourth quarter of 2008. In June 2009, </font><font size="2"><i>Xience
PRIME</i></font><font size="2">, Abbott's next generation drug eluting stent, received CE Mark approval and was launched in Europe in August 2009. Abbott received approval to market </font> <font size="2"><i>Xience V</i></font><font size="2"> in Japan in
January 2010 and </font><font size="2"><i>Xience V</i></font><font size="2"> became the market-leading drug eluting stent in Japan in
the second quarter of 2010. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2010, the U.S. government passed health care reform legislation which included an increase in Medicaid rebate rates and the extension of the rebate to drugs provided through Medicaid
managed care </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">28</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=29,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=466639,FOLIO='28',FILE='DISK114:[11ZAD1.11ZAD42901]DO42901A.;11',USER='MBLOUNT',CD='17-FEB-2011;14:47' -->
<a name="page_do42901_1_29"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">organizations
beginning in 2010. The legislation also imposes annual fees to be paid by pharmaceutical manufacturers and medical device companies beginning in 2011 and 2013, respectively, as well as
additional rebates related to the Medicare Part&nbsp;D "donut hole" beginning in 2011. In addition to a one-time charge of approximately $60&nbsp;million to reduce deferred tax assets
associated with retiree health care liabilities related to the Medicare Part&nbsp;D retiree drug subsidy, the legislation negatively impacted Abbott's performance by more than $200&nbsp;million in
2010 and that is expected to increase to more than $400&nbsp;million in 2011. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott's
short- and long-term debt totaled $18.9&nbsp;billion at December&nbsp;31, 2010, largely incurred to finance acquisitions. Operating cash flows in excess of
capital expenditures and cash dividends have partially funded acquisitions over the last three years. At December&nbsp;31, 2010, Abbott's long-term debt rating was AA by Standard and
Poor's Corporation and A1 by Moody's Investors Service. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
April 2008, Abbott and Takeda concluded their TAP Pharmaceutical Products&nbsp;Inc. (TAP) joint venture, evenly splitting the value and assets of the joint venture in a
tax-free exchange. Abbott received TAP's </font><font size="2"><i>Lupron</i></font><font size="2"> business in exchange for Abbott's 50&nbsp;percent ownership in TAP. </font> <font size="2"><i>Lupron's</i></font><font size="2"> U.S. results are included in
the Pharmaceutical Products segment beginning in May 2008. Abbott also receives payments based on specified
development, approval and commercial events being achieved with respect to products retained by Takeda and payments from Takeda based on sales of products retained by Takeda. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2011, Abbott will focus on several key initiatives. In the pharmaceutical business, Abbott will continue to build its global presence, expand its presence in emerging markets and
diversify its sources of growth with the Solvay Pharmaceuticals and Piramal Healthcare Solutions acquisitions. Abbott will
also continue maximizing the market potential for </font><font size="2"><i>HUMIRA</i></font><font size="2">. Pharmaceutical research and development efforts will continue to focus a significant portion
of expenditures on compounds for immunology, oncology, neuroscience, pain management, HCV, chronic kidney disease and women's health. Such compounds include one Phase&nbsp;III compound for multiple
sclerosis, one Phase&nbsp;III compound and three Phase&nbsp;II compounds in oncology, three Phase&nbsp;II compounds targeting HCV, three Phase&nbsp;II compounds targeting Alzheimer's disease
or cognitive disorders of schizophrenia, two Phase&nbsp;II compounds targeting chronic kidney disease, and one Phase&nbsp;II compound each in women's health and pain management. In the vascular
business, Abbott will continue to focus on marketing </font><font size="2"><i>Xience PRIME</i></font><font size="2"> in Europe and other markets, obtaining regulatory review of </font> <font size="2"><i>Xience Nano</i></font><font size="2">, </font><font size="2"><i>Xience PRIME</i></font><font size="2">, and the </font><font size="2"><i>MitraClip</i></font><font size="2"> device in
the U.S. and a limited European roll-out as well as further clinical development of </font><font size="2"><i>ABSORB</i></font><font size="2">, its bioresorbable vascular scaffold (BVS)
device. In the other business segments, Abbott will focus on developing or acquiring differentiated technologies in higher growth segments of those markets. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Critical Accounting Policies  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><i> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sales Rebates</i></font><font size="2"> —&nbsp;&nbsp;Approximately 50&nbsp;percent of Abbott's consolidated gross revenues are subject to various forms of rebates and
allowances that Abbott records as reductions of revenues at the time of sale. Most of these rebates and allowances are in the Pharmaceutical Products segment and the Nutritional Products segment.
Abbott provides rebates to pharmacy benefit management companies, state agencies that administer the federal Medicaid program, insurance companies that administer Medicare drug plans, state agencies
that administer the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC), wholesalers, group purchasing organizations, and other government agencies and private entities.
Rebate amounts are usually based upon the volume of purchases using contractual or statutory prices for a product. Factors used in the rebate calculations include the identification of which products
have been sold subject to a rebate, which customer or government agency price terms apply, and the estimated lag time between sale and payment of a rebate. Using historical trends, adjusted for
current changes, Abbott estimates the amount of the rebate that will be paid, and records the liability as a reduction of gross sales when Abbott records its sale of the product. Settlement of the
rebate generally occurs from two to 24&nbsp;months after sale. Abbott regularly analyzes the historical rebate trends and makes adjustments to reserves for changes in trends and terms of rebate
programs. Rebates and chargebacks </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">29</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=2,SEQ=30,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=538674,FOLIO='29',FILE='DISK114:[11ZAD1.11ZAD42901]DO42901A.;11',USER='MBLOUNT',CD='17-FEB-2011;14:47' -->
<a name="page_do42901_1_30"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;text-align:justify"><font size="2">charged
against gross sales in 2010, 2009 and 2008 amounted to approximately $4.9&nbsp;billion, $4.4&nbsp;billion and $3.8&nbsp;billion, respectively, or 23.1&nbsp;percent, 23.8&nbsp;percent
and 22.8&nbsp;percent, respectively, based on gross sales of approximately $21.1&nbsp;billion, $18.4&nbsp;billion and $16.8&nbsp;billion, respectively, subject to rebate. A
one-percentage point increase in the percentage of rebates to related gross sales would decrease net sales by approximately $211&nbsp;million in 2010. Abbott considers a
one-percentage point increase to be a reasonably likely increase in the percentage of
rebates to related gross sales. Other allowances charged against gross sales were approximately $415&nbsp;million, $414&nbsp;million and $362&nbsp;million for cash discounts in 2010, 2009 and
2008, respectively, and $537&nbsp;million, $456&nbsp;million and $439&nbsp;million for returns in 2010, 2009 and 2008, respectively. Cash discounts are known within 15 to 30&nbsp;days of sale,
and therefore can be reliably estimated. Returns can be reliably estimated because Abbott's historical returns are low, and because sales returns terms and other sales terms have remained relatively
unchanged for several periods. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Management
analyzes the adequacy of ending rebate accrual balances each quarter. In the domestic nutritional business, management uses both internal and external data available to
estimate the level of inventory in the distribution channel. Management has access to several large customers' inventory management data, and for other customers, utilizes data from a third party that
measures time on the retail shelf. These sources allow management to make reliable estimates of inventory in the distribution channel. Except for a transition period before or after a change in the
supplier for the WIC business in a state, inventory in the distribution channel does not vary substantially. Management also estimates the states' processing lag time based on claims data. In
addition, internal processing time is a factor in estimating the accrual. In the WIC business, the state where the sale is made, which is the determining factor for the applicable price, is reliably
determinable. Estimates are required for the amount of WIC sales within each state where Abbott has the WIC business. External data sources utilized for that estimate are participant data from the
U.S. Department of Agriculture (USDA), which administers the WIC program, participant data from some of the states, and internally administered market research. The USDA has been making its data
available for many years. Internal data includes historical redemption rates and pricing data. At December&nbsp;31, 2010, Abbott had the exclusive WIC business in 23 states. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the domestic pharmaceutical business, the most significant charges against gross sales are for Medicaid and Medicare Rebates, Pharmacy Benefit Manager Rebates and Wholesaler
Chargebacks. In order to evaluate the adequacy of the ending accrual balances, management uses both internal and external data to estimate the level of inventory in the distribution channel and the
rebate claims processing lag time. External data sources used to estimate the inventory in the distribution channel include inventory levels periodically reported by wholesalers and third party market
data purchased by Abbott. Management estimates the processing lag time based on periodic sampling of claims data. To estimate the price rebate percentage, systems and calculations are used to track
sales by product by customer and to estimate the contractual or statutory price. Abbott's systems and calculations have developed over time as rebates have become more significant, and Abbott believes
they are reliable. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table is an analysis of the four largest rebate accruals, which comprise approximately 69&nbsp;percent of the consolidated rebate provisions charged against revenues in
2010. Remaining rebate </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">30</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=3,SEQ=31,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=710228,FOLIO='30',FILE='DISK114:[11ZAD1.11ZAD42901]DO42901A.;11',USER='MBLOUNT',CD='17-FEB-2011;14:47' -->
<a name="page_do42901_1_31"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">provisions
charged against gross sales are not significant in the determination of operating earnings. (</font><font size="2"><i>dollars in millions</i></font><font size="2">) </font></p>
 <div style="padding:0pt;position:relative;width:73%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"110%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="110%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="61pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="83pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="83pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="60pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Domestic Pharmaceutical Products </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Domestic<br>
Nutritionals<br>
WIC Rebates </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Medicaid and<br>
Medicare&nbsp;Rebates </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Pharmacy Benefit<br>
Manager Rebates </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Wholesaler<br>
Chargebacks </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Balance at January&nbsp;1, 2008</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">199</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">420</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">237</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">92</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Provisions</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">808</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">556</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">397</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,034</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Payments</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(845</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(681</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(406</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(980</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Balance at December&nbsp;31, 2008</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">162</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">295</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">228</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">146</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Provisions</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">747</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">563</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">505</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,134</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Payments</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(756</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(506</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(494</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(1,120</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Balance at December&nbsp;31, 2009</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">153</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">352</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">239</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">160</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Provisions</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">616</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">899</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">841</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,162</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Payments</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(640</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(617</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(670</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(1,163</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Balance at December&nbsp;31, 2010</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">129</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">634</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">410</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">159</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Historically,
adjustments to prior years' rebate accruals have not been material to net income. Abbott employs various techniques to verify the accuracy of claims submitted to it, and
where possible, works with the organizations submitting claims to gain insight into changes that might affect the rebate amounts. For Medicaid, Medicare and other government agency programs, the
calculation of a rebate involves interpretations of relevant regulations, which are subject to challenge or change in interpretation. </font></p>


<p style="font-family:times;text-align:justify"><font size="2"><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income Taxes</i></font><font size="2"> —&nbsp;&nbsp;Abbott operates in numerous countries where its income tax returns are subject to audits and adjustments. Because Abbott
operates globally, the nature of the audit items are often very complex, and the objectives of the government auditors can result in a tax on the same income in more than one country. Abbott employs
internal and external tax professionals to minimize audit adjustment amounts where possible. In accordance with the accounting rules relating to the measurement of tax contingencies, in order to
recognize an uncertain tax benefit, the taxpayer must be more likely than not of sustaining the position, and the measurement of the benefit is calculated as the largest amount that is more than
50&nbsp;percent likely to be realized upon resolution of the benefit. Application of these rules requires a significant amount of judgment. In the U.S., Abbott's federal income tax returns through
2005 are settled, and the income tax returns for years after 2005 are open. Abbott does not record deferred income taxes on earnings reinvested indefinitely in foreign subsidiaries. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><i> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pension and Post-Employment Benefits</i></font><font size="2"> —&nbsp;&nbsp;Abbott offers pension benefits and post-employment health care to many of
its employees. Abbott engages outside actuaries to assist in the determination of the obligations and costs under these programs. Abbott must develop long-term assumptions, the most
significant of which are the health care cost trend rates, discount rates and the expected return on plan assets. The discount rates used to measure liabilities were determined based on
high-quality fixed income securities that match the duration of the expected retiree benefits. The health care cost trend rates represent Abbott's expected annual rates of change in the
cost of health care benefits and is a forward projection of health care costs as of the measurement date. A difference between the assumed rates and the actual rates, which will not be known for
decades, can be significant in relation to the obligations and the annual cost recorded for these programs. Negative asset returns in 2008 due to poor market conditions and low interest rates have
significantly increased actuarial losses for these plans. At December&nbsp;31, 2010, pretax net actuarial losses and prior service costs and (credits) recognized in Accumulated other comprehensive
income (loss) for Abbott's defined benefit plans and medical and dental plans were losses of $2.9&nbsp;billion and $307 million, respectively. Actuarial losses and gains are amortized over the
remaining service attribution periods of the employees under the corridor method, in accordance with the rules for accounting for post-employment benefits. Differences between the expected
long-term return on plan </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">31</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=4,SEQ=32,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=985652,FOLIO='31',FILE='DISK114:[11ZAD1.11ZAD42901]DO42901A.;11',USER='MBLOUNT',CD='17-FEB-2011;14:47' -->
<a name="page_do42901_1_32"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">assets
and the actual annual return are amortized over a five-year period. Note&nbsp;4 to the consolidated financial statements describes the impact of a one-percentage point
change in the health care cost trend rate; however, there can be no certainty that a change would be limited to only one percentage point. </font></p>


<p style="font-family:times;text-align:justify"><font size="2"><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Valuation of Intangible Assets</i></font><font size="2"> —&nbsp;&nbsp;Abbott has acquired and continues to acquire significant intangible assets that Abbott records at fair
value. Transactions involving the purchase or sale of intangible assets occur with some frequency between companies in the health care field and valuations are usually based on a discounted cash flow
analysis. The discounted cash flow model requires assumptions about the timing and amount of future net cash flows, risk, the cost of capital, terminal
values and market participants. Each of these factors can significantly affect the value of the intangible asset. Abbott engages independent valuation experts who review Abbott's critical assumptions
and calculations for acquisitions of significant intangibles. Abbott reviews definite-lived intangible assets for impairment each quarter using an undiscounted net cash flows approach. If the
undiscounted cash flows of an intangible asset are less than the carrying value of an intangible asset, the intangible asset is written down to its fair value, which is usually the discounted cash
flow amount. Where cash flows cannot be identified for an individual asset, the review is applied at the lowest group level for which cash flows are identifiable. Goodwill and indefinite-lived
intangible assets, which relate to in-process research and development acquired in a business combination, are reviewed for impairment annually or when an event that could result in an
impairment occurs. At December&nbsp;31, 2010, goodwill and intangibles amounted to $15.9&nbsp;billion and $12.2&nbsp;billion, respectively, and amortization expense for intangible assets
amounted to $1.4&nbsp;billion in 2010. There were no impairments of goodwill in 2010, 2009 or 2008. </font></p>


<p style="font-family:times;text-align:justify"><font size="2"><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Litigation</i></font><font size="2"> —&nbsp;&nbsp;Abbott accounts for litigation losses in accordance with FASB Accounting Standards Codification No.&nbsp;450,
"Contingencies." Under ASC No.&nbsp;450, loss contingency provisions are recorded for probable losses at management's best estimate of a loss, or when a best estimate cannot be made, a minimum loss
contingency amount is recorded. These estimates are often initially developed substantially earlier than the ultimate loss is known, and the estimates are refined each accounting period as additional
information becomes known. Accordingly, Abbott is often initially unable to develop a best estimate of loss, and therefore the minimum amount, which could be zero, is recorded. As information becomes
known, either the minimum loss amount is increased, resulting in additional loss provisions, or a best estimate can be made, also resulting in additional loss provisions. Occasionally, a best estimate
amount is changed to a lower amount when events result in an expectation of a more favorable outcome than previously expected. Abbott estimates the range of possible loss to be from approximately
$75&nbsp;million to $115&nbsp;million for its legal proceedings and environmental exposures. Reserves of approximately $95&nbsp;million have been recorded at December&nbsp;31, 2010 for these
proceedings and exposures. These reserves represent management's best estimate of probable loss, as defined by FASB ASC No.&nbsp;450, "Contingencies." </font></p>


<p style="font-family:times;text-align:justify"><font size="2"><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock Compensation</i></font><font size="2"> —&nbsp;&nbsp;Abbott records the fair value of stock options in its results of operations. Since there is no market for trading
employee stock options, management must use a fair value method. There is no certainty that the results of a fair value method would be the value at which employee stock options would be traded for
cash. Fair value methods require management to make several assumptions, the most significant of which are the selection of a fair value model, stock price volatility and the average life of an
option. Abbott has readily available grant-by-grant historical activity for several years in its option administration system that it uses in developing some of its
assumptions. Abbott uses the Black-Scholes model to value stock options. Abbott uses both historical volatility of its stock price and the implied volatility of traded options to develop the
volatility assumptions. Abbott uses the historical grant activity, combined with expectations about future exercise activity, to develop the average life assumptions. Abbott has also used the
historical grant data to evaluate whether certain holders of stock options exercised their options differently than other holders and has not found any differentiating pattern among holders. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">32</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=5,SEQ=33,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=22395,FOLIO='32',FILE='DISK114:[11ZAD1.11ZAD42901]DO42901A.;11',USER='MBLOUNT',CD='17-FEB-2011;14:47' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_dq42901_1_33"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>


<p style="font-family:times;text-align:justify"><font size="2"><b> Results of Operations  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Sales  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table details the components of sales growth by reportable segment for the last three years: </font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="49pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="27pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="36pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="46pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th rowspan="2" style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" rowspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Components of Change % </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th rowspan="2" style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" rowspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Total<br>
% Change </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Price </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Volume </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Exchange </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total Net Sales</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2010 vs. 2009</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
14.3</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
(0.1</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"><br>)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
13.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
1.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2009 vs. 2008</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">4.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(0.1</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">8.3</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(4.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2008 vs. 2007</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">13.9</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1.4</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">9.3</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">3.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total U.S.</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2010 vs. 2009</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
6.8</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
0.7</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
6.1</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
—</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2009 vs. 2008</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">0.4</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(0.3</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">0.7</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2008 vs. 2007</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">10.1</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">3.4</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">6.7</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total International</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2010 vs. 2009</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
20.7</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
(0.8</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"><br>)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
19.3</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
2.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2009 vs. 2008</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">7.7</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">0.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">15.1</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(7.6</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2008 vs. 2007</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">17.8</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(0.5</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">12.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">6.3</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Pharmaceutical Products Segment</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2010 vs. 2009</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
20.7</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
0.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
19.5</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
1.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2009 vs. 2008</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(1.3</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(0.1</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">3.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(4.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2008 vs. 2007</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">14.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1.9</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">9.1</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">3.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Nutritional Products Segment</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2010 vs. 2009</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
4.7</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
1.7</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
1.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
1.8</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2009 vs. 2008</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">7.3</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1.5</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">8.6</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(2.8</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2008 vs. 2007</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">12.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">3.4</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">6.9</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1.9</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Diagnostic Products Segment</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2010 vs. 2009</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
6.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
0.1</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
4.3</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
1.6</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2009 vs. 2008</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">0.1</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1.4</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">3.7</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(5.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2008 vs. 2007</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">13.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1.3</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">6.8</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">5.1</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Vascular Products Segment</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2010 vs. 2009</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
18.6</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
(4.7</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"><br>)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
22.3</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
1.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2009 vs. 2008</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">20.1</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(2.9</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">26.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(3.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2008 vs. 2007</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">34.7</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(4.6</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">35.8</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">3.5</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Worldwide
sales growth in 2010 reflects the acquisition of Solvay's pharmaceuticals business on February&nbsp;15, 2010, unit growth and the positive effect of the relatively weaker
U.S. dollar. Worldwide sales growth in 2009 reflects unit growth and the acquisition of Advanced Medical Optics,&nbsp;Inc. on February&nbsp;25, 2009, partially offset by the negative effect of the
relatively stronger U.S. dollar. Worldwide, U.S. and Pharmaceutical Products segment sales also reflect decreased sales of </font><font size="2"><i>Depakote</i></font><font size="2"> due to generic
competition in 2009. Excluding U.S. </font><font size="2"><i>Depakote</i></font><font size="2"> sales, worldwide sales increased 7.7&nbsp;percent, U.S. sales increased 7.6&nbsp;percent and
Pharmaceutical Products segment sales increased 4.3&nbsp;percent from 2008 to 2009. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">33</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=34,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=703355,FOLIO='33',FILE='DISK114:[11ZAD1.11ZAD42901]DQ42901A.;10',USER='ANEETZ',CD='14-FEB-2011;16:22' -->
<a name="page_dq42901_1_34"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">Worldwide
2008 sales growth reflects unit growth and the positive effect of the relatively weaker U.S. dollar. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
comparison of significant product group sales is as follows. Percent changes are versus the prior year and are based on unrounded numbers. </font></p>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="37pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="37pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="37pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Percent<br>
Change </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Percent<br>
Change </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Percent<br>
Change </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="17" style="font-family:times;" align="CENTER"><font size="1"><b><i>(dollars in millions)</i></b></font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Pharmaceuticals&nbsp;—</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">U.S. Specialty</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
4,596</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
(2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"><br>)</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
4,676</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
(10</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"><br>)</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
5,211</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
20</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">U.S. Primary Care</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">3,010</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(1</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">3,043</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">3,102</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(1</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">International Pharmaceuticals</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">8,287</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">5</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">7,861</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">6</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">7,399</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">23</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Nutritionals&nbsp;—</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">U.S. Pediatric Nutritionals</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
1,208</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
(7</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"><br>)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
1,306</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
3</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
1,268</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
3</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">International Pediatric Nutritionals</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,676</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">9</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,543</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">12</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,374</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">26</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">U.S. Adult Nutritionals</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,345</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">6</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,269</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">9</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,162</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">8</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">International Adult Nutritionals</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,268</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">15</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,106</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">3</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,070</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">13</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Diagnostics&nbsp;—</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Immunochemistry</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
2,904</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
4</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
2,798</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
(2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"><br>)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
2,843</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"><br>
13</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decreased
sales of </font><font size="2"><i>Depakote</i></font><font size="2"> due to generic competition impacted U.S. Specialty product sales in 2010, 2009 and 2008 and lower sales of </font> <font size="2"><i>Zemplar</i></font><font size="2">, </font><font size="2"><i>Kaletra</i></font><font size="2"> and </font><font size="2"><i>Lupron</i></font><font size="2"> affected U.S. Specialty
product sales in 2010. These were partially offset by increased sales of </font><font size="2"><i>HUMIRA</i></font><font size="2"> in all three years and the addition of </font> <font size="2"><i>Lupron</i></font><font size="2"> sales from the conclusion of
the TAP joint venture in April 2008 which increased U.S. Specialty product sales in 2009 and 2008. U.S. sales of
</font><font size="2"><i>HUMIRA</i></font><font size="2"> were $2.8&nbsp;billion, $2.5&nbsp;billion and $2.2&nbsp;billion in 2010, 2009, and 2008, respectively, and U.S. sales of </font> <font size="2"><i>Depakote</i></font><font size="2"> were
$161&nbsp;million, $331&nbsp;million and $1.3&nbsp;billion in 2010, 2009 and 2008, respectively. U.S. Primary Care sales were
impacted by the discontinuation of </font><font size="2"><i>Azmacort</i></font><font size="2"> and generic competition for </font><font size="2"><i>Cardizem LA</i></font><font size="2"> in 2010, by
decreased sales of </font><font size="2"><i>Synthroid</i></font><font size="2"> in 2009 and 2008 and by decreased sales of </font><font size="2"><i>Omnicef</i></font><font size="2"> and </font> <font size="2"><i>Biaxin</i></font><font size="2"> in 2008 due to
generic competition. These were partially offset in all three years by increased sales of </font> <font size="2"><i>Niaspan</i></font><font size="2"> and in 2010 and 2008 by higher </font><font size="2"><i>TriCor/Trilipix</i></font><font size="2"> franchise
sales. Increased sales volume of
</font><font size="2"><i>HUMIRA</i></font><font size="2"> in 2010, 2009 and 2008 favorably impacted International Pharmaceuticals sales, partially offset by decreased sales of clarithromycin.
International sales of </font><font size="2"><i>HUMIRA</i></font><font size="2"> were $3.7&nbsp;billion, $3.0&nbsp;billion and $2.3&nbsp;billion in 2010, 2009 and 2008, respectively. The relatively
weaker dollar increased International Pharmaceutical sales in 2010 and 2008 by 1.9&nbsp;percent and 7.3&nbsp;percent, respectively. The relatively stronger U.S. dollar decreased International
Pharmaceutical sales in 2009 by 8.6&nbsp;percent. International Pediatric Nutritionals sales increases were due primarily to volume growth in developing countries. U.S. Pediatric Nutritionals sales
in 2010 were affected by the voluntary recall of certain Similac-brand powder infant formulas in September 2010. International Adult Nutritionals sales and Immunochemistry sales in 2010 and 2008 were
positively impacted by the effect of the relatively weaker U.S. dollar and were negatively impacted in 2009 by the effect of the relatively stronger U.S. dollar. Abbott has periodically sold product
rights to non-strategic products and has recorded the related gains in net sales in accordance with Abbott's revenue recognition policies as discussed in Note&nbsp;1 to the consolidated
financial statements. Related net sales were approximately $58&nbsp;million, $120&nbsp;million and $111&nbsp;million in 2010, 2009 and 2008, respectively. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
expiration of licenses, patent protection and generic competition can affect the future revenues and operating income of Abbott. There are currently no significant patent or license
expirations in the next three years. Under a license agreement for </font><font size="2"><i>TriCor</i></font><font size="2"> 145 mg, generic competition could begin as early as March 2011 but is not
expected until July 2012. Under an agreement relating to Abbott's niacin products </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">34</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=2,SEQ=35,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=277868,FOLIO='34',FILE='DISK114:[11ZAD1.11ZAD42901]DQ42901A.;10',USER='ANEETZ',CD='14-FEB-2011;16:22' -->
<a name="page_dq42901_1_35"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">and
acquired with the Kos Pharmaceuticals acquisition, </font><font size="2"><i>Niaspan</i></font><font size="2"> may become subject to generic competition in September 2013. </font></p>


<p style="font-family:times;text-align:justify"><font size="2"><b> Operating Earnings  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit margins were 58.3&nbsp;percent of net sales in 2010, 57.1&nbsp;percent in 2009 and 57.3&nbsp;percent in 2008. The
increase in the gross profit margin in 2010 was due, in part, to improved margins in the pharmaceutical, vascular, diabetes and diagnostics businesses and the favorable effect of exchange on the gross
profit margin ratio. The decrease in the gross profit margin in 2009 was due, in part, to the negative impact from lower sales of </font><font size="2"><i>Depakote</i></font><font size="2"> and the
unfavorable effect of exchange on the gross profit margin ratio; partially offset by improved margins in the vascular and diagnostics businesses. The increase in the gross profit margin in 2008 was
due, in part, to favorable product mix and the favorable impact of foreign exchange. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the U.S., states receive price rebates from manufacturers of infant formula under the federally subsidized Special Supplemental Nutrition Program for Women, Infants, and Children.
There are also rebate programs for pharmaceutical products. These rebate programs continue to have a negative effect on the gross profit margins of the Nutritional and Pharmaceutical Products
segments. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research
and development expense was $3.724&nbsp;billion in 2010, $2.744&nbsp;billion in 2009 and $2.689&nbsp;billion in 2008 and represented increases of 35.7&nbsp;percent in
2010, 2.0&nbsp;percent in 2009 and 7.3&nbsp;percent in 2008. Excluding charges related to the Solvay restructurings announced in September 2010, research and development expenses in 2010 increased
29.4&nbsp;percent. This increase, exclusive of the effects of the restructuring charges, reflects the acquisitions of Solvay's pharmaceuticals business in February 2010 and Facet Biotech in April
2010. The increase in 2009 reflects the favorable effect of exchange rates which reduced research and development expense in 2009. Excluding the effect of exchange, research and development expenses
increased 3.4&nbsp;percent in 2009. The increases in 2010, 2009 and 2008 also reflect continued pipeline spending, including programs in vascular devices, biologics, neuroscience, oncology and
hepatitis C. The majority of research and development expenditures are concentrated on pharmaceutical products. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Selling,
general and administrative expenses increased 23.4&nbsp;percent in 2010, decreased 0.4&nbsp;percent in 2009 and increased 13.9&nbsp;percent in 2008. Excluding charges
related to the Solvay restructuring and integration charges, selling, general and administrative expenses in 2010 increased 18.2&nbsp;percent. This increase, exclusive of the effects of the
restructuring and integration charges, reflects the acquisitions of Solvay's pharmaceuticals business in 2010 and Advanced Medical Optics,&nbsp;Inc. in 2009 and higher provisions for litigation in
2010. The 2009 decrease reflects the favorable effect of exchange rates which was offset by expenses relating to the acquisition of Advanced Medical Optics,&nbsp;Inc. and the settlement of
litigation. Excluding the effects of the charges and exchange, selling, general and administrative expenses increased 0.9&nbsp;percent in 2009. The 2008 increase reflects the settlement of
litigation relating to </font><font size="2"><i>TriCor</i></font><font size="2">, which increased selling, general and administration expenses by 3.1&nbsp;percentage points. The remaining increases in
selling, general and administrative expenses were due primarily to increased selling and marketing support for new and existing products, including continued spending for </font> <font size="2"><i>HUMIRA</i></font><font size="2"> and </font><font size="2"><i>Xience V</i></font><font size="2">, and inflation. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Conclusion of TAP Pharmaceutical Products&nbsp;Inc. Joint Venture and Sale of Abbott's Spine Business  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On April&nbsp;30, 2008, Abbott and Takeda concluded their TAP Pharmaceutical Products&nbsp;Inc. (TAP) joint venture, evenly
splitting the value and assets of the joint venture. Abbott exchanged its 50&nbsp;percent equity interest in TAP for the assets, liabilities and employees related to TAP's </font> <font size="2"><i>Lupron</i></font><font size="2"> business. Subsequent to
the conclusion of the joint venture, TAP was merged into two Takeda entities. The exchange of Abbott's investment in TAP
for TAP's </font><font size="2"><i>Lupron</i></font><font size="2"> business resulted in a gain at closing of approximately $94&nbsp;million. The Internal Revenue Service has issued a private letter
ruling that the transaction qualifies as tax-free for U.S. income tax purposes. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">35</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=3,SEQ=36,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=679455,FOLIO='35',FILE='DISK114:[11ZAD1.11ZAD42901]DQ42901A.;10',USER='ANEETZ',CD='14-FEB-2011;16:22' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_ds42901_1_36"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </font></p>

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beginning on May&nbsp;1, 2008, Abbott began recording U.S. </font><font size="2"><i>Lupron</i></font><font size="2"> net sales and costs in its operating results
and no longer records income from the TAP joint venture. TAP's sales of </font><font size="2"><i>Lupron</i></font><font size="2"> were $182&nbsp;million for the four months ended April&nbsp;30, 2008.
Abbott also receives payments based on specified development, approval and commercial events being achieved with respect to products retained by Takeda and payments from Takeda based on sales of
products retained by Takeda, which are recorded by Abbott as Other (income) expense, net when the specified event is achieved or as the applicable sales are made. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
exchange transaction was accounted for as a sale of Abbott's equity interest in TAP and as an acquisition of TAP's </font><font size="2"><i>Lupron</i></font><font size="2"> business.
The sale of Abbott's equity interest in TAP resulted in the recording of net assets related to the </font><font size="2"><i>Lupron</i></font><font size="2"> business, primarily cash, receivables,
inventory and other assets, net of accounts payable and other accrued liabilities, offset by a credit to Abbott's investment in TAP in the amount of approximately $280&nbsp;million. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the acquired </font><font size="2"><i>Lupron</i></font><font size="2"> business, Abbott recorded intangible assets, primarily </font><font size="2"><i>Lupron</i></font><font size="2">
product rights, of approximately $700&nbsp;million, goodwill of approximately $350&nbsp;million and deferred tax liabilities related primarily to the intangible assets of approximately
$260&nbsp;million. The intangible assets are being amortized over 15&nbsp;years. Abbott agreed to remit cash to Takeda if certain research and development events were not achieved on the
development assets retained by Takeda. These amounts were recorded as a liability at closing in the amount of approximately $1.1&nbsp;billion. Related deferred tax assets of approximately
$410&nbsp;million were also recorded. Of the $1.1&nbsp;billion, Abbott made tax-deductible payments of $36&nbsp;million, $83&nbsp;million and $200&nbsp;million in 2010, 2009 and
2008. In 2009 events occurred resulting in the remaining payments not being required and the remaining liability in the amount of $797&nbsp;million was derecognized and recorded as income in Other
(income) expense, net. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2008, Abbott sold its spine business for approximately $360&nbsp;million in cash, resulting in an after-tax gain of approximately $147&nbsp;million which is presented
as Gain on sale of discontinued operations, net of taxes, in the accompanying statement of income. The operations and financial position of the spine business are not presented as discontinued
operations because the effects would not be significant. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Restructurings  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In 2010, Abbott management approved a restructuring plan primarily related to the acquisition of Solvay's pharmaceuticals business.
This plan streamlines operations, improves efficiencies and reduces costs in certain Solvay sites and functions as well as in certain Abbott and Solvay commercial organizations in various countries.
Action plans have been identified and most are expected to be implemented within the next two years. This plan will result in pretax charges of approximately $810&nbsp;million to $970&nbsp;million
over the life of the plan. These charges include employee-related costs of approximately $650&nbsp;million, accelerated depreciation and asset write-downs of approximately $105&nbsp;million, and
other related exit costs of up to approximately $215&nbsp;million, mainly related to discontinuation of certain research and development programs and product transfers. Under this plan, Abbott
recorded charges to Cost of products sold, Research and development and Selling, general and administrative of approximately $99&nbsp;million, $152&nbsp;million and $272&nbsp;million,
respectively. Additional charges of $12&nbsp;million were subsequently recorded primarily for accelerated depreciation. The following summarizes the activity for this restructuring: </font> <font size="2"><i>(dollars in millions)</i></font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="34pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2010 restructuring charge</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">523</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Payments, impairments and other adjustments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(113</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Accrued balance at December&nbsp;31, 2010</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">410</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2010 and prior years, Abbott management approved plans to realign its worldwide pharmaceutical and vascular manufacturing operations and selected domestic and international commercial
and research and development operations in order to reduce costs. In 2010, 2009 and 2008, Abbott recorded charges of approximately $56&nbsp;million, $114&nbsp;million and $36&nbsp;million,
respectively, reflecting the impairment of </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">36</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=37,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=557230,FOLIO='36',FILE='DISK114:[11ZAD1.11ZAD42901]DS42901A.;10',USER='ANEETZ',CD='14-FEB-2011;16:22' -->
<a name="page_ds42901_1_37"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">manufacturing
facilities and other assets, employee severance and other related charges. Approximately $56&nbsp;million in 2010 is classified as Cost of products sold and $114&nbsp;million and
$36&nbsp;million in 2009 and 2008, respectively, are classified as Selling, general and administrative. An additional $13&nbsp;million, $47&nbsp;million and $81&nbsp;million were subsequently
recorded in 2010, 2009 and 2008, respectively, relating to these restructurings, primarily for accelerated depreciation. The following summarizes the activity for these restructurings: </font> <font size="2"><i>(dollars in millions)</i></font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="34pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Accrued balance at January&nbsp;1, 2008</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">194</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2008 restructuring charges</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">36</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Payments, impairments and other adjustments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(125</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Accrued balance at December&nbsp;31, 2008</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">105</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2009 restructuring charges</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">114</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Payments, impairments and other adjustments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(74</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Accrued balance at December&nbsp;31, 2009</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">145</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2010 restructuring charges</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">56</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Payments and other adjustments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(124</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Accrued balance at December&nbsp;31, 2010</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">77</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2008, Abbott management approved a plan to streamline global manufacturing operations, reduce overall costs, and improve efficiencies in Abbott's core diagnostic business. In 2008,
Abbott recorded a charge to Cost of products sold of approximately $129&nbsp;million under the plan. Additional charges of approximately $60&nbsp;million, $54&nbsp;million and $16&nbsp;million
were recorded in 2010, 2009 and 2008, respectively, relating to this restructuring, primarily for accelerated depreciation and product transfer costs. Additional charges will be incurred through 2011
as a result of product re-registration timelines required under manufacturing regulations in a number of countries and product transition timelines. The following summarizes the activity
for this restructuring: </font><font size="2"><i>(dollars in millions)</i></font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="30pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2008 restructuring charge</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">129</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Payments and other adjustments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(19</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Accrued balance at December&nbsp;31, 2008</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">110</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Payments and other adjustments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(12</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Accrued balance at December&nbsp;31, 2009</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">98</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Payments and other adjustments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(10</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Accrued balance at December&nbsp;31, 2010</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">88</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2"><b> Interest expense and Interest (income)  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In 2010, interest expense increased due primarily to increased debt levels. In 2009 and 2008, interest expense decreased primarily as a
result of lower interest rates, partially offset by increased debt levels in 2009 related to the acquisition of Advanced Medical Optics,&nbsp;Inc. Interest income decreased in 2010 due to lower
investment balances, decreased in 2009 due to lower interest rates and increased in 2008 due to higher interest rates. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Other (income) expense, net  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other (income) expense, net, for 2009 includes the derecognition of a contingent liability of $797&nbsp;million associated with the
conclusion of the TAP Pharmaceutical Products&nbsp;Inc. joint venture as discussed above, a $287&nbsp;million gain from the settlement reached between Abbott and Medtronic,&nbsp;Inc. resolving
all outstanding intellectual property litigation between the two parties and income from the recording of certain investments at fair value in connection with business acquisitions. Other (income) </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">37</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=2,SEQ=38,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=899918,FOLIO='37',FILE='DISK114:[11ZAD1.11ZAD42901]DS42901A.;10',USER='ANEETZ',CD='14-FEB-2011;16:22' -->
<a name="page_ds42901_1_38"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">expense,
net, for 2010, 2009 and 2008 also includes ongoing contractual payments from Takeda associated with the conclusion of the TAP joint venture and a gain in 2008 on the sale of an equity
investment accounted for as an available-for-sale investment. In addition, Abbott recorded a gain of approximately $94&nbsp;million in connection with the dissolution of the
TAP joint venture in 2008. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Taxes on Earnings  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The income tax rates on earnings from continuing operations were 19.0&nbsp;percent in 2010, 20.1&nbsp;percent in 2009 and
19.2&nbsp;percent in 2008. As a result of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act which were signed into law in 2010, Abbott recorded a
charge of approximately $60&nbsp;million in 2010 to reduce deferred tax assets associated with retiree health care liabilities related to the Medicare Part&nbsp;D retiree drug subsidy. The tax
rate in 2009 was affected by a higher tax rate applied to the derecognition of a contingent liability associated with the conclusion of the TAP Pharmaceutical Products&nbsp;Inc. joint venture and
the Medtronic intellectual property litigation settlement. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
October 2010, Puerto Rico enacted legislation that assesses a tax beginning in 2011 on certain products manufactured in Puerto Rico. This excise tax will be recorded in Cost of
products sold although the tax is expected to be creditable for U.S. income tax purposes. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Research and Development Programs  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott currently has numerous pharmaceutical, medical and nutritional products in development. The significant areas of therapeutic
focus include the following: </font></p>


<p style="font-family:times;text-align:justify"><font size="2">Pharmaceutical
Products&nbsp;— </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Immunology&nbsp;—
Projects are ongoing to identify new mechanisms with the potential to treat an array of immune-mediated diseases. Projects include early stage work in
oral DMARD therapies and a number of biologic candidates. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Phase&nbsp;III
trials are ongoing for additional indications of </font><font size="2"><i>HUMIRA</i></font><font size="2"> including&nbsp;ulcerative colitis in Japan, ankylosing
spondylitits in China, pediatric Crohn's disease in the U.S. and the European Union (EU), uvetis in the U.S., EU and Japan, and peripheral and axial spondyloarthritis in the U.S. and EU. Global
regulatory applications for&nbsp;ulcerative colitis were submitted in early 2011. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neuroscience/Pain&nbsp;—
Abbott is focused on the development of compounds that target receptors in the brain that help regulate mood, memory and other neurological
functions to address conditions such as Alzheimer's disease, schizophrenia, pain, Parkinson's disease and multiple sclerosis (MS). This includes three compounds directed toward the treatment of
Alzheimer's disease. ABT-126 and ABT-288 are completing Phase&nbsp;II studies in early 2011 and ABT-384 will complete its Phase&nbsp;II study later in 2011.
Daclizumab, a next-generation antibody, entered Phase&nbsp;III clinical trials for relapsing remitting MS in the second quarter of 2010. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Oncology&nbsp;—
Abbott is focused on the development of targeted treatments that inhibit tumor growth and improve response to common cancer therapies. Abbott has new
molecular entities in development for more than a dozen types of cancer including: </font></p>

<ul>
<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">ABT-869, a multi-targeted kinase inhibitor, for which a Phase&nbsp;III trial for liver cancer was initiated
in 2010 and Phase&nbsp;II studies for other cancer types are ongoing.  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">ABT-263, a Bcl-2 family protein antagonist, currently in Phase&nbsp;II development for chronic
lymphoid leukemia.  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">ABT-888, a PARP-inhibitor, is completing Phase&nbsp;II in early 2011. </font></dd></dl>
</ul>
<p style="font-family:times;" align="CENTER"><font size="2">38</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=3,SEQ=39,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=66937,FOLIO='38',FILE='DISK114:[11ZAD1.11ZAD42901]DS42901A.;10',USER='ANEETZ',CD='14-FEB-2011;16:22' -->
<a name="page_ds42901_1_39"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<ul>
<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Elotuzamab under a collaboration agreement acquired as part of the Facet Biotech acquisition in 2010. Abbott expects to
begin Phase&nbsp;III development of elotuzamab for the treatment of multiple myeloma with its partner in 2011. </font></dd></dl>
</ul>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hepatitis
C&nbsp;— Abbott's antiviral program is focused on developing treatments for hepatitis C (HCV) and includes a partnership with Enanta Pharmaceuticals to discover
protease inhibitors as well as internal programs focused on additional viral targets. In 2010, Abbott initiated Phase&nbsp;II clinical trials to evaluate three of Abbott's HCV antiviral agents,
including the investigational protease inhibitor ABT-450, part of the Enanta collaboration. Polymerase inhibitors ABT-333 and ABT-072 as well as
ABT-267, a NS5A inhibitor, are currently being developed exclusively by Abbott. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Women's
Health&nbsp;— In 2010, Abbott entered into a collaboration agreement with Neurocrine to develop and commercialize elagolix, an oral gonadotropin-releasing hormone
(GnRH) antagonist, for the treatment of endometriosis-related pain and fibroids. A Phase&nbsp;II study in endometriosis was recently completed. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chronic
Kidney Disease&nbsp;— In 2010, Abbott entered into an agreement with Reata Pharmaceuticals for ex-U.S. rights, excluding certain Asian markets, to
bardoxolone, an investigational treatment for chronic kidney disease (CKD). A Phase&nbsp;IIb study was recently completed and a global Phase&nbsp;III trial is targeted to begin in 2011. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, new formulations of Abbott's existing pharmaceutical products, including </font><font size="2"><i>Lupron</i></font><font size="2"> 6-month depot and </font> <font size="2"><i>AndroGel</i></font><font size="2"> 1.62%, are currently under FDA review.
Work is also
continuing on numerous early-stage programs, including the biologic acquired from Pangenetics for chronic pain in late 2009, a cMet antibody for cancer in partnership with Pierre Fabre&nbsp;SA, and
other programs across all of Abbott's therapeutic areas of focus. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Vascular&nbsp;—
Ongoing projects in the pipeline include: </font></p>

<ul>
<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2"><i>Xience Nano</i></font><font size="2">, a version of </font><font size="2"><i>Xience
V</i></font><font size="2"> for small vessels, currently under regulatory review in the U.S.  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2"><i>Xience PRIME</i></font><font size="2">, the next-generation drug-eluting
stent (DES) based on </font><font size="2"><i>Xience V</i></font><font size="2"> attributes. Ongoing clinical trials for </font><font size="2"><i>Xience PRIME</i></font><font size="2"> in the U.S. are
evaluating a range of stent sizes, including small vessel and long lengths.  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2"><i>ABSORB</i></font><font size="2">, a bioresorbable vascular scaffold (BVS) device for the treatment
of coronary artery disease that is gradually resorbed into the vessel wall. In 2010 Abbott released four-year data from its </font><font size="2"><i>ABSORB</i></font><font size="2"> clinical
trial, which showed efficacy and safety results consistent with the three-year data. In early 2010, Abbott also initiated the </font><font size="2"><i>ABSORB EXTEND</i></font><font size="2">
clinical trial which will enroll up to 1,000 patients with more complex coronary artery disease. In 2011 after receiving CE Mark approval for </font><font size="2"><i>ABSORB</i></font><font size="2">,
Abbott announced its plans to initiate a randomized, controlled clinical trial later in 2011 to further study the device in an expanded population in Europe. A global trial, including the U.S. and
other geographies, is planned for later this year.  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2"><i>MitraClip</i></font><font size="2"> device for the treatment of mitral
regurgitation&nbsp;— In September 2010, Abbott announced additional data from the EVEREST II (Endovascular Valve Edge-to Edge REpair STudy) trial on the safety and clinical
benefits of the </font><font size="2"><i>MitraClip</i></font><font size="2"> system. Abbott's </font><font size="2"><i>MitraClip</i></font><font size="2"> system which is on the market in Europe is
currently under review for approval by the FDA.  </font> <font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">•</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Coronary and endovascular core product projects, including new coronary and endovascular guide wires, and the </font> <font size="2"><i>Herculink Elite</i></font><font size="2">
stent for renal indication in the U.S., are at various stages of development and/or undergoing regulatory approvals. </font></dd></dl>
</ul>

<p style="font-family:times;text-align:justify"><font size="2">Medical
Optics&nbsp;— Abbott is expanding its proprietary laser platforms into new vision correction applications, including cataract surgery, and is developing new diagnostic
instruments and treatments to improve visual outcomes. Synchrony, a next-generation intraocular lens (IOL) designed to mimic the eye's </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">39</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=4,SEQ=40,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=150751,FOLIO='39',FILE='DISK114:[11ZAD1.11ZAD42901]DS42901A.;10',USER='ANEETZ',CD='14-FEB-2011;16:22' -->
<a name="page_ds42901_1_40"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;text-align:justify"><font size="2">natural
ability to change focus and deliver improved vision at all distances for patients following cataract surgery, is currently under FDA review. Abbott is also developing new products for patients
undergoing cataract surgery, including new intraocular lenses that address astigmatism, a new insertion system to facilitate micro-incision surgery and an ophthalmic viscoelastic for the U.S. market. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Molecular
Diagnostics&nbsp;— Numerous new molecular diagnostic products, including oncology and infectious disease assays as well as improved instrument systems, are
currently under development. An assay to aid in the management of HCV-infected patients undergoing antiviral therapy is currently under U.S. regulatory review. Additional assays to detect
the presence of HIV virus, tuberculosis, and CMV viral load and a test to detect hepatitis B drug resistance in patients are under regulatory review for CE Mark approval. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Core
Laboratory Diagnostics&nbsp;— Abbott is researching dozens of novel biomarkers focusing on areas such as diabetes, infectious disease, and neuroscience disorders and
also has several next generation instrument systems for hematology, immunochemistry and blood screening in development. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diabetes
Care&nbsp;— Abbott is developing new products for diabetes patients including the next generation </font><font size="2"><i>Freestyle</i></font><font size="2"> glucose
monitoring system with new features supporting the insulin-using patient. This new system is currently under regulatory review for CE Mark approval and a filing for FDA approval is expected to be
submitted in 2011. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nutrition&nbsp;—
Abbott is focusing its R&amp;D spend on six benefit platforms that span the pediatric, adult and performance nutrition areas: immunity, cognition, lean body
mass, inflammation, metabolism and tolerance. Numerous new products that build on advances in these benefit platforms are currently under development and are expected to be launched in 2011. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Given
the diversity of Abbott's business, its intention to remain a broad-based healthcare company and the numerous sources for potential future growth, no individual project is expected
to be material to cash flows or results of operations. Factors considered included research and development expenses projected to be incurred for the project (compound or device) over the next year
relative to Abbott's total research and development expenses as well as qualitative factors, such as marketplace perceptions and impact of a new product on Abbott's overall market position. There were
no delays in Abbott's 2010 research and development activities that are expected to have a material impact on operations. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;While
the aggregate cost to complete the numerous pharmaceutical and medical device projects currently in development is expected to be material, the total cost to complete will depend
upon Abbott's ability to successfully complete each project, the rate at which each project advances, and the ultimate timing for completion. Given the potential for significant delays and the high
rate of failure inherent in the research and development of new pharmaceutical and medical device products and technologies, it is not possible to accurately estimate the total cost to complete all
projects currently in development. However, Abbott plans to continue to manage our portfolio of projects to achieve research and development spend equal to approximately 9.5&nbsp;percent to
10&nbsp;percent of sales each year. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Business Combinations, Technology Acquisitions and Related Transactions  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On January&nbsp;1, 2009, Abbott adopted the provisions of SFAS No.&nbsp;141 (revised 2007), "Business Combinations," as codified in
FASB ASC No.&nbsp;805, "Business Combinations." Under ASC No.&nbsp;805, acquired in-process research and development is accounted for as an indefinite-lived intangible asset until
approval or discontinuation rather than as expense. In addition, acquisition costs in connection with an acquisition are expensed rather than added to the cost of an acquisition and the fair value of
contingent consideration at the date of an acquisition is added to the cost of the acquisition. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
September&nbsp;8, 2010, Abbott acquired Piramal Healthcare Limited's Healthcare Solutions business, a leader in the Indian branded generics market, for $2.2&nbsp;billion, in cash,
plus additional payments of $400&nbsp;million annually in 2011, 2012, 2013 and 2014. Abbott recorded a $1.6&nbsp;billion liability for the present </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">40</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=5,SEQ=41,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=837785,FOLIO='40',FILE='DISK114:[11ZAD1.11ZAD42901]DS42901A.;10',USER='ANEETZ',CD='14-FEB-2011;16:22' -->
<a name="page_ds42901_1_41"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">value
of the additional payments at the acquisition date. The acquisition was financed with current cash. The preliminary allocation of the fair value of the acquisition resulted in the recording of
$2.7&nbsp;billion of deductible acquired intangible assets and $1.0&nbsp;billion of deductible goodwill. Acquired intangible assets consist primarily of trade names, customer relationships and
associated rights and will be amortized over an average of 19&nbsp;years. The allocation of the fair value of the acquisition will be finalized when the valuation is completed. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
February 2010, Abbott acquired Solvay's pharmaceuticals business (Solvay Pharmaceuticals) for approximately $6.1&nbsp;billion, in cash, plus additional payments of up to EUR
100&nbsp;million per year if certain sales milestones are met in 2011, 2012 and 2013. Contingent consideration of approximately $290&nbsp;million was recorded based on a preliminary valuation. The
acquisition of Solvay Pharmaceuticals provides Abbott with a large and complementary portfolio of pharmaceutical products and expands Abbott's presence in key global emerging markets. Abbott acquired
control of this business on February&nbsp;15, 2010 and the financial results of the acquired operations are included in these financial statements beginning
on that date. Net sales for the acquired operations for 2010 were approximately $3.1&nbsp;billion. Pretax loss of the acquired operations, including acquisition, integration and restructuring
expenses, for 2010 was approximately $395&nbsp;million. The acquisition was funded with current cash and short-term investments. The preliminary allocation of the fair value of the
acquisition is shown in the table below </font><font size="2"><i>(in billions of dollars)</i></font><font size="2">. The allocation of the fair value of the acquisition will be finalized when the
valuation is completed. </font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="31pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Goodwill, non-deductible</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2.2</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Acquired intangible assets, non-deductible</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4.1</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Acquired in-process research and development, non-deductible</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">0.5</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Acquired net tangible assets</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">0.7</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Deferred income taxes recorded at acquisition</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1.1</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total preliminary allocation of fair value</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">6.4</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquired
intangible assets consist primarily of product rights for currently marketed products and are amortized over 2 to 14&nbsp;years (average of 11&nbsp;years). Acquired
in-process research and development is accounted for as indefinite lived intangible assets until regulatory approval or discontinuation. The net tangible assets acquired consist primarily
of trade accounts receivable of approximately $675&nbsp;million, inventory of approximately $390&nbsp;million, property and equipment of approximately $725&nbsp;million, net of assumed
liabilities, primarily trade accounts payable, accrued compensation and other liabilities. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following unaudited pro forma financial information reflects the consolidated results of operations of Abbott as if the acquisition of Solvay Pharmaceuticals had taken place on
January&nbsp;1, 2010 and January&nbsp;1, 2009. The pro forma information includes adjustments for amortization of intangible assets and fair value adjustments to acquisition-date
inventory as well as acquisition, integration and restructuring expenses. The pro forma financial information is not necessarily indicative
of the results of operations as they would have been had the transaction been effected on the assumed date. (</font><font size="2"><i>in billions of dollars, except per share
amounts</i></font><font size="2">) </font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="32pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="32pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net sales</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">35.8</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">34.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net earnings</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">4.6</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">5.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Diluted earnings per common share</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">2.96</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">3.36</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
March 2010, Abbott acquired STARLIMS Technologies for approximately $100&nbsp;million, in cash, net of cash held by STARLIMS, providing Abbott with leading products and expertise to
build its position in laboratory informatics. A substantial portion of the fair value of the acquisition has been allocated to goodwill and amortizable intangible assets. The allocation of the fair
value of the acquisition will be finalized when the valuation is completed. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">41</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=6,SEQ=42,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=280654,FOLIO='41',FILE='DISK114:[11ZAD1.11ZAD42901]DS42901A.;10',USER='ANEETZ',CD='14-FEB-2011;16:22' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_dt42901_1_42"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In April 2010, Abbott acquired the outstanding shares of Facet Biotech Corporation for approximately $430&nbsp;million, in cash, net of cash held by Facet. The
acquisition enhances Abbott's early- and mid-stage pharmaceutical pipeline, including a biologic for multiple sclerosis and compounds that complement Abbott's oncology program. A
substantial portion of the fair value of the acquisition has been allocated to acquired in-process research and development that is accounted for as an indefinite-lived intangible asset
until regulatory approval or discontinuation. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
February 2009, Abbott acquired the outstanding shares of Advanced Medical Optics,&nbsp;Inc. (AMO) for approximately $1.4&nbsp;billion in cash, net of cash held by AMO. Prior to
the acquisition, Abbott held a small investment in AMO. Abbott acquired AMO to take advantage of increasing demand for vision care technologies due to population growth and demographic shifts and
AMO's premier position in its field. Abbott acquired control of this business on February&nbsp;25, 2009 and the financial results of the acquired operations are included in these financial
statements beginning on that date. The acquisition was financed with long-term debt. The allocation of the fair value of the acquisition is shown in the table below: </font> <font size="2"><i>(dollars in billions)</i></font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="31pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Goodwill, non-deductible</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1.7</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Acquired intangible assets, non-deductible</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">0.9</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Acquired in-process research and development, non-deductible</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">0.2</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Acquired net tangible assets</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">0.4</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Acquired debt</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1.5</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Deferred income taxes recorded at acquisition</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(0.3</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total allocation of fair value</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1.4</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquired
intangible assets consist of established customer relationships, developed technology and trade names and are amortized over 2 to 30&nbsp;years (average of 15&nbsp;years).
Acquired in-process research and development is accounted for as an indefinite-lived intangible asset until regulatory approval or discontinuation. The net tangible assets acquired consist
primarily of trade accounts receivable, inventory, property and equipment and other assets, net of assumed liabilities, primarily trade accounts payable, accrued compensation and other liabilities. In
addition, subsequent to the acquisition, Abbott repaid substantially all of the acquired debt of AMO. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
October 2009, Abbott acquired 100&nbsp;percent of Visiogen,&nbsp;Inc. for $400&nbsp;million, in cash, providing Abbott with a next-generation accommodating
intraocular lens (IOL) technology to address presbyopia for cataract patients. The allocation of the fair value of the acquisition resulted in non-deductible acquired
in-process research and development of approximately $200&nbsp;million which is accounted for as an indefinite-lived intangible asset until regulatory approval or discontinuation,
non-deductible definite-lived intangible assets of approximately $24&nbsp;million and goodwill of approximately $200&nbsp;million. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
October 2009, Abbott acquired Evalve,&nbsp;Inc. for $320&nbsp;million, in cash, plus an additional payment of $90&nbsp;million to be made upon completion of certain regulatory
milestones. Abbott acquired Evalve to obtain a presence in the growing area of non-surgical treatment for structural heart disease. Including a previous investment in Evalve, Abbott has
acquired 100&nbsp;percent of the outstanding shares of Evalve. In connection with the acquisition, the carrying amount of this investment was revalued to fair value resulting in recording
$28&nbsp;million of income, which is reported as Other (income) expense, net. The allocation of the fair value of the acquisition resulted in non-deductible definite-lived intangible
assets of approximately $140&nbsp;million, non-deductible acquired in-process research and development of approximately $220&nbsp;million which is accounted for as an
indefinite-lived intangible asset until regulatory approval or discontinuation, goodwill of approximately $100&nbsp;million and deferred income taxes of approximately $110&nbsp;million. Acquired
intangible assets consist of developed technology and will be amortized over 11&nbsp;years. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
January 2009, Abbott acquired Ibis Biosciences,&nbsp;Inc. (Ibis) for $175&nbsp;million, in cash, to expand Abbott's position in molecular diagnostics for infectious disease.
Including a $40&nbsp;million investment in Ibis </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">42</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=43,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=836363,FOLIO='42',FILE='DISK114:[11ZAD1.11ZAD42901]DT42901A.;15',USER='MBLOUNT',CD='16-FEB-2011;09:21' -->
<a name="page_dt42901_1_43"> </a>


<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">in
2008, Abbott has acquired 100&nbsp;percent of the outstanding shares of Ibis. A substantial portion of the fair value of the acquisition has been allocated to goodwill and amortizable intangible
assets, and acquired in-process research and development which is accounted for as an indefinite-lived intangible asset until regulatory approval or discontinuation. The investment in Ibis
in 2008 resulted in a charge to acquired in-process research and development. In connection with the acquisition, the carrying amount of this investment was revalued to fair value
resulting in recording $33&nbsp;million of income, which is reported as Other (income) expense, net. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
for the acquisition of Solvay Pharmaceuticals, had the above acquisitions taken place on January&nbsp;1 of the previous year, consolidated net sales and income would not have
been significantly different from reported amounts. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2010, Abbott entered into an agreement to acquire licensing rights outside the U.S., excluding certain Asian markets, to a product in development for the treatment of chronic kidney
disease resulting in a charge to acquired in-process research and development of $238&nbsp;million. In addition, Abbott acquired an equity interest of approximately $62&nbsp;million.
In 2011, Abbott expects to acquire an additional equity interest and make milestone and other payments related to the license agreement totaling approximately $300&nbsp;million. In 2010, Abbott also
entered into an agreement to develop and commercialize a product for the treatment of endometriosis resulting in a charge to acquired in-process research and development of
$75&nbsp;million. Additional payments of approximately $500&nbsp;million could be required for the achievement of certain development, regulatory and commercial milestones. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2009, Abbott acquired the global rights to a novel biologic for the treatment of chronic pain for $170&nbsp;million, in cash, resulting in a charge to acquired
in-process research and development. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Goodwill  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At December&nbsp;31, 2010, goodwill recorded as a result of business combinations totaled $15.9&nbsp;billion. Goodwill is reviewed
for impairment annually or when an event that could result in an impairment occurs. The results of the last impairment test indicated that the fair value of each reporting unit was substantially in
excess of its carrying value except for the Medical Optics unit. While the fair value of the Medical Optics business exceeds its carrying value, extended economic pressure particularly in the LASIK
surgery business and longer regulatory approval timelines for products currently under development could result in a valuation in the future where the fair value of the Medical Optics unit has
declined below its carrying value, thereby triggering the requirement to estimate the implied fair value of the goodwill and measure for impairment. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Financial Condition  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Cash Flow  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash from operating activities of continuing operations amounted to $8.7&nbsp;billion, $7.3&nbsp;billion and
$7.0&nbsp;billion in 2010, 2009 and 2008, respectively. $2.0&nbsp;billion of long-term debt to be paid in March and May of 2011 will be funded out of operating cash flow and
borrowings. Abbott funded $525&nbsp;million in 2010, $862&nbsp;million in 2009 and $285&nbsp;million in 2008 to defined pension plans. Abbott expects pension funding for its main domestic
pension plan of $200&nbsp;million annually. Abbott expects annual cash flow from operating activities to continue to exceed Abbott's capital expenditures and cash dividends. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Debt and Capital  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At December&nbsp;31, 2010, Abbott's long-term debt rating was AA by Standard&nbsp;&amp; Poor's Corporation and A1 by
Moody's Investors Service. Abbott has readily available financial resources, including unused lines of credit of $6.7&nbsp;billion that support commercial paper borrowing arrangements of which a
$3.0&nbsp;billion facility </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">43</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=2,SEQ=44,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=699417,FOLIO='43',FILE='DISK114:[11ZAD1.11ZAD42901]DT42901A.;15',USER='MBLOUNT',CD='16-FEB-2011;09:21' -->
<a name="page_dt42901_1_44"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">expires
in October 2012 and a $3.7&nbsp;billion facility expires in 2013. Related compensating balances, which are subject to withdrawal by Abbott at its option, and commitment fees are not
material. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
October 2008, the board of directors authorized the purchase of up to $5&nbsp;billion of Abbott's common shares from time to time. Under this authorization, 14.8&nbsp;million
shares were purchased in 2010 at a cost of approximately $800&nbsp;million, 14.5&nbsp;million shares were purchased in 2009 at a cost of approximately $800&nbsp;million and 146,400 shares were
purchased in 2008 at a cost of approximately $8&nbsp;million. In 2008, Abbott also purchased approximately 19.0&nbsp;million of its common shares at a cost of approximately $1.1&nbsp;billion
under a prior authorization. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
a registration statement filed with the Securities and Exchange Commission in February 2009, Abbott issued $3.0&nbsp;billion of long-term debt in the second quarter
of 2010 that matures in 2015, 2020 and 2040 with interest rates of 2.7&nbsp;percent, 4.125&nbsp;percent and 5.3&nbsp;percent, respectively. Proceeds from this debt were used to pay down
short-term borrowings. Under the February 2009 registration statement, Abbott issued $3.0&nbsp;billion of long-term debt in the first quarter of 2009 that matures in 2019 and
2039 with interest rates of 5.125&nbsp;percent and 6.0&nbsp;percent, respectively. Proceeds from this debt were used to fund the acquisition of Advanced Medical Optics,&nbsp;Inc. and to repay
debt of Advanced Medical Optics,&nbsp;Inc. In addition, Abbott repaid $1&nbsp;billion of long-term notes that were due in 2009 using short-term borrowings. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
connection with the judgment entered by the U.S. District Court for the Eastern District of Texas against Abbott in its litigation with New York University and Centocor,&nbsp;Inc.,
Abbott executed a collaterized escrow agreement in February 2010 with a financial institution to secure the judgment in the event that Abbott's appeal to the federal circuit court is unsuccessful in
overturning the district court's decision. Abbott has deposited approximately $1.87&nbsp;billion with the escrow agent and considers these assets to be restricted. The assets are invested in U.S.
Treasury bills and money market funds per the terms of the agreement. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Working Capital  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Working capital was $5.1&nbsp;billion at December&nbsp;31, 2010, $10.3&nbsp;billion at December&nbsp;31, 2009 and
$5.5&nbsp;billion at December&nbsp;31, 2008. The decrease in working capital in 2010 was due primarily to cash and investments used to acquire Solvay's pharmaceuticals business and Piramal
Healthcare Limited's Healthcare Solutions business. The increase in working capital in 2009 was due primarily to increased levels of cash and investments and the derecognition of a contingent
liability associated with the conclusion of the TAP joint venture; partially offset by increased debt levels. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Capital Expenditures  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures of $1.0&nbsp;billion in 2010, $1.1&nbsp;billion in 2009 and $1.3&nbsp;billion in 2008 were principally for
upgrading and expanding manufacturing, research and development, investments in information technology and administrative support facilities in all segments, and for laboratory instruments placed with
customers. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">44</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=3,SEQ=45,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=995418,FOLIO='44',FILE='DISK114:[11ZAD1.11ZAD42901]DT42901A.;15',USER='MBLOUNT',CD='16-FEB-2011;09:21' -->
<a name="page_dt42901_1_45"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Contractual Obligations  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes Abbott's estimated contractual obligations as of December&nbsp;31, 2010: </font> <font size="2"><i>(dollars in millions)</i></font></p>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="10pt"></td>
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="45pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="47pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="47pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="50pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="14" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Payment Due By Period </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Total </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2011 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2012-2013 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2014-2015 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2016 and<br>
Thereafter </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Long-term debt, including current maturities and future interest payments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">22,549</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,757</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,519</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,358</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">14,915</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Operating lease obligations</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">637</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">129</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">200</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">128</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">180</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Capitalized auto lease obligations</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">90</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">30</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">60</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Purchase commitments (a)</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,737</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,668</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">68</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Other long-term liabilities reflected on the consolidated balance sheet&nbsp;—</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Benefit plan obligations</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,807</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">480</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">413</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,914</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Other</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,333</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3,143</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">777</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">413</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total (b)</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">33,153</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,584</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">6,470</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3,677</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">17,422</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
<div style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(a)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Purchase
commitments are for purchases made in the normal course of business to meet operational and capital expenditure requirements.
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(b)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Unrecognized
tax benefits totaling $2.5&nbsp;billion are excluded from the table above as Abbott is unable to reasonably estimate the period of cash
settlement with the respective taxing authorities on such items. </font></dd></dl>
 </div>
 <p style="font-family:times;text-align:justify"><font size="2"><b> Contingent Obligations  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott has periodically entered into agreements in the ordinary course of business, such as assignment of product rights, with other
companies which has resulted in Abbott becoming secondarily liable for obligations that Abbott was previously primarily liable. Since Abbott no longer maintains a business relationship with the other
parties, Abbott is unable to develop an estimate of the maximum potential amount of future payments, if any, under these obligations. Based upon past experience, the likelihood of payments under these
agreements is remote. In addition, Abbott periodically acquires a business or product rights in which Abbott agrees to pay contingent consideration based on attaining certain thresholds or based on
the occurrence of certain events. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Legislative Issues  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the first quarter 2010, the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act
(collectively referred to herein as "health care reform legislation") were signed into law in the U.S. Health care reform legislation included an increase in the basic Medicaid rebate rate from
15.1&nbsp;percent to 23.1&nbsp;percent and extended the rebate to drugs provided through Medicaid managed care organizations. These Medicaid rebate changes will continue to have a negative effect
on the gross profit margin of the Pharmaceutical Products segment in future quarters. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beginning
in 2013, health care reform legislation will eliminate the federal income tax deduction for prescription drug expenses of retirees for which Abbott receives reimbursement under
the Medicare Part&nbsp;D retiree drug subsidy program. As a result, Abbott recorded a charge of approximately $60&nbsp;million in the first quarter 2010 to reduce deferred tax assets associated
with retiree health care liabilities. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2011, Abbott will begin recording the annual fee imposed by health care reform legislation on companies that sell branded prescription drugs to specified government programs. The
amount of the annual fee will be based on the ratio of certain of Abbott's sales as compared to the total such sales of all </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">45</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=4,SEQ=46,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=331590,FOLIO='45',FILE='DISK114:[11ZAD1.11ZAD42901]DT42901A.;15',USER='MBLOUNT',CD='16-FEB-2011;09:21' -->
<a name="page_dt42901_1_46"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">covered
entities multiplied by a fixed dollar amount specified in the legislation by year. In 2011, additional rebates will be incurred related to the Medicare Part&nbsp;D coverage gap "donut hole."
Beginning in 2013, Abbott will record the 2.3&nbsp;percent excise tax imposed by health care reform legislation on the sale of certain medical devices in the U.S. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott's
primary markets are highly competitive and subject to substantial government regulations throughout the world. Abbott expects debate to continue over the availability, method of
delivery, and payment for health care products and services. It is not possible to predict the extent to which Abbott or the health care industry in general might be adversely affected by these
factors in the future. A more complete discussion of these factors is contained in Item&nbsp;1, Business, and Item&nbsp;1A, Risk Factors, to the Annual Report on Form&nbsp;10-K. </font></p>


<p style="font-family:times;text-align:justify"><font size="2"><b> Private Securities Litigation Reform Act of 1995 — A Caution Concerning Forward-Looking Statements  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Abbott cautions investors that any
forward-looking statements or projections made by Abbott, including those made in this document, are subject to risks and uncertainties that may cause actual results to differ materially from those
projected. Economic, competitive, governmental, technological and other factors that may affect Abbott's operations are discussed in Item&nbsp;1A, Risk Factors, to the Annual Report on
Form&nbsp;10-K. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">46</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=5,SEQ=47,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=751229,FOLIO='46',FILE='DISK114:[11ZAD1.11ZAD42901]DT42901A.;15',USER='MBLOUNT',CD='16-FEB-2011;09:21' -->
<a name="page_dt42901_1_47"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><a name="dt42901_item_7a._quantitative_and_qual__ite02669"> </a>
<a name="toc_dt42901_1"> </a></font> <font size="2"><b>  ITEM 7A.&nbsp;&nbsp;&nbsp;&nbsp;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK    <br>    </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="dt42901_financial_instruments_and_risk_management"> </a>
<a name="toc_dt42901_2"> </a></font> <font size="2"><b>  Financial Instruments and Risk Management    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Market Price Sensitive Investments  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott holds available-for-sale equity securities from strategic technology acquisitions. The market value of
these investments was approximately $75&nbsp;million as of December&nbsp;31, 2010 and 2009. Abbott monitors these investments for other than temporary declines in market value, and charges
impairment losses to income when an other than temporary decline in value occurs. A hypothetical 20&nbsp;percent decrease in the share prices of these investments would decrease their fair value at
December&nbsp;31, 2010 by approximately $15&nbsp;million. (A 20&nbsp;percent decrease is believed to be a reasonably possible near-term change in share prices.) </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Non-Publicly Traded Equity Securities  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott holds equity securities from strategic technology acquisitions that are not traded on public stock exchanges. The carrying value
of these investments was approximately $165&nbsp;million and $78&nbsp;million as of December&nbsp;31, 2010 and 2009, respectively. Except for one equity investment recorded at
$62&nbsp;million, no other individual investment is in excess of $18&nbsp;million. Abbott monitors these investments for other than temporary declines in market value, and charges impairment
losses to income when an other than temporary decline in estimated value occurs. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Interest Rate Sensitive Financial Instruments  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At December&nbsp;31, 2010 and 2009, Abbott had interest rate hedge contracts totaling $7.3&nbsp;billion and $5.5&nbsp;billion,
respectively, to manage its exposure to changes in the fair value of debt due in 2011 through 2020. The effect of these hedges is to change the fixed interest rate to a variable rate. Abbott does not
use derivative financial instruments, such as interest rate swaps, to manage its exposure to changes in interest rates for its investment securities. At December&nbsp;31, 2010, Abbott had
$2.6&nbsp;billion of domestic commercial paper outstanding with an average annual interest rate of 0.27% with an average remaining life of 24&nbsp;days. The fair value of long-term
debt at December&nbsp;31, 2010 and 2009 amounted to $15.7&nbsp;billion and $12.3&nbsp;billion, respectively (average interest rates of 5.2% and 5.3%, respectively) with maturities through 2040.
At December&nbsp;31, 2010 and 2009, the fair value of current and long-term investment securities amounted to approximately $2.1&nbsp;billion. A hypothetical 100-basis
point change in the interest rates would not have a material effect on cash flows, income or market values. (A 100-basis point change is believed to be a reasonably possible
near-term change in rates.) </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Foreign Currency Sensitive Financial Instruments  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott enters into foreign currency forward exchange contracts to manage its exposure to foreign currency denominated intercompany
loans and trade payables and third-party trade payables and receivables. The contracts are marked-to-market, and resulting gains or losses are reflected in income and are
generally offset by losses or gains on the foreign currency exposure being managed. At December&nbsp;31, 2010 and 2009, Abbott held $10.8&nbsp;billion and $7.5&nbsp;billion, respectively, of
such contracts, which mature in the next twelve months. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, certain Abbott foreign subsidiaries enter into foreign currency forward exchange contracts to manage exposures to changes in foreign exchange rates for anticipated
intercompany purchases by those subsidiaries whose functional currencies are not the U.S. dollar. These contracts are designated as cash flow hedges of the variability of the cash flows due to changes
in foreign currency exchange rates and are marked-to-market with the resulting gains or losses reflected in Accumulated other comprehensive income (loss). Gains or losses will
be included in Cost of products sold at the time the </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">47</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=6,SEQ=48,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=509033,FOLIO='47',FILE='DISK114:[11ZAD1.11ZAD42901]DT42901A.;15',USER='MBLOUNT',CD='16-FEB-2011;09:21' -->
<a name="page_dt42901_1_48"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">products
are sold, generally within the next twelve months. At December&nbsp;31, 2010 and 2009, Abbott held $1.3&nbsp;billion and $2.0&nbsp;billion, respectively, of such contracts, which all
mature in the following calendar year. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott
has designated foreign denominated short-term debt of approximately $650&nbsp;million and approximately $575&nbsp;million as of December&nbsp;31, 2010 and 2009,
respectively, as a hedge of the net investment in a foreign subsidiary. Accordingly, changes in the fair value of this debt due to changes in exchange rates are recorded in Accumulated other
comprehensive income (loss), net of tax. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table reflects the total foreign currency forward contracts outstanding at December&nbsp;31, 2010 and 2009: </font><font size="2"><i>(dollars in
millions)</i></font></p>
 <div style="padding:0pt;position:relative;width:57%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"140%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="140%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="45pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="46pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="70pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="42pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="46pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="70pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Contract<br>
Amount </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Weighted<br>
Average<br>
Exchange<br>
Rate </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Fair and<br>
Carrying Value<br>
Receivable/<br>
(Payable) </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Contract<br>
Amount </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Weighted<br>
Average<br>
Exchange<br>
Rate </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Fair and<br>
Carrying Value<br>
Receivable/<br>
(Payable) </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="1"><b>Receive primarily U.S. Dollars<br>
in exchange for<br>
the following currencies:</b></font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="2">Euro</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,803</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1.347</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">16</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,045</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1.482</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(20</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="2">British Pound</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,422</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1.581</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,246</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1.658</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(2</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="2">Japanese Yen</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,256</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">82.7</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(2</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,057</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">89.8</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(46</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="2">Canadian Dollar</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">538</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1.021</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">448</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1.064</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(4</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="2">All other currencies</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,090</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">N/A</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(25</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,714</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">N/A</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(11</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="2">Total</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">12,109</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(5</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">9,510</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(83</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">48</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=7,SEQ=49,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=975896,FOLIO='48',FILE='DISK114:[11ZAD1.11ZAD42901]DT42901A.;15',USER='MBLOUNT',CD='16-FEB-2011;09:21' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_du42901_1_49"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>


<p style="font-family:times;text-align:justify"><font size="2">
<a name="DU42901A_main_toc"></a> </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><a name="du42901_item_8._financial_statements_and_supplementary_data"> </a></font> <font size="2"><b>  ITEM 8.&nbsp;&nbsp;&nbsp;&nbsp;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">
<a name="DU42901_TOC"></a> </font></p>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>
<!-- COMMAND=ADD_START_LINKTABLE -->

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="10pt"></td>
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="25pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Page </b></font></th>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><a href="#ga42901_abbott_laboratories_and_subsid__abb05008"></a><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><a href="#ga42901_abbott_laboratories_and_subsid__abb05008"><font size="2"> </font><font size="2">Consolidated Statement of Earnings</font></a></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><a href="#ga42901_abbott_laboratories_and_subsid__abb05008"><font size="2">50</font></a></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><a href="#gb42901_abbott_laboratories_and_subsid__abb03793"></a><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><a href="#gb42901_abbott_laboratories_and_subsid__abb03793"><font size="2"> </font><font size="2">Consolidated Statement of Cash Flows</font></a></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><a href="#gb42901_abbott_laboratories_and_subsid__abb03793"><font size="2">51</font></a></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><a href="#Balance_sheet"></a><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><a href="#Balance_sheet"><font size="2"> </font><font size="2">Consolidated Balance Sheet</font></a></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><a href="#Balance_sheet"><font size="2">52</font></a></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><a href="#ge42901_abbott_laboratories_and_subsid__abb05260"></a><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><a href="#ge42901_abbott_laboratories_and_subsid__abb05260"><font size="2"> </font><font size="2">Consolidated Statement of Shareholders' Investment</font></a></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><a href="#ge42901_abbott_laboratories_and_subsid__abb05260"><font size="2">54</font></a></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><a href="#The_statedments"></a><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><a href="#The_statedments"><font size="2"> </font><font size="2">Notes to Consolidated Financial Statements</font></a></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><a href="#The_statedments"><font size="2">55</font></a></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><a href="#gm42901_management_report_on_internal___man02570"></a><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><a href="#gm42901_management_report_on_internal___man02570"><font size="2"> </font><font size="2">Management Report on Internal Control Over Financial Reporting</font></a></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><a href="#gm42901_management_report_on_internal___man02570"><font size="2">85</font></a></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><a href="#gn42901_reports_of_independent__gn402342"></a><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><a href="#gn42901_reports_of_independent__gn402342"><font size="2"> </font><font size="2">Reports of Independent Registered Public Accounting Firm</font></a></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><a href="#gn42901_reports_of_independent__gn402342"><font size="2">86</font></a></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
<!-- COMMAND=ADD_END_LINKTABLE -->
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">49</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=50,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=292710,FOLIO='49',FILE='DISK114:[11ZAD1.11ZAD42901]DU42901A.;14',USER='VSTEFAN',CD='14-FEB-2011;04:19' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_ga42901_1_50"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->



<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="ga42901_abbott_laboratories_and_subsid__abb05008"> </a>
<a name="toc_ga42901_1"> </a></font> <font size="2"><b><br>  Abbott Laboratories and Subsidiaries    <br>    <br>    Consolidated Statement of Earnings<br>  (dollars and shares in thousands except per share data)    <br>    </b></font></p>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="10pt"></td>
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="68pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="68pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="68pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Year Ended December&nbsp;31 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net Sales</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">35,166,721</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">30,764,707</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">29,527,552</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Cost of products sold</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">14,665,192</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">13,209,329</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">12,612,022</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Research and development</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3,724,424</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,743,733</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,688,811</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Acquired in-process research and development</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">313,200</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">170,000</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">97,256</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Selling, general and administrative</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">10,376,324</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">8,405,904</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">8,435,624</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total Operating Cost and Expenses</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">29,079,140</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">24,528,966</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">23,833,713</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Operating Earnings</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">6,087,581</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">6,235,741</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,693,839</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Interest expense</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">553,135</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">519,656</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">528,474</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Interest (income)</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(105,453</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(137,779</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(201,229</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">(Income) from the TAP Pharmaceutical Products&nbsp;Inc. joint venture</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(118,997</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net foreign exchange (gain) loss</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(10,924</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">35,584</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">84,244</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Other (income) expense, net</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(62,011</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1,375,494</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(454,939</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Earnings from Continuing Operations Before Taxes</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,712,834</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">7,193,774</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,856,286</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Taxes on Earnings from Continuing Operations</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,086,662</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,447,936</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,122,070</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Earnings from Continuing Operations</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,626,172</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,745,838</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,734,216</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Gain on Sale of Discontinued Operations, net of taxes</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">146,503</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net Earnings</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,626,172</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,745,838</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,880,719</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Basic Earnings Per Common Share&nbsp;—</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Continuing Operations</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2.98</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3.71</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3.06</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Gain on Sale of Discontinued Operations, net of taxes</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">0.10</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net Earnings</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2.98</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3.71</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3.16</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Diluted Earnings Per Common Share&nbsp;—</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Continuing Operations</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2.96</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3.69</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3.03</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Gain on Sale of Discontinued Operations, net of taxes</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">0.09</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net Earnings</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2.96</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3.69</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3.12</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,546,400</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,546,983</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,545,355</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Dilutive Common Stock Options and Awards</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">9,622</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">8,143</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">15,398</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options and Awards</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,556,022</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,555,126</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,560,753</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Outstanding Common Stock Options Having No Dilutive Effect</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">29,403</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">66,189</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">30,579</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">The
accompanying notes to consolidated financial statements are an integral part of this statement. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">50</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=51,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=652241,FOLIO='50',FILE='DISK114:[11ZAD1.11ZAD42901]GA42901A.;13',USER='VSTEFAN',CD='14-FEB-2011;04:11' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_gb42901_1_51"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="gb42901_abbott_laboratories_and_subsid__abb03793"> </a>
<a name="toc_gb42901_1"> </a></font> <font size="2"><b><br>  Abbott Laboratories and Subsidiaries    <br>    <br>    Consolidated Statement of Cash Flows<br>  (dollars in thousands)    <br>    </b></font></p>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="65pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="59pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="59pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Year Ended December&nbsp;31 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Cash Flow From (Used in) Operating Activities of Continuing Operations:</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Net earnings</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,626,172</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,745,838</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,880,719</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Less: Gain on sale of discontinued operations</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 146,503</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Earnings from continuing operations</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 4,626,172</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 5,745,838</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 4,734,216</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Adjustments to reconcile earnings from continuing operations to net cash from operating activities of continuing operations&nbsp;—</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Depreciation</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,207,450</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,210,977</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,051,728</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Amortization of intangible assets</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,416,855</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 878,533</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 787,101</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Derecognition of a contingent liability associated with the conclusion of the TAP Pharmaceutical Products&nbsp;Inc. joint venture</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (797,130</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Share-based compensation</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 387,183</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 366,357</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 347,015</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Gain on dissolution of the TAP Pharmaceutical Products&nbsp;Inc. joint venture</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (94,248</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Acquired in-process research and development</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 313,200</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 170,000</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 97,256</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Investing and financing (gains) losses, net</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 126,337</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 41,967</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 111,238</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Trade receivables</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (394,665</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (387,749</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (948,314</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Inventories</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 139,857</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 230,555</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (257,476</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Prepaid expenses and other assets</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 553,145</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (386,889</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 436,218</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Trade accounts payable and other liabilities</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 572,533</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (374,715</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 569,056</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Income taxes</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (212,086</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 577,416</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 160,830</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Net Cash From Operating Activities of Continuing Operations</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 8,735,981</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 7,275,160</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 6,994,620</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Cash Flow From (Used in) Investing Activities of Continuing Operations:</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Acquisitions of businesses and technologies, net of cash acquired</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (9,433,243</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (2,370,630</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (250,000</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Acquisitions of property and equipment</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (1,015,075</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (1,089,048</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (1,287,724</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Sales of Boston Scientific common stock</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 318,645</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Purchases of investment securities</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (805,932</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (248,970</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (923,937</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Proceeds from sales of investment securities</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 954,361</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 16,306</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 130,586</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Deposit of restricted funds</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (1,870,000</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Other</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (18,426</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (6,368</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (75,061</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Net Cash (Used in) Investing Activities of Continuing Operations</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (12,188,315</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (3,698,710</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (2,087,491</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Cash Flow From (Used in) Financing Activities of Continuing Operations:</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">(Repayments of) proceeds from issuance of short-term debt and other</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (203,854</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 3,217,331</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (324,739</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Proceeds from issuance of long-term debt and debt with maturities over 3&nbsp;months</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 4,000,000</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 3,000,000</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Repayments of long-term debt and debt with maturities over 3&nbsp;months</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (1,673,998</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (2,483,176</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (913,948</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Purchases of common shares</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (866,825</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (826,345</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (1,081,806</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Proceeds from stock options exercised, including income tax benefit</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 328,411</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 508,669</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,008,843</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Dividends paid</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (2,671,475</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (2,414,460</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (2,174,252</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Net Cash (Used in) From Financing Activities of Continuing Operations</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (1,087,741</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,002,019</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (3,485,902</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Effect of exchange rate changes on cash and cash equivalents</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (620,893</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 118,848</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (115,160</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Net cash provided from the sale of discontinued operations</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 349,571</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Net (Decrease) Increase in Cash and Cash Equivalents</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (5,160,968</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 4,697,317</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,655,638</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Cash and Cash Equivalents, Beginning of Year</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 8,809,339</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 4,112,022</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2,456,384</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Cash and Cash Equivalents, End of Year</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3,648,371</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">8,809,339</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,112,022</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">
The accompanying notes to consolidated financial statements are an integral part of this statement. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">51</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=52,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=712414,FOLIO='51',FILE='DISK114:[11ZAD1.11ZAD42901]GB42901A.;14',USER='JMCGUAN',CD='14-FEB-2011;18:20' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_gc42901_1_52"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;text-align:justify"><font size="2">
<a name="Balance_sheet"></a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries  </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Consolidated Balance Sheet<br>
(dollars in thousands)  </b></font></p>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="10pt"></td>
<td style="font-family:times;" width="10pt"></td>
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="68pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="68pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="68pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="3" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>December&nbsp;31 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th colspan="3" style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2"><b>Assets</b></font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Current Assets:</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Cash and cash equivalents</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3,648,371</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">8,809,339</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,112,022</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Investments, primarily time deposits and certificates of deposit</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,803,079</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,122,709</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">967,603</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Restricted funds, primarily U.S. treasury bills</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,872,490</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Trade receivables, less allowances of&nbsp;— 2010: $388,564; 2009:&nbsp;$311,546; 2008: $263,632</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">7,184,034</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">6,541,941</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,465,660</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Inventories:</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Finished products</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,058,735</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,289,280</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,545,950</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Work in process</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">383,580</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">448,487</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">698,140</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Materials</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">746,419</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">527,110</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">531,759</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="3" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total inventories</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3,188,734</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3,264,877</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,775,849</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Deferred income taxes</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3,076,051</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,364,142</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,462,871</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Other prepaid expenses and receivables</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,544,770</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,210,883</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,258,554</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="3" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total Current Assets</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">22,317,529</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">23,313,891</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">17,042,559</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="3" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Investments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">302,049</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,132,866</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,073,736</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="3" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Property and Equipment, at Cost:</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Land</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">648,988</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">546,204</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">509,606</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Buildings</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,334,236</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,010,439</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3,698,861</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Equipment</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">11,813,618</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">11,325,450</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">10,366,267</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Construction in progress</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">577,460</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">604,813</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">613,939</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="3" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">17,374,302</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">16,486,906</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">15,188,673</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Less: accumulated depreciation and amortization</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">9,403,346</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">8,867,417</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">7,969,507</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="3" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net Property and Equipment</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">7,970,956</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">7,619,489</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">7,219,166</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="3" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Intangible Assets, net of amortization</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">12,151,628</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">6,291,989</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,151,106</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Goodwill</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">15,930,077</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">13,200,174</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">9,987,361</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Deferred Income Taxes and Other Assets</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">790,027</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">858,214</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,945,276</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="3" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">59,462,266</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">52,416,623</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">42,419,204</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="3" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">52</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=53,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=672560,FOLIO='52',FILE='DISK114:[11ZAD1.11ZAD42901]GC42901A.;11',USER='ANEETZ',CD='14-FEB-2011;17:58' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_gd42901_1_53"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="gd42901_abbott_laboratories_and_subsid__abb03336"> </a>
<a name="toc_gd42901_1"> </a></font> <font size="2"><b><br>  Abbott Laboratories and Subsidiaries    <br>    <br>    Consolidated Balance Sheet<br>  (dollars in thousands)    <br>    </b></font></p>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="68pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="68pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="68pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>December&nbsp;31 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2"><b>Liabilities and Shareholders' Investment</b></font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Current Liabilities:</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Short-term borrowings</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,349,796</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,978,438</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,691,069</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Trade accounts payable</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,535,759</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,280,542</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,351,436</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Salaries, wages and commissions</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,328,665</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,117,410</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,011,312</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Other accrued liabilities</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">6,014,772</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,363,032</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,216,742</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Dividends payable</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">680,749</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">620,640</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">559,064</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Income taxes payable</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,307,723</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">442,140</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">805,397</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Obligation in connection with conclusion of the TAP Pharmaceutical Products&nbsp;Inc. joint venture</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">36,105</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">915,982</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Current portion of long-term debt</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,044,970</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">211,182</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,040,906</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total Current Liabilities</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">17,262,434</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">13,049,489</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">11,591,908</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Long-term Debt</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">12,523,517</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">11,266,294</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">8,713,327</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Post-employment Obligations and Other Long-term Liabilities</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">7,199,851</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,202,111</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,595,278</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Commitments and Contingencies</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Shareholders' Investment:</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Preferred shares, one dollar par value Authorized&nbsp;— 1,000,000 shares, none issued</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Common shares, without par value Authorized&nbsp;— 2,400,000,000 shares Issued at stated capital amount&nbsp;— Shares: 2010: 1,619,689,876;
2009: 1,612,683,987; 2008: 1,601,580,899</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">8,744,703</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">8,257,873</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">7,444,411</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Common shares held in treasury, at cost&nbsp;— Shares: 2010: 72,705,928; 2009: 61,516,398; 2008: 49,147,968</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(3,916,823</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(3,310,347</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(2,626,404</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Earnings employed in the business</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">18,927,101</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">17,054,027</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">13,825,383</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Accumulated other comprehensive income (loss)</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1,366,846</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">854,074</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1,163,839</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total Abbott Shareholders' Investment</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">22,388,135</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">22,855,627</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">17,479,551</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Noncontrolling Interests in Subsidiaries</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">88,329</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">43,102</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">39,140</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total Shareholders' Investment</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">22,476,464</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">22,898,729</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">17,518,691</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">59,462,266</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">52,416,623</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">42,419,204</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">The
accompanying notes to consolidated financial statements are an integral part of this statement. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">53</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=54,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=707972,FOLIO='53',FILE='DISK114:[11ZAD1.11ZAD42901]GD42901A.;9',USER='VSTEFAN',CD='14-FEB-2011;04:12' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_ge42901_1_54"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->



<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="ge42901_abbott_laboratories_and_subsid__abb05260"> </a>
<a name="toc_ge42901_1"> </a></font> <font size="2"><b><br>  Abbott Laboratories and Subsidiaries    <br>    <br>    Consolidated Statement of Shareholders' Investment<br>  (dollars in thousands except per share data)    <br>    </b></font></p>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="61pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="61pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="61pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Year Ended December&nbsp;31 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Common Shares:</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Beginning of Year Shares: 2010: 1,612,683,987; 2009: 1,601,580,899; 2008: 1,580,854,677</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">8,257,873</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">7,444,411</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">6,104,102</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Issued under incentive stock programs<br>
Shares: 2010: 7,005,889; 2009: 11,103,088; 2008: 20,726,222</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 305,947</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 530,373</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,001,507</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Tax benefit from option shares and vesting of restricted stock awards (no share effect)</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 10,124</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 15,351</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 64,714</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Share-based compensation</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 388,493</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 366,128</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 342,315</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Issuance of restricted stock awards</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (217,734</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (98,390</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (68,227</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">End of Year<br>
Shares: 2010: 1,619,689,876; 2009: 1,612,683,987; 2008: 1,601,580,899</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">8,744,703</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">8,257,873</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">7,444,411</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Common Shares Held in Treasury:</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Beginning of Year<br>
Shares: 2010: 61,516,398; 2009: 49,147,968; 2008: 30,944,537</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(3,310,347</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(2,626,404</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1,213,134</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Private transaction in 2008<br>
Shares purchased: 15,176,500;<br>
Shares issued: 14,870,195</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (378,931</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Issued under incentive stock programs<br>
Shares: 2010: 4,166,200; 2009: 2,477,853; 2008: 1,607,326</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 224,237</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 133,042</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 40,946</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Purchased<br>
Shares: 2010: 15,355,730; 2009: 14,846,283; 2008: 19,504,452</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (830,713</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (816,985</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (1,075,285</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">End of Year<br>
Shares: 2010: 72,705,928; 2009: 61,516,398; 2008: 49,147,968</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(3,916,823</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(3,310,347</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(2,626,404</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Earnings Employed in the Business:</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Beginning of Year</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">17,054,027</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">13,825,383</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">10,805,809</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Net earnings</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 4,626,172</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 5,745,838</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 4,880,719</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Cash dividends declared on common shares (per share&nbsp;— 2010: $1.76; 2009: $1.60; 2008: $1.44)</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (2,731,584</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (2,476,036</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (2,228,776</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Cost of common shares retired in excess of stated capital amount</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (11,055</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (25,040</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (70,590</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Cost of treasury shares issued (above) below market value</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (10,459</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (16,118</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 438,221</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">End of Year</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">18,927,101</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">17,054,027</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">13,825,383</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Accumulated Other Comprehensive Income (Loss):</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Beginning of Year</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">854,074</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1,163,839</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,081,763</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Other comprehensive (loss) income</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (2,220,920</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2,017,913</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (3,245,602</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">End of Year</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1,366,846</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">854,074</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1,163,839</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Comprehensive Income</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,405,252</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">7,763,751</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,635,117</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Noncontrolling Interests in Subsidiaries:</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Beginning of Year</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">43,102</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">39,140</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">45,405</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Noncontrolling Interests' share of income, business combinations, net of distributions and share repurchases</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 45,227</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 3,962</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (6,265</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">End of Year</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">88,329</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">43,102</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">39,140</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">The accompanying notes to consolidated financial statements are an integral part of this statement. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">54</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=55,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=967485,FOLIO='54',FILE='DISK114:[11ZAD1.11ZAD42901]GE42901A.;11',USER='VSTEFAN',CD='14-FEB-2011;04:12' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_gf42901_1_55"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;text-align:justify"><font size="2">
<a name="The_statedments"></a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries  </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note 1 — Summary of Significant Accounting Policies  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NATURE OF BUSINESS — Abbott's principal business is the discovery, development, manufacture and sale of a broad line of health care products. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CONCENTRATION
OF RISK AND GUARANTEES — Due to the nature of its operations, Abbott is not subject to significant concentration risks relating to customers, products or
geographic locations, except that three U.S. wholesalers accounted for 23&nbsp;percent of trade receivables as
of December&nbsp;31, 2010 and 2009, and 27&nbsp;percent of trade receivables as of December&nbsp;31, 2008. Product warranties are not significant. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott
has no material exposures to off-balance sheet arrangements; no special purpose entities; nor activities that include non-exchange-traded contracts
accounted for at fair value. Abbott has periodically entered into agreements in the ordinary course of business, such as assignment of product rights, with other companies which has resulted in Abbott
becoming secondarily liable for obligations that Abbott was previously primarily liable. Since Abbott no longer maintains a business relationship with the other parties, Abbott is unable to develop an
estimate of the maximum potential amount of future payments, if any, under these obligations. Based upon past experience, the likelihood of payments under these agreements is remote. Abbott
periodically acquires a business or product rights in which Abbott agrees to pay contingent consideration based on attaining certain thresholds or based on the occurrence of certain events. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BASIS
OF CONSOLIDATION — The consolidated financial statements include the accounts of the parent company and subsidiaries, after elimination of intercompany transactions.
The accounts of foreign subsidiaries are consolidated as of November&nbsp;30, due to the time needed to consolidate these subsidiaries. In December 2009, a foreign subsidiary acquired certain
technology that was accounted for as acquired in-process research and development. This transaction was recorded in 2009 due to the significance of the amount. No other events occurred
related to these foreign subsidiaries in December 2010, 2009 and 2008 that materially affected the financial position, results of operations or cash flows. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effective
January&nbsp;1, 2009, Abbott adopted SFAS No.&nbsp;160, "Noncontrolling Interests in Consolidated Financial Statements&nbsp;— an amendment of ARB
No.&nbsp;51," as codified in FASB ASC No.&nbsp;810, "Consolidation" and accordingly, noncontrolling interests in subsidiaries are presented as a component of total equity as of December&nbsp;31,
2010, 2009 and 2008. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;USE
OF ESTIMATES — The financial statements have been prepared in accordance with generally accepted accounting principles in the United States and necessarily include
amounts based on estimates and assumptions by management. Actual results could differ from those amounts. Significant estimates include amounts for sales rebates, income taxes, pension and other
post-employment benefits, valuation of intangible assets, litigation, share-based compensation, derivative financial instruments, and inventory and accounts receivable exposures. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;REVENUE
RECOGNITION — Revenue from product sales is recognized upon passage of title and risk of loss to customers. Provisions for discounts, rebates and sales incentives to
customers, and returns and other adjustments are provided for in the period the related sales are recorded. Sales incentives to customers are not material. Historical data is readily available and
reliable, and is used for estimating the amount of the reduction in gross sales. Revenue from the launch of a new product, from an improved version of an existing product, or for shipments in excess
of a customer's normal requirements are recorded when the conditions noted above are met. In those situations, management records a returns reserve for such revenue, if necessary. Sales of product
rights for marketable products are recorded as </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">55</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=56,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=453132,FOLIO='55',FILE='DISK114:[11ZAD1.11ZAD42901]GF42901A.;16',USER='MWEINST',CD='15-FEB-2011;10:21' -->
<a name="page_gf42901_1_56"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>


<p style="font-family:times;text-align:justify"><font size="2"><b> Note 1 — Summary of Significant Accounting Policies (Continued) </b></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">revenue
upon disposition of the rights. Revenue from license of product rights, or for performance of research or selling activities, is recorded over the periods earned. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;INCOME
TAXES — Deferred income taxes are provided for the tax effect of differences between the tax bases of assets and liabilities and their reported amounts in the
financial statements at the enacted statutory rate to be in effect when the taxes are paid. U.S. income taxes are provided on those earnings of foreign subsidiaries which are intended to be remitted
to the parent company. Deferred income taxes are not provided on undistributed earnings reinvested indefinitely in foreign subsidiaries as working capital and plant and equipment. Interest and
penalties on income tax obligations are included in taxes on income. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;EARNINGS
PER SHARE — Effective January&nbsp;1, 2009, Abbott adopted FSP EITF&nbsp;03-6-1, "Determining Whether Instruments Granted in Share-Based
Payment Transactions Are Participating Securities," as codified in FASB ASC No.&nbsp;260, "Earnings Per Share," which requires that unvested restricted stock units and awards that contain
non-forfeitable rights to dividends be treated as participating securities and be included in the computation of earnings per share under the two-class method. Under the
two-class method, net earnings are allocated between common shares and participating securities. Net earnings allocated to common shares in 2010 and 2009 were $4.613&nbsp;billion and
$5.733&nbsp;billion, respectively. Net earnings allocated to common shares in 2008 were not significantly different than net earnings. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;PENSION
AND POST-EMPLOYMENT BENEFITS — Abbott accrues for the actuarially determined cost of pension and post-employment benefits over the service
attribution periods of the employees. Abbott must develop long-term assumptions, the most significant of which are the health care cost trend rates, discount rates and the expected return
on plan assets. Differences between the expected long-term return on plan assets and the actual return are amortized over a five-year period. Actuarial losses and gains are
amortized over the remaining service attribution periods of the employees under the corridor method. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;FAIR
VALUE MEASUREMENTS — For assets and liabilities that are measured using quoted prices in active markets, total fair value is the published market price per unit
multiplied by the number of units held without consideration of transaction costs. Assets and liabilities that are measured using significant other observable inputs are valued by reference to similar
assets or liabilities, adjusted for contract restrictions and other terms specific to that asset or liability. For these items, a significant portion of fair value is derived by reference to quoted
prices of similar assets or liabilities in active markets. For all remaining assets and liabilities, fair value is derived using a fair value model, such as a discounted cash flow model or
Black-Scholes model. Purchased intangible assets are recorded at fair value. The fair value of significant purchased intangible assets is based on independent appraisals. Abbott uses a discounted cash
flow model to value intangible assets. The discounted cash flow model requires assumptions about the timing and amount of future net cash flows, risk, the cost of capital, terminal values and market
participants. Intangible assets, and goodwill and indefinite-lived intangible assets are reviewed for impairment at least on a quarterly and annual basis, respectively. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SHARE-BASED
COMPENSATION — The value of stock options and restricted stock awards and units are amortized over their service period, which could be shorter than the vesting
period if an employee is retirement eligible, with a charge to compensation expense. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;LITIGATION
— Abbott accounts for litigation losses in accordance with FASB ASC No.&nbsp;450, "Contingencies." Under ASC No.&nbsp;450, loss contingency provisions are
recorded for probable losses at </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">56</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=2,SEQ=57,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=571422,FOLIO='56',FILE='DISK114:[11ZAD1.11ZAD42901]GF42901A.;16',USER='MWEINST',CD='15-FEB-2011;10:21' -->
<a name="page_gf42901_1_57"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note 1 — Summary of Significant Accounting Policies (Continued) </b></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">management's
best estimate of a loss, or when a best estimate cannot be made, a minimum loss contingency amount is recorded. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CASH,
CASH EQUIVALENTS AND INVESTMENTS — Cash equivalents consist of time deposits and certificates of deposit with original maturities of three months or less. Investments
in marketable equity securities are classified as available-for-sale and are recorded at fair value with any unrealized holding gains or losses, net of tax, included in
Accumulated other comprehensive income (loss). Investments in equity securities that are not traded on public stock exchanges are recorded at cost. Investments in debt securities are classified as
held-to-maturity, as management has both the intent and ability to hold these securities to maturity, and are reported at cost, net of any unamortized premium or discount.
Income relating to these securities is reported as interest income. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott
reviews the carrying value of investments each quarter to determine whether an other than temporary decline in market value exists. Abbott considers factors affecting the
investee, factors affecting the industry the investee operates in and general equity market trends. Abbott considers the length of time an investment's market value has been below carrying value and
the near-term prospects for recovery to carrying value. When Abbott determines that an other than temporary decline has occurred, the investment is written down with a charge to Other
(income) expense, net. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TRADE
RECEIVABLE VALUATIONS — Accounts receivable are stated at their net realizable value. The allowance against gross trade receivables reflects the best estimate of
probable losses inherent in the receivables portfolio determined on the basis of historical experience, specific allowances for known troubled accounts and other currently available information. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;INVENTORIES
— Inventories are stated at the lower of cost (first-in, first-out basis) or market. Cost includes material and conversion costs. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;PROPERTY
AND EQUIPMENT — Depreciation and amortization are provided on a straight-line basis over the estimated useful lives of the assets. The following table
shows estimated useful lives of property and equipment: </font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="187pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" nowrap="" align="LEFT"><div style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:48pt;"><font size="1"><b>Classification

<!-- COMMAND=ADD_SCROPPEDRULE,48pt -->

 </b></font></div></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Estimated Useful Lives </b></font></th>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Buildings</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 10 to 50&nbsp;years (average 27&nbsp;years)</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Equipment</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 3 to 20&nbsp;years (average 11&nbsp;years)</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;PRODUCT
LIABILITY — Abbott accrues for product liability claims, on an undiscounted basis, when it is probable that a liability has been incurred and the amount of the
liability can be reasonably estimated based on existing information. The liabilities are adjusted quarterly as additional information becomes available. Receivables for insurance recoveries for
product liability claims are recorded as assets, on an undiscounted basis, when it is probable that a recovery will be realized. Prior to 2009, Abbott carried third-party insurance coverage in amounts
that reflect historical loss experience, which did not include coverage for sizable losses. Beginning in 2009, product liability losses are self-insured. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;RESEARCH
AND DEVELOPMENT COSTS — Internal research and development costs are expensed as incurred. Clinical trial costs incurred by third parties are expensed as the
contracted work is performed. Where contingent milestone payments are due to third parties under research and development arrangements, the milestone payment obligations are expensed when the
milestone results are achieved. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">57</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=3,SEQ=58,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=125956,FOLIO='57',FILE='DISK114:[11ZAD1.11ZAD42901]GF42901A.;16',USER='MWEINST',CD='15-FEB-2011;10:21' -->
<a name="page_gf42901_1_58"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;2 — Supplemental Financial Information  </b></font></p>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="10pt"></td>
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;" align="CENTER"><font size="2"><b><i>(dollars in millions)</i></b></font><br></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Long-term Investments:</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Equity securities</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">240</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">153</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">147</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Note receivable from Boston Scientific, 4% interest</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 880</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 865</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Other</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 62</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 100</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 62</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">302</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,133</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,074</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
judgment entered by the U.S. District Court for the Eastern District of Texas against Abbott in its litigation with New York University and Centocor,&nbsp;Inc. requires Abbott to
secure the judgment in the event that its appeal to the Federal Circuit court is unsuccessful in overturning the district court's decision. In 2010, Abbott deposited $1.87&nbsp;billion with an
escrow agent and considers these assets to be restricted. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
(income) expense, net, for 2009 includes the derecognition of a contingent liability of $797&nbsp;million associated with the conclusion of the TAP Pharmaceutical
Products&nbsp;Inc. joint venture as discussed in Note&nbsp;11, a $287&nbsp;million gain from the settlement reached between Abbott and Medtronic,&nbsp;Inc. resolving all outstanding
intellectual property litigation between the two parties and income from the recording of certain investments at fair value in connection with business acquisitions. Other (income) expense, net, for
2010, 2009 and 2008 also includes ongoing contractual payments from Takeda associated with the conclusion of the TAP joint venture and a gain in 2008 on the sale of an equity investment accounted for
as an available-for-sale investment. In addition, Abbott recorded a gain of approximately $94&nbsp;million in connection with the dissolution of the TAP joint venture in
2008. </font></p>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="10pt"></td>
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;" align="CENTER"><font size="2"><b><i>(dollars in millions)</i></b></font><br></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Other Accrued Liabilities:</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Accrued rebates payable to government agencies</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">900</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">641</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">577</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Accrued other rebates (a)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 862</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 668</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 455</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">All other (b)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 4,253</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 3,054</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 3,185</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">6,015</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">4,363</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">4,217</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(a)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Accrued
wholesaler chargeback rebates of </font><font size="2"><b>$</b></font><font size="2">216, $217 and $210 at December&nbsp;31, 2010, 2009 and 2008,
respectively, are netted in trade receivables because Abbott's customers are invoiced at a higher catalog price but only remit to Abbott their contract price for the products. </font></dd></dl>
<p style="font-family:times;" align="CENTER"><font size="2">58</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=4,SEQ=59,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=295208,FOLIO='58',FILE='DISK114:[11ZAD1.11ZAD42901]GF42901A.;16',USER='MWEINST',CD='15-FEB-2011;10:21' -->
<a name="page_gf42901_1_59"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>


<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;2 — Supplemental Financial Information (Continued) </b></font></p>

<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(b)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">2010
includes acquisition consideration payable of $400 related to the acquisition of Piramal Healthcare Limited's Healthcare Solutions business. </font></dd></dl>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="10pt"></td>
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;" align="CENTER"><font size="2"><b><i>(dollars in millions)</i></b></font><br></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Post-employment Obligations and Other Long-term Liabilities:</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Defined benefit pension plans and post-employment medical and dental plans for significant plans</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,425</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,394</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,713</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">All other (c)</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 4,775</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2,808</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,882</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">7,200</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,202</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4,595</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(c)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">2010
includes acquisition consideration payable of $1,150 related to the acquisition of Piramal Healthcare Limited's Healthcare Solutions business. </font></dd></dl>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="44pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="44pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="44pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;" align="CENTER"><font size="2"><b><i>(dollars in millions)</i></b></font><br></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Comprehensive Income, net of tax:</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Foreign currency (loss) gain translation adjustments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(2,291</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,295</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(2,208</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net actuarial (losses) and prior service cost and credits and amortization of net actuarial losses and prior service cost and credits, net of taxes of
$(70) in 2010, $8 in 2009 and $638 in 2008</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (59</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (260</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (987</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Unrealized gains (losses) on marketable equity securities, net of taxes of $(4) in 2009 and $28 in 2008</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 7</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (49</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net adjustments for derivative instruments designated as cash flow hedges</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 129</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (24</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (2</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Other comprehensive (loss) income</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (2,221</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2,018</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (3,246</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net Earnings</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 4,626</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 5,746</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 4,881</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Comprehensive Income</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,405</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">7,764</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,635</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;<br></font></p>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="44pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="44pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="44pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;" align="CENTER"><font size="2"><b><i>(dollars in millions)</i></b></font><br></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Supplemental Accumulated Other Comprehensive Income Information, net of tax:</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Cumulative foreign currency translation (gain) adjustments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(744</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(3,035</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(740</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net actuarial losses and prior service cost and credits</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2,220</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2,161</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,901</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Cumulative unrealized (gains) on marketable equity securities</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (24</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (24</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (17</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Cumulative (gains) losses on derivative instruments designated as cash flow hedges</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (85</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 44</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 20</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;<br></font></p>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;" align="CENTER"><font size="2"><b><i>(dollars in millions)</i></b></font><br></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Supplemental Cash Flow Information:</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Income taxes paid</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">810</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">635</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">772</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Interest paid</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 580</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 514</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 561</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">59</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=5,SEQ=60,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=1038547,FOLIO='59',FILE='DISK114:[11ZAD1.11ZAD42901]GF42901A.;16',USER='MWEINST',CD='15-FEB-2011;10:21' -->
<a name="page_gf42901_1_60"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;2 — Supplemental Financial Information (Continued) </b></font></p>
 
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the acquired </font><font size="2"><i>Lupron</i></font><font size="2"> business in 2008, as discussed in Note&nbsp;11, Abbott recorded intangible assets, primarily </font> <font size="2"><i>Lupron</i></font><font size="2"> product rights, of approximately
$700&nbsp;million, goodwill of approximately $350&nbsp;million and deferred tax liabilities related to the
intangible assets of approximately $260&nbsp;million. Abbott also recorded a liability of approximately $1.1&nbsp;billion relating to an agreement to remit cash to Takeda if certain research and
development events are not achieved on the development assets retained by Takeda. Related deferred tax assets of approximately $410&nbsp;million were also recorded. The sale of Abbott's equity
interest in TAP resulted in the recording of net assets related to the </font><font size="2"><i>Lupron</i></font><font size="2"> business, primarily cash, receivables, inventory and other assets, net of
accounts payable and other accrued liabilities, offset by a credit to Abbott's investment in TAP in the amount of approximately $280&nbsp;million. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;3 — Financial Instruments, Derivatives and Fair Value Measures  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain Abbott foreign subsidiaries enter into foreign currency forward exchange contracts to manage exposures to changes in foreign exchange rates for anticipated intercompany purchases
by those subsidiaries whose functional currencies are not the U.S. dollar. These contracts, totaling $1.3&nbsp;billion, $2.0&nbsp;billion and $129&nbsp;million at December&nbsp;31, 2010, 2009
and 2008, respectively, are designated as cash flow hedges of the variability of the cash flows due to changes in foreign exchange rates and are recorded at fair value. Accumulated gains and losses as
of December&nbsp;31, 2010 will be included in Cost of products sold at the time the products are sold, generally through the next twelve months. The amount of hedge ineffectiveness was not
significant in 2010, 2009 and 2008. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott
enters into foreign currency forward exchange contracts to manage currency exposures for foreign currency denominated third-party trade payables and receivables, and for
intercompany loans and trade accounts payable where the receivable or payable is denominated in a currency other than the functional currency of the entity. For intercompany loans, the contracts
require Abbott to sell or
buy foreign currencies, primarily European currencies and Japanese yen, in exchange for primarily U.S. dollars and other European currencies. For intercompany and trade payables and receivables, the
currency exposures are primarily the U.S. dollar, European currencies and Japanese yen. At December&nbsp;31, 2010, 2009 and 2008, Abbott held $10.8&nbsp;billion, $7.5&nbsp;billion and
$8.3&nbsp;billion, respectively, of such foreign currency forward exchange contracts. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott
has designated foreign denominated short-term debt as a hedge of the net investment in a foreign subsidiary of approximately $650&nbsp;million, $575&nbsp;million
and $585&nbsp;million as of December&nbsp;31, 2010, 2009 and 2008, respectively. Accordingly, changes in the fair value of this debt due to changes in exchange rates are recorded in Accumulated
other comprehensive income (loss), net of tax. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott
is a party to interest rate hedge contracts totaling $7.3&nbsp;billion, $5.5&nbsp;billion and $2.5&nbsp;billion at December&nbsp;31, 2010, 2009 and 2008, respectively, to
manage its exposure to changes in the fair value of fixed-rate debt due 2011 through 2020. These contracts are designated as fair value hedges of the variability of the fair value of
fixed-rate debt due to changes in the long-term benchmark interest rates. The effect of the hedge is to change a fixed-rate interest obligation to a variable rate
for that portion of the debt. Abbott records the contracts at fair value and adjusts the carrying amount of the fixed-rate debt by an offsetting amount. No hedge ineffectiveness was
recorded in income in 2010, 2009 and 2008 for these hedges. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross
unrealized holding gains (losses) on available-for-sale equity securities totaled $40&nbsp;million and $(1) million, respectively, at December&nbsp;31,
2010; $42&nbsp;million and $(3) million, respectively, at December&nbsp;31, 2009 and $55&nbsp;million and $(23) million, respectively, at December&nbsp;31, 2008. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">60</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=6,SEQ=61,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=396832,FOLIO='60',FILE='DISK114:[11ZAD1.11ZAD42901]GF42901A.;16',USER='MWEINST',CD='15-FEB-2011;10:21' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_gg42901_1_61"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries  </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued)  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;3&nbsp;— Financial Instruments, Derivatives and Fair Value Measures (Continued)  </b></font></p>


<p style="font-family:times;text-align:justify"><font size="2">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes the amounts and location of certain derivative financial instruments as of December&nbsp;31: </font></p>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="1">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="8pt"></td>
<td style="font-family:times;" width="28%"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="25pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="25pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="25pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="18%"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="25pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="25pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="25pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="18%"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="10" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Fair Value — Assets </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="10" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Fair Value — Liabilities </b></font></th>
</tr>
<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Balance Sheet Caption </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Balance Sheet Caption </b></font></th>
</tr>
<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="21" style="font-family:times;" align="CENTER"><font size="1"><b><i>(dollars in millions)</i></b></font><br></th>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Interest rate swaps designated as fair value hedges</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1">138</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1">80</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1">170</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1"> Deferred income taxes and other assets</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1">36</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1">218</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1">—</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1"> Post-employment obligations and other long-term liabilities</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Interest rate swaps designated as fair value hedges</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1"> 8</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1"> Other prepaid expenses and receivables</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1"> n/a</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;" valign="TOP"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Foreign currency forward exchange contracts —</font></p></td>
<td style="font-family:times;" valign="TOP"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Hedging instruments</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1"> 16</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1"> Other prepaid expenses</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1"> 10</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1"> 27</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1"> 7</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1"> Other accrued liabilities</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;" valign="TOP"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Others not designated as hedges</font></p></td>
<td style="font-family:times;" valign="TOP"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 109</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 31</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 148</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> and receivables</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 120</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 87</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 93</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;" valign="TOP"><p style="font-family:times;margin-top:9pt;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Debt designated as a hedge of net investment in a foreign subsidiary</font></p></td>
<td style="font-family:times;" valign="TOP"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"><br>
—</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"><br>
—</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"><br>
—</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;" align="left"><font size="1"> </font><font size="1"> n/a</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"><br>
650</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"><br>
575</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"><br>
585</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;" align="left"><font size="1"> </font><font size="1"> Short-term borrowings</font></p></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;">&nbsp;</td>
<td style="font-family:times;">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1">271</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1">111</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1">318</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1">816</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1">907</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1">685</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;">&nbsp;</td>
<td style="font-family:times;">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes the activity for foreign currency forward exchange contracts designated as cash flow hedges, debt designated as a
hedge of net investment in a foreign subsidiary and the amounts and location of income (expense) and gain (loss) reclassified into income and for certain other derivative financial instruments. The
amount of hedge ineffectiveness was not significant in 2010, 2009 and 2008 for these hedges. </font></p>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="1">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="36%"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="23pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="28pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="28pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="23pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="25pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="21pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="24%"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Gain (loss) Recognized in<br>
Other Comprehensive<br>
Income (loss) </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Income (expense) and Gain (loss) Reclassified into Income </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Income Statement Caption </b></font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="17" style="font-family:times;" align="CENTER"><font size="1"><b><i>(dollars in millions)</i></b></font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="TOP"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Foreign currency forward exchange contracts designated as cash flow hedges</font></p></td>
<td style="font-family:times;" valign="TOP"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">170</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">(65</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">(7</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">63</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">(64</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">(8</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1"> Cost of products sold</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;" valign="TOP"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Debt designated as a hedge of net investment in a foreign subsidiary</font></p></td>
<td style="font-family:times;" valign="TOP"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> (75</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 15</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> (212</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> n/a</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="TOP"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Interest rate swaps designated as fair value hedges</font></p></td>
<td style="font-family:times;" valign="TOP"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> n/a</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> n/a</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> n/a</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 248</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> (309</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 195</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> Interest expense</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Foreign currency forward exchange contracts not designated as hedges</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1"> n/a</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1"> n/a</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1"> n/a</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1"> 155</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1"> (106</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="1"> 292</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="1"> Net foreign exchange (gain) loss</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The interest rate swaps are designated as fair value hedges of the variability of the fair value of fixed-rate debt due to changes in
the long-term benchmark interest rates. The hedged debt is marked to market, offsetting the effect of marking the interest rate swaps to market. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
carrying values and fair values of certain financial instruments as of December&nbsp;31 are shown in the table below. The carrying values of all other financial instruments
approximate their estimated fair </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">61</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=62,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=99460,FOLIO='61',FILE='DISK114:[11ZAD1.11ZAD42901]GG42901A.;21',USER='EYOUNG',CD='18-FEB-2011;08:38' -->
<a name="page_gg42901_1_62"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;3&nbsp;— Financial Instruments, Derivatives and Fair Value Measures (Continued) </b></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">values.
The counterparties to financial instruments consist of select major international financial institutions. Abbott does not expect any losses from nonperformance by these counterparties. </font></p>
 <div style="padding:0pt;position:relative;width:73%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="1">


<!-- COMMAND=ADD_TABLEWIDTH,"110%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="110%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="8pt"></td>
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="42pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="41pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="42pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="41pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="42pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="41pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="5" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="5" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="5" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Carrying<br>
Value </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Fair<br>
Value </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Carrying<br>
Value </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Fair<br>
Value </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Carrying<br>
Value </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Fair<br>
Value </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="17" style="font-family:times;" align="CENTER"><font size="1"><b><i>(dollars in millions)</i></b></font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Long-term Investments:</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Available-for-sale equity securities</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">240</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">240</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">153</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">153</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">147</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">147</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Note receivable</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 880</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 925</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 865</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 824</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Other</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 62</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 43</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 100</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 79</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 62</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 56</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Total Long-term Debt</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> (14,568</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> (15,723</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> (11,477</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> (12,304</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> (9,754</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> (10,458</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Foreign Currency Forward Exchange Contracts:</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Receivable position</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 125</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 125</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 31</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 31</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 148</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 148</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">(Payable) position</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> (130</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> (130</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> (114</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> (114</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> (100</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> (100</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Interest Rate Hedge Contracts:</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Receivable position</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 146</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 146</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 80</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 80</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 170</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 170</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">(Payable) position</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> (36</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> (36</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> (218</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> (218</font></td>
<td style="font-family:times;"><font size="1">)</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">62</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=2,SEQ=63,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=429599,FOLIO='62',FILE='DISK114:[11ZAD1.11ZAD42901]GG42901A.;21',USER='EYOUNG',CD='18-FEB-2011;08:38' -->
<a name="page_gg42901_1_63"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;3&nbsp;— Financial Instruments, Derivatives and Fair Value Measures (Continued) </b></font></p>
 
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis in the balance sheet: </font></p>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="1">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="8pt"></td>
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="59pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="70pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="81pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="64pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Basis of Fair Value Measurement </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Outstanding<br>
Balances </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Quoted<br>
Prices in<br>
Active&nbsp;Markets </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Significant&nbsp;Other<br>
Observable<br>
Inputs </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Significant<br>
Unobservable<br>
Inputs </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="11" style="font-family:times;" align="CENTER"><font size="1"><b><i>(dollars in millions)</i></b></font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">December 31, 2010:</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Equity securities</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">75</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">75</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">—</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">—</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Interest rate swap financial instruments</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 146</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 146</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Foreign currency forward exchange contracts</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 125</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 125</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Total Assets</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">346</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">75</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">271</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">—</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Fair value of hedged long-term debt</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">7,444</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">—</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">7,444</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">—</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Interest rate swap financial instruments</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 36</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 36</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Foreign currency forward exchange contracts</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 130</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 130</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Contingent consideration related to business combinations</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 365</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 365</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Total Liabilities</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">7,975</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">—</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">7,610</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">365</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">December&nbsp;31, 2009:</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Equity and other securities</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">104</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">75</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">—</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">29</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Interest rate swap financial instruments</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 80</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 80</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Foreign currency forward exchange contracts</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 31</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 31</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Total Assets</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">215</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">75</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">111</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">29</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Fair value of hedged long-term debt</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">5,362</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">—</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">5,362</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">—</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Interest rate swap financial instruments</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 218</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 218</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Foreign currency forward exchange contracts</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 114</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 114</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Total Liabilities</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">5,694</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">—</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">5,694</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">—</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">December&nbsp;31, 2008:</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Equity and other securities</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">144</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">105</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">10</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">29</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Interest rate swap financial instruments</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 170</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 170</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Foreign currency forward exchange contracts</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 148</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 148</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Total Assets</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">462</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">105</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">328</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">29</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Fair value of hedged long-term debt</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">2,670</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">—</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">2,670</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">—</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Foreign currency forward exchange contracts</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 100</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 100</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> —</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Total Liabilities</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">2,770</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">—</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">2,770</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">—</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The fair value of the debt was determined based on the face value of the debt adjusted for the fair value of the interest rate swaps, which is
based on a discounted cash flow analysis. The fair value of the contingent consideration was determined based on an independent appraisal adjusted for the time value of money. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">63</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=3,SEQ=64,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=608067,FOLIO='63',FILE='DISK114:[11ZAD1.11ZAD42901]GG42901A.;21',USER='EYOUNG',CD='18-FEB-2011;08:38' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_gh42901_1_64"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries  </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued)  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;4&nbsp;— Post-Employment Benefits  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retirement plans consist of defined benefit, defined contribution and medical and dental plans. Information for Abbott's major defined benefit plans and post-employment
medical and dental benefit plans is as follows: (</font><font size="2"><i>dollars in millions</i></font><font size="2">) </font></p>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="40pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="40pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="40pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="40pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="40pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="40pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Defined Benefit Plans </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Medical and<br>
Dental Plans </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Projected benefit obligations, January&nbsp;1</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">6,852</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,541</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,783</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,705</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,443</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,514</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Service cost&nbsp;— benefits earned during the year</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 288</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 221</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 233</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 60</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 45</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 43</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Interest cost on projected benefit obligations</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 421</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 368</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 353</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 101</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 94</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 92</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Losses (gains), primarily changes in discount rates, plan design changes, law changes and differences between actual and estimated health care
costs</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 565</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 747</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (278</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (153</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 175</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (158</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Benefits paid</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (289</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (251</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (241</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (74</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (58</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (68</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Acquisition of Solvay's pharmaceuticals business</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,045</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 28</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Other, primarily foreign currency translation</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (276</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 226</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (309</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 6</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 6</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 20</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Projected benefit obligations, December&nbsp;31</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">8,606</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">6,852</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,541</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,673</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,705</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,443</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Plans' assets at fair value, January&nbsp;1</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,812</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3,997</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,667</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">341</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">266</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">307</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Actual return on plans' assets</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 782</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,096</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (1,568</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 55</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 62</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (106</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Company contributions</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 525</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 862</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 285</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 74</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 71</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 133</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Benefits paid</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (289</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (251</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (241</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (74</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (58</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (68</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Acquisition of Solvay's pharmaceuticals business</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 763</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Other, primarily foreign currency translation</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (142</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 108</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (146</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Plans' assets at fair value, December&nbsp;31</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">7,451</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,812</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3,997</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">396</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">341</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">266</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Projected benefit obligations greater than plans' assets, December&nbsp;31</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1,155</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1,040</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1,544</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1,277</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1,364</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1,177</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Long-term assets</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">27</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">21</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">16</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Short-term liabilities</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (34</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (31</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (24</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Long-term liabilities</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (1,148</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (1,030</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (1,536</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (1,277</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (1,364</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (1,177</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Net liability</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1,155</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1,040</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1,544</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1,277</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1,364</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1,177</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Amounts Recognized in Accumulated Other Comprehensive Income (loss):</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Actuarial losses, net</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,879</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,699</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,554</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">713</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">685</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">587</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Prior service cost (credits)</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 30</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 34</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 38</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (406</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (184</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (206</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Total</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,909</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,733</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,592</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">307</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">501</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">381</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The projected benefit obligations for non-U.S. defined benefit plans was $3.0&nbsp;billion, $2.0&nbsp;billion and
$1.3&nbsp;billion at December&nbsp;31, 2010, 2009 and 2008, respectively. The accumulated benefit obligations for all defined benefit plans was $7.5&nbsp;billion, $5.8&nbsp;billion and
$4.7&nbsp;billion at December&nbsp;31, 2010, 2009 and 2008, respectively. For plans where the accumulated benefit obligations exceeded plan assets at December&nbsp;31, 2010, 2009 and 2008, the
aggregate accumulated benefit obligations were $2.0&nbsp;billion, $1.5&nbsp;billion and </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">64</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=65,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=56217,FOLIO='64',FILE='DISK114:[11ZAD1.11ZAD42901]GH42901A.;20',USER='VSTEFAN',CD='14-FEB-2011;04:12' -->
<a name="page_gh42901_1_65"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>


<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;4&nbsp;— Post-Employment Benefits (Continued) </b></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">$4.2&nbsp;billion,
respectively; the projected benefit obligations were $2.2&nbsp;billion, $1.8&nbsp;billion and $4.8&nbsp;billion, respectively; and the aggregate plan assets were
$1.1&nbsp;billion, $780&nbsp;million and $3.3&nbsp;billion, respectively. </font></p>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="34pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="34pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="34pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="30pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="30pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="30pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Defined Benefit Plans </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Medical and Dental Plans </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="17" style="font-family:times;" align="CENTER"><font size="1"><b><i>(dollars in millions)</i></b></font><br></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Service cost&nbsp;— benefits earned during the year</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">288</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">221</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">233</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">60</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">45</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">43</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Interest cost on projected benefit obligations</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 421</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 368</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 353</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 101</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 94</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 92</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Expected return on plans' assets</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (571</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (506</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (487</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (31</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (24</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (33</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Amortization of actuarial losses</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 136</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 52</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 34</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 38</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 30</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 29</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Amortization of prior service cost (credits)</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 4</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 4</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 4</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (22</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (22</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (21</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total cost</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">278</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">139</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">137</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">146</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">123</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">110</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
comprehensive income (loss) for 2010 includes amortization of actuarial losses and prior service cost of $136&nbsp;million and $4&nbsp;million, respectively, and net actuarial
losses of $305&nbsp;million for defined benefit plans and amortization of actuarial losses and prior service credits of $38&nbsp;million and $22&nbsp;million, respectively, and net actuarial
gains of $177&nbsp;million for medical and dental plans. Other comprehensive income (loss) for 2009 includes amortization of actuarial losses and prior service cost of $52&nbsp;million and
$4&nbsp;million, respectively, and net actuarial losses of $197&nbsp;million for defined benefit plans and amortization of actuarial losses and prior service credits of $30&nbsp;million and
$22&nbsp;million, respectively, and net actuarial losses of $128&nbsp;million for medical and dental plans. Other comprehensive income (loss) for 2008 includes amortization of actuarial losses and
prior service cost of $34&nbsp;million and $4&nbsp;million, respectively, and net actuarial losses of $1.6&nbsp;billion for defined benefit plans and amortization of
actuarial losses and prior service credits of $29&nbsp;million and $21&nbsp;million, respectively, and net actuarial gains of $19&nbsp;million for medical and dental plans. The pretax amount of
actuarial losses and prior service cost (credits) included in Accumulated other comprehensive income (loss) at December&nbsp;31, 2010 that is expected to be recognized in the net periodic benefit
cost in 2011 is $174&nbsp;million and $4&nbsp;million, respectively, for defined benefit pension plans and $43&nbsp;million and $(41) million, respectively, for medical and dental plans. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
weighted average assumptions used to determine benefit obligations for defined benefit plans and medical and dental plans are as follows: </font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="31pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="31pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="31pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Discount rate</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 5.4</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 5.8</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 6.7</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Expected aggregate average long-term change in compensation</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 5.1</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 5.2</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 4.3</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
weighted average assumptions used to determine the net cost for defined benefit plans and medical and dental plans are as follows: </font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="31pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="31pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="31pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Discount rate</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 5.8</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 6.7</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 6.2</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Expected return on plan assets</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 7.8</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 8.2</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 8.4</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Expected aggregate average long-term change in compensation</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 4.9</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 4.3</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 4.2</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">65</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=2,SEQ=66,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=557475,FOLIO='65',FILE='DISK114:[11ZAD1.11ZAD42901]GH42901A.;20',USER='VSTEFAN',CD='14-FEB-2011;04:12' -->
<a name="page_gh42901_1_66"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;4&nbsp;— Post-Employment Benefits (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
assumed health care cost trend rates for medical and dental plans at December&nbsp;31 were as follows: </font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="41pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="41pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="41pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Health care cost trend rate assumed for the next year</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 7</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 7</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 7</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Rate that the cost trend rate gradually declines to</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 5</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 5</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 5</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Year that rate reaches the assumed ultimate rate</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2016</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2016</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2012</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
discount rates used to measure liabilities were determined based on high-quality fixed income securities that match the duration of the expected retiree benefits. The
health care cost trend rates represent Abbott's expected annual rates of change in the cost of health care benefits and is a forward projection of health care costs as of the measurement date. A
one-percentage point increase/(decrease) in the assumed health care cost trend rate would increase/(decrease) the accumulated post-employment benefit obligations as of
December&nbsp;31, 2010, by $240&nbsp;million /$(194)&nbsp;million, and the total of the service and interest cost components of net post-employment health care cost for the year then
ended by approximately $30&nbsp;million /$(23) million. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">66</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=3,SEQ=67,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=793176,FOLIO='66',FILE='DISK114:[11ZAD1.11ZAD42901]GH42901A.;20',USER='VSTEFAN',CD='14-FEB-2011;04:12' -->
<a name="page_gh42901_1_67"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;4&nbsp;— Post-Employment Benefits (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table summarizes the bases used to measure defined benefit plans' assets at fair value: </font></p>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="10pt"></td>
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="59pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="70pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="81pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="64pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Basis of Fair Value Measurement </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Outstanding<br>
Balances </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Quoted<br>
Prices in<br>
Active Markets </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Significant Other<br>
Observable<br>
Inputs </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Significant<br>
Unobservable<br>
Inputs </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="11" style="font-family:times;" align="CENTER"><font size="1"><b><i>(dollars in millions)</i></b></font><br></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">December&nbsp;31, 2010:</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Equities:</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">U.S. large cap (a)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,523</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,499</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">24</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">U.S. mid cap (b)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 437</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 162</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 275</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">International (c)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 1,552</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 758</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 794</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Fixed income securities:</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">U.S. government securities (d)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 793</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 355</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 438</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Corporate debt instruments&nbsp;(e)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 524</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 237</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 286</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 1</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Non-U.S. government securities (f)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 758</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 172</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 586</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Other (g)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 40</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 20</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 19</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 1</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Absolute return funds (h)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 1,426</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 258</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 582</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 586</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Commodities (i)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 242</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 5</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 234</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 3</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Other (j)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 156</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 156</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="TOP" bgcolor="White">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">7,451</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">3,622</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">3,238</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">591</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">December&nbsp;31, 2009:</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Equities:</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">U.S. large cap (a)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,267</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,247</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">20</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">U.S. mid cap (b)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 339</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 105</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 234</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">International (c)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 1,186</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 455</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 731</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Fixed income securities:</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">U.S. government securities (d)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 753</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 321</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 430</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Corporate debt instruments&nbsp;(e)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 478</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 203</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 272</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 3</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Non-U.S. government securities (f)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 346</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 163</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 183</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Other (g)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 46</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 21</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 23</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Absolute return funds (h)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 1,296</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 237</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 536</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 523</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Other (j)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 101</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 74</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 27</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">5,812</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">2,826</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">2,456</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">530</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(a)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">A
mix of index funds that track the S&amp;P&nbsp;500 (45&nbsp;percent in 2010 and 40&nbsp;percent in 2009) and separate actively managed equity accounts
that are benchmarked to the Russell 1000 (55&nbsp;percent in 2010 and 60&nbsp;percent in 2009).
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(b)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">A
mix of index funds (75&nbsp;percent) and separate actively managed equity accounts (25&nbsp;percent) that track or are benchmarked to the
S&amp;P&nbsp;400 midcap index.
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(c)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Primarily
separate actively managed pooled investment accounts that are benchmarked to the MSCI and MSCI emerging market indices. </font></dd></dl>
<p style="font-family:times;" align="CENTER"><font size="2">67</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=4,SEQ=68,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=620612,FOLIO='67',FILE='DISK114:[11ZAD1.11ZAD42901]GH42901A.;20',USER='VSTEFAN',CD='14-FEB-2011;04:12' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_gi42901_1_68"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries  </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued)  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;4&nbsp;— Post-Employment Benefits (Continued)  </b></font></p>

<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(d)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Index
funds not actively managed (45&nbsp;percent in 2010 and 75&nbsp;percent in 2009) and separate actively managed accounts (55&nbsp;percent in 2010
and 25&nbsp;percent in 2009).
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(e)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Index
funds not actively managed (15&nbsp;percent in 2010 and 75&nbsp;percent in 2009) and separate actively managed accounts (85&nbsp;percent in 2010
and 25&nbsp;percent in 2009).
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(f)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Primarily
United Kingdom, Japan and Irish government-issued bonds.
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(g)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Primarily
mortgage backed securities.
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(h)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Primarily
funds invested by managers that have a global mandate with the flexibility to allocate capital broadly across a wide range of asset classes and
strategies including, but not limited to equities, fixed income, commodities, interest rate futures, currencies and other securities to outperform an agreed upon benchmark with specific return and
volatility targets.
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(i)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Primarily
investments in liquid commodity future contracts.
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(j)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Primarily
cash and cash equivalents. </font></dd></dl>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equities
that are valued using quoted prices are valued at the published market prices. Equities in a common collective trust or a registered investment company that are valued using
significant other observable inputs are valued at the net asset value (NAV) provided by the fund administrator. The NAV is based on the value of the underlying assets owned by the fund minus its
liabilities. Fixed income securities that are valued using significant other observable inputs are valued at prices obtained from independent financial service industry-recognized vendors. Absolute
return funds and commodities are valued at the NAV provided by the fund administrator. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table summarizes the change in the value of assets that are measured using significant unobservable inputs: </font><font size="2"><i>(dollars in
millions)</i></font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


</font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="10pt"></td>
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="30pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="30pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">January&nbsp;1</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">530</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">303</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Transfers (out of) in from other categories</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> (37</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 3</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Actual return on plan assets:</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Assets on hand at year end</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 41</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 99</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Assets sold during the year</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> (2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> (5</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Purchases, sales and settlements, net</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 59</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 130</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">December&nbsp;31</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">591</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">530</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
investment mix of equity securities, fixed income and other asset allocation strategies is based upon achieving a desired return, balancing higher return, more volatile equity
securities, and lower return, less volatile fixed income securities. Investment allocations are made across a range of markets, industry sectors, capitalization sizes, and in the case of fixed income
securities, maturities and credit quality. The plans do not directly hold any securities of Abbott. There are no known significant concentrations of risk in the plans' assets. Abbott's medical and
dental plans' assets are invested in a similar mix as the pension plan assets. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
plans' expected return on assets, as shown above, is based on management's expectations of long-term average rates of return to be achieved by the underlying investment
portfolios. In establishing </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">68</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=69,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=586911,FOLIO='68',FILE='DISK114:[11ZAD1.11ZAD42901]GI42901A.;27',USER='MBLOUNT',CD='16-FEB-2011;09:21' -->
<a name="page_gi42901_1_69"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;4&nbsp;— Post-Employment Benefits (Continued) </b></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">this
assumption, management considers historical and expected returns for the asset classes in which the plans are invested, as well as current economic and capital market conditions. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott
funds its domestic pension plans according to IRS funding limitations. International pension plans are funded according to similar regulations. Abbott funded $525&nbsp;million
in 2010, $862&nbsp;million in 2009 and $285&nbsp;million in 2008 to defined pension plans. Abbott expects pension funding for its main domestic pension plan of $200&nbsp;million annually. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total
benefit payments expected to be paid to participants, which includes payments funded from company assets as well as paid from the plans, are as follows:
(</font><font size="2"><i>dollars in millions</i></font><font size="2">) </font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="63pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="59pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Defined<br>
Benefit Plans </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Medical and<br>
Dental Plans </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2011</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">301</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">81</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2012</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 306</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 85</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2013</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 318</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 87</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2014</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 331</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 93</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2015</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 350</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 99</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2016 to 2020</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 2,071</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 595</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Abbott Stock Retirement Plan is the principal defined contribution plan. Abbott's contributions to this plan were $147&nbsp;million in 2010, $137&nbsp;million in 2009 and
$129&nbsp;million in 2008. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott
provides certain other post-employment benefits, primarily salary continuation plans, to qualifying domestic employees, and accrues for the related cost over the
service lives of the employees. </font></p>


<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;5&nbsp;— Taxes on Earnings  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Taxes on earnings from continuing operations reflect the annual effective rates, including charges for interest and penalties. Deferred income taxes reflect the tax consequences on
future years of differences between the tax bases of assets and liabilities and their financial reporting amounts. U.S. income taxes are provided on those earnings of foreign subsidiaries which are
intended to be remitted to the parent company. Abbott does not record deferred income taxes on earnings reinvested indefinitely in foreign subsidiaries. Undistributed earnings reinvested indefinitely
in foreign subsidiaries as working capital and plant and equipment aggregated $26.8&nbsp;billion at December&nbsp;31, 2010. It is not practicable to determine the amount of deferred income taxes
not provided on these earnings. In the U.S., Abbott's federal income tax returns through 2005 are settled, and the income tax returns for years after 2005 are open. There are numerous other income tax
jurisdictions for which tax returns are not yet settled, none of which are individually significant. Reserves for interest and penalties are not significant. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">69</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=2,SEQ=70,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=634393,FOLIO='69',FILE='DISK114:[11ZAD1.11ZAD42901]GI42901A.;27',USER='MBLOUNT',CD='16-FEB-2011;09:21' -->
<a name="page_gi42901_1_70"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;5&nbsp;— Taxes on Earnings (Continued) </b></font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnings
from continuing operations before taxes, and the related provisions for taxes on earnings from continuing operations, were as follows: (</font><font size="2"><i>dollars in
millions</i></font><font size="2">) </font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="10pt"></td>
<td style="font-family:times;" width="10pt"></td>
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="3" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Earnings From Continuing Operations Before Taxes:</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Domestic</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(275</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,502</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(81</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Foreign</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 5,988</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 5,692</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 5,937</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="3" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,713</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">7,194</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,856</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="3" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM">
<th colspan="3" style="font-family:times;" align="CENTER"><br><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1"><b><br>&nbsp;</b></font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b><br>
2010 </b></font></th>
<th style="font-family:times;"><font size="1"><b><br>&nbsp;</b></font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b><br>
2009 </b></font></th>
<th style="font-family:times;"><font size="1"><b><br>&nbsp;</b></font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b><br>
2008 </b></font></th>
<th style="font-family:times;"><font size="2"><br>&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Taxes on Earnings From Continuing Operations:</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Current:</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">U.S. Federal, State and Possessions</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,462</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">194</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,188</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Foreign</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 835</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 521</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 782</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="3" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total current</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2,297</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 715</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,970</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="3" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Deferred:</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Domestic</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (1,068</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 905</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (845</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="3" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Foreign</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (142</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (172</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (3</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="3" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total deferred</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (1,210</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 733</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (848</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="3" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,087</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,448</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,122</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="3" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Differences
between the effective income tax rate and the U.S. statutory tax rate were as follows: </font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="42pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="42pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="42pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Statutory tax rate on earnings from continuing operations</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 35.0</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 35.0</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 35.0</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Benefit of lower foreign tax rates and tax exemptions</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (19.4</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (16.4</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (16.7</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">State taxes, net of federal benefit</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 0.4</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1.0</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 0.2</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Adjustments primarily related to resolution of prior years' accrual requirements</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (0.5</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Domestic dividend exclusion</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (0.6</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">All other, net</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 3.0</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 0.5</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1.8</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Effective tax rate on earnings from continuing operations</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 19.0</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 20.1</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 19.2</font></td>
<td style="font-family:times;"><font size="2">%</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of December&nbsp;31, 2010, 2009 and 2008, total deferred tax assets were $6.1&nbsp;billion, $4.4&nbsp;billion and $5.4&nbsp;billion, respectively, and total deferred tax
liabilities were $3.0&nbsp;billion, $1.8&nbsp;billion and $1.4&nbsp;billion, respectively. Abbott has incurred losses in a foreign jurisdiction where realization of the future economic benefit
is so remote that the benefit is not reflected as a deferred tax asset. Valuation allowances for </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">70</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=3,SEQ=71,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=808705,FOLIO='70',FILE='DISK114:[11ZAD1.11ZAD42901]GI42901A.;27',USER='MBLOUNT',CD='16-FEB-2011;09:21' -->
<a name="page_gi42901_1_71"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>


<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;5&nbsp;— Taxes on Earnings (Continued) </b></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">recorded
deferred tax assets were not significant. The tax effect of the differences that give rise to deferred tax assets and liabilities were as follows: (</font><font size="2"><i>dollars in
millions</i></font><font size="2">) </font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="10pt"></td>
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="44pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="44pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="44pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Compensation and employee benefits</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,327</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,332</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1,496</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Trade receivable reserves</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 525</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 369</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 434</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Inventory reserves</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 293</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 251</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 261</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Deferred intercompany profit</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 255</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 232</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 248</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">State income taxes</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 233</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 187</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 137</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Depreciation</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (64</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (93</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (64</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Acquired in-process research and development and other accruals and reserves not currently deductible</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 3,401</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,889</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2,771</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td colspan="2" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Other, primarily the excess of book basis over tax basis of intangible assets</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (2,905</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (1,593</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (1,293</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="0">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3,065</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2,574</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">3,990</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td colspan="2" style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table summarizes the gross amounts of unrecognized tax benefits without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such
unrecognized tax benefits were settled. (</font><font size="2"><i>dollars in millions</i></font><font size="2">) </font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">January&nbsp;1</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">2,172</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,523</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,126</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Increase due to current year tax positions</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 635</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 544</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 385</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Increase due to prior year tax positions</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 171</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 234</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 418</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Decrease due to current year tax positions</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> (25</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Decrease due to prior year tax positions</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> (94</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> (90</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> (240</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Settlements</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> (160</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> (39</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> (121</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Lapse of statute</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> (20</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">December&nbsp;31</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">2,724</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">2,172</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,523</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
total amount of unrecognized tax benefits that, if recognized, would impact the effective tax rate is approximately $2.5&nbsp;billion. Although it is reasonably possible that a
change in the balance of
unrecognized tax benefits may occur within the next twelve months, at this time it is not possible to estimate the range of change due to the uncertainty of the potential outcomes. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;6&nbsp;— Segment and Geographic Area Information  </b></font></p>


<p style="font-family:times;text-align:justify"><font size="2">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott's principal business is the discovery, development, manufacture and sale of a broad line of health care products. Abbott's products are generally sold directly to retailers,
wholesalers, hospitals, </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">71</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=4,SEQ=72,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=686634,FOLIO='71',FILE='DISK114:[11ZAD1.11ZAD42901]GI42901A.;27',USER='MBLOUNT',CD='16-FEB-2011;09:21' -->
<a name="page_gi42901_1_72"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;6&nbsp;— Segment and Geographic Area Information (Continued) </b></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">health
care facilities, laboratories, physicians' offices and government agencies throughout the world. Abbott's reportable segments are as follows: </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><i> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pharmaceutical Products</i></font><font size="2"> —&nbsp;&nbsp;Worldwide sales of a broad line of pharmaceuticals. For segment reporting purposes, four pharmaceutical
divisions are aggregated and reported as the Pharmaceutical Products segment. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nutritional Products</i></font><font size="2"> —&nbsp;&nbsp;Worldwide sales of a broad line of adult and pediatric nutritional products. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><i> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diagnostic Products</i></font><font size="2"> —&nbsp;&nbsp;Worldwide sales of diagnostic systems and tests for blood banks,
hospitals, commercial laboratories and alternate-care testing sites. For segment reporting purposes, three diagnostic divisions are aggregated and reported as the Diagnostic Products
segment. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vascular Products</i></font><font size="2"> —&nbsp;&nbsp;Worldwide sales of coronary, endovascular and vessel closure products. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott's
underlying accounting records are maintained on a legal entity basis for government and public reporting requirements. Segment disclosures are on a performance basis consistent
with internal management reporting. Intersegment transfers of inventory are recorded at standard cost and are not a measure of segment operating earnings. The cost of some corporate functions and the
cost of certain employee benefits are charged to segments at predetermined rates that approximate cost. Remaining costs, if any, are not allocated to segments. For acquisitions prior to 2006,
substantially all intangible assets and related amortization are not allocated to segments. The following segment information has been prepared in accordance with the internal accounting policies of
Abbott, as described above, and are not presented in accordance with generally accepted accounting principles applied to the consolidated financial statements. </font><font size="2"><i>(dollars in
millions)</i></font></p>
 <div style="padding:0pt;position:relative;width:54%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="1">


<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="150%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="6pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="37pt"></td>
<td style="font-family:times;" width="6pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="37pt"></td>
<td style="font-family:times;" width="6pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="37pt"></td>
<td style="font-family:times;" width="6pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="32pt"></td>
<td style="font-family:times;" width="6pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="32pt"></td>
<td style="font-family:times;" width="6pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="32pt"></td>
<td style="font-family:times;" width="6pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="32pt"></td>
<td style="font-family:times;" width="6pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="32pt"></td>
<td style="font-family:times;" width="6pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="32pt"></td>
<td style="font-family:times;" width="6pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="37pt"></td>
<td style="font-family:times;" width="6pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="32pt"></td>
<td style="font-family:times;" width="6pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="32pt"></td>
<td style="font-family:times;" width="6pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="37pt"></td>
<td style="font-family:times;" width="6pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="37pt"></td>
<td style="font-family:times;" width="6pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="37pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Net Sales to<br>
External Customers (a) </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Operating and<br>
Earnings (a) </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Depreciation<br>
and Amortization </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Additions to<br>
Long-term Asset </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Total Assets </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Pharmaceuticals&nbsp;(b)</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">19,894</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">16,486</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">16,708</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">7,408</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">6,443</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">6,331</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">993</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">384</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">323</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">10,631</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">239</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">831</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">22,816</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">11,215</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">10,356</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Nutritionals</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 5,532</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 5,284</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 4,924</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 777</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 910</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 859</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 177</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 157</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 135</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 163</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 173</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 281</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 3,244</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 3,368</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 3,220</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Diagnostics</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 3,794</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 3,578</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 3,575</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 559</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 406</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 375</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 244</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 282</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 312</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 319</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 453</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 270</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 3,462</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 3,688</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 3,218</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Vascular (b)</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 3,194</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 2,692</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 2,241</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 910</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 557</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 205</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 252</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 238</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 240</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 528</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 611</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 489</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 5,390</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 5,403</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 4,822</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Total Reportable Segments</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 32,414</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 28,040</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 27,448</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">9,654</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">8,316</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">7,770</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">1,666</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">1,061</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">1,010</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">11,641</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">1,476</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">1,871</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">34,912</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">23,674</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">21,616</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Other</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 2,753</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 2,725</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1"> 2,080</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><font size="1"> </font><font size="1">Net Sales</font></p></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">35,167</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">30,765</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">29,528</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
<div style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(a)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Net
sales and operating earnings were favorably affected by the relatively weaker U.S. dollar in 2010 and 2008 and for 2009 were unfavorably affected by the
relatively stronger U.S. dollar.
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(b)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Additions
to long-term assets in 2010 for the Pharmaceutical Products segment include goodwill of $3,249 and intangibles of $7,261. Additions to
long-term assets in 2010 and 2009 for the Vascular Products segment include goodwill of $310 and $158, respectively, and intangibles of $129 and $373, </font></dd></dl>
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">72</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=5,SEQ=73,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=49653,FOLIO='72',FILE='DISK114:[11ZAD1.11ZAD42901]GI42901A.;27',USER='MBLOUNT',CD='16-FEB-2011;09:21' -->
<a name="page_gi42901_1_73"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;6&nbsp;— Segment and Geographic Area Information (Continued) </b></font></p>
 <div style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
<p style="font-family:times;text-align:justify"></p>

<ul>


<p style="font-family:times;text-align:justify"><font size="2">respectively.
Additions to long-term assets in 2008 for the Pharmaceutical Products segment includes acquired intangible assets of $700 and for the Vascular Products segment includes
goodwill of $321. </font></p>

</ul>
 </div>

 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="20pt"></td>
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="44pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;" align="CENTER"><font size="1"><b><i>(dollars in millions)</i></b></font><br></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total Reportable Segment Operating Earnings</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">9,654</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">8,316</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">7,770</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Corporate functions and benefit plans costs</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (558</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (354</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (377</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Non-reportable segments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 69</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 209</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 133</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net interest expense</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (448</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (382</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (327</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Acquired in-process research and development</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (313</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (170</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (97</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Share-based compensation</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (387</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (366</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (347</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Other, net (c)</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (2,304</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (59</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> (899</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Consolidated Earnings from Continuing Operations Before Taxes</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,713</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">7,194</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">5,856</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(c)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Other,
net, for 2010 includes charges of $881 for integration, restructuring and other costs associated with the acquisitions of Solvay and Piramal and $189
for the impairment of the intangible asset related to sibutramine. Other, net, for 2009, includes the derecognition of a contingent liability of $797 established in connection with the conclusion of
the TAP joint venture and a $287 gain from a patent litigation settlement. </font></dd></dl>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="20pt"></td>
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="45pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="45pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="45pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="45pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="45pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="45pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
<th colspan="2" style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;" align="CENTER"><font size="1"><b><i>(dollars in millions)</i></b></font><br></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td colspan="10" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2"> Total Reportable Segment Assets</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">34,912</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">23,674</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">21,616</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td colspan="10" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2"> Cash, investments and restricted funds</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 7,626</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 11,065</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 6,153</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td colspan="10" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2"> Current deferred income taxes</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 3,076</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2,364</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2,463</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td colspan="10" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2"> Non-reportable segments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 5,385</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 5,371</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,094</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td colspan="10" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2"> All other, net, primarily goodwill and intangible assets not allocated to reportable segments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 8,463</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 9,943</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 11,093</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td colspan="10" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2"> Total Assets</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">59,462</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">52,417</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">42,419</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">73</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=6,SEQ=74,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=451560,FOLIO='73',FILE='DISK114:[11ZAD1.11ZAD42901]GI42901A.;27',USER='MBLOUNT',CD='16-FEB-2011;09:21' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_gj42901_1_74"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries  </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued)  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;6&nbsp;— Segment and Geographic Area Information (Continued)  </b></font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="20pt"></td>
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="45pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="45pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="45pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="45pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="45pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="45pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Net Sales to External<br>
Customers (d) </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Long-term Assets </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="17" style="font-family:times;" align="CENTER"><font size="1"><b><i>(dollars in millions)</i></b></font><br></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="1">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">United States</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">15,194</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">14,453</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">14,495</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">16,769</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">14,886</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">14,271</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Japan</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2,025</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,590</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,249</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,172</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,161</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,046</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Germany</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,846</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,481</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,381</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 5,950</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 6,914</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 5,833</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">The Netherlands</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2,001</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,801</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,753</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 312</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 365</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 175</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Italy</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,144</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,172</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,089</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 242</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 274</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 248</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Canada</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,036</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 902</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 924</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 224</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 166</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 131</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">France</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,216</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 959</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 977</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 87</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 106</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 114</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Spain</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,066</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 970</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 909</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 291</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 342</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 284</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">United Kingdom</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 888</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 779</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 725</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,272</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,095</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,008</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">All Other Countries</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 8,751</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 6,658</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 6,026</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 10,826</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 3,794</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2,267</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Consolidated</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">35,167</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">30,765</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">29,528</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">37,145</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">29,103</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">25,377</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(d)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Sales
by country are based on the country that sold the product. </font></dd></dl>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;7 — Litigation and Environmental Matters  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott has been identified as a potentially responsible party for investigation and cleanup costs at a number of locations in the United States and Puerto Rico under federal and state
remediation laws and is investigating potential contamination at a number of company-owned locations. Abbott has recorded an estimated cleanup cost for each site for which management believes Abbott
has a probable loss exposure. No individual site cleanup exposure is expected to exceed $3&nbsp;million, and the aggregate cleanup exposure is not expected to exceed $15&nbsp;million. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
are a number of patent disputes with third parties who claim Abbott's products infringe their patents. In April 2007, New York University (NYU) and Centocor,&nbsp;Inc. filed a
lawsuit in the Eastern District of Texas asserting that </font><font size="2"><i>HUMIRA</i></font><font size="2"> infringes a patent co-owned by NYU and Centocor and exclusively licensed to
Centocor. In June 2009, a jury found that Abbott had willfully infringed the patent and awarded NYU and Centocor approximately $1.67&nbsp;billion in past compensatory damages. In October 2009, the
district court overturned the jury's finding that Abbott's infringement was willful, but denied Abbott's request to overturn the jury's verdict on validity, infringement, and damages. In December
2009, the district court issued a final judgment and awarded the plaintiffs an additional $175&nbsp;million in prejudgment interest. Abbott has appealed the jury's verdict. Abbott is confident in
the merits of its case and believes that it will prevail on appeal. As a result, no reserves have been recorded in this case. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Within
the next year, legal proceedings may occur that may result in a change in the estimated reserves recorded by Abbott. For its legal proceedings and environmental exposures Abbott
estimates the range of possible loss to be from approximately $75&nbsp;million to $115&nbsp;million. The recorded reserve balance at December&nbsp;31, 2010 for these proceedings and exposures
was approximately $95&nbsp;million. These reserves represent management's best estimate of probable loss, as defined by FASB ASC No.&nbsp;450, "Contingencies." </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">74</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=75,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=77058,FOLIO='74',FILE='DISK114:[11ZAD1.11ZAD42901]GJ42901A.;16',USER='BHOLLIN',CD='16-FEB-2011;10:38' -->
<a name="page_gj42901_1_75"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;7 — Litigation and Environmental Matters (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;While
it is not feasible to predict the outcome of all such proceedings and exposures with certainty, management believes that their ultimate disposition should not have a material
adverse effect on Abbott's financial position, cash flows, or results of operations, except for the patent case discussed in the second paragraph of this footnote, the resolution of which could be
material to cash flows or results of operations. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2009, Abbott and Medtronic,&nbsp;Inc. reached a settlement resolving all outstanding intellectual property litigation between the two parties. Under the terms of the settlement,
Medtronic paid Abbott $400&nbsp;million. The settlement also includes a mutual agreement not to pursue additional litigation on current and future vascular products, subject to specific conditions
and time limits. In connection with the settlement, Abbott recognized a gain of $287&nbsp;million which is included in Other (income) expense, net. The remaining amounts are being recognized as
royalty income as earned. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;8 — Incentive Stock Program  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The 2009 Incentive Stock Program authorizes the granting of nonqualified stock options, replacement stock options, restricted stock awards, restricted stock units, performance awards,
foreign benefits and other share-based awards. Stock options, replacement stock options and restricted stock awards and units comprise the majority of benefits that have been granted and are currently
outstanding under this program and a prior program. In 2010, Abbott granted 1,597,276 stock options, 589,970 replacement stock options, 1,850,892 restricted stock awards and 6,099,307 restricted stock
units under this program. The purchase price of shares under option must be at least equal to the fair market value of the common stock on the date of grant, and the maximum term of an option is
10&nbsp;years. Options vest equally over three years except for replacement options, which vest in six months. Options granted before January&nbsp;1, 2005 included a replacement feature. Except
for options outstanding that have a replacement feature, options granted after December&nbsp;31, 2004 do not include a replacement feature. When an employee tenders mature shares to Abbott upon
exercise of a stock option, a replacement stock option may be granted equal to the amount of shares tendered. Replacement options are granted at the then current market price for a term that expires
on the date of the underlying option grant. Upon a change in control of Abbott, all outstanding stock options become fully exercisable, and all terms and conditions of all restricted stock awards and
units are deemed satisfied. Restricted stock awards generally vest between 3 and 5&nbsp;years and for restricted stock awards that vest over 5&nbsp;years, no more than one-third of the
award vests in any one year upon Abbott reaching a minimum return on equity target. Restricted stock units vest over three years and upon vesting, the recipient receives one share of Abbott stock for
each vested restricted stock unit. The aggregate fair market value of restricted stock awards and units is recognized as expense over the service period. Restricted stock awards and settlement of
vested restricted stock units are issued out of treasury shares. Abbott generally issues new shares for exercises of stock options. Abbott does not have a policy of purchasing its shares relating to
its share-based programs. At December&nbsp;31, 2010, approximately 200&nbsp;million shares were reserved for future grants. Subsequent to year-end, the reserve was reduced by
approximately 24&nbsp;million shares for stock options and restricted stock awards and units granted by the Board of Directors. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
number of restricted stock awards and units outstanding and the weighted-average grant-date fair value at December&nbsp;31, 2009 and December&nbsp;31, 2010 was
8,703,247 and $53.64 and 12,449,413 and $54.02, respectively. The number of restricted stock awards and units, and the weighted-average grant-date fair value, that were granted, vested and
lapsed during 2010 were 7,950,199 and $54.15, 3,781,223 and $53.50 </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">75</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=2,SEQ=76,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=188886,FOLIO='75',FILE='DISK114:[11ZAD1.11ZAD42901]GJ42901A.;16',USER='BHOLLIN',CD='16-FEB-2011;10:38' -->
<a name="page_gj42901_1_76"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>


<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;8 — Incentive Stock Program (Continued) </b></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">and
422,810 and $53.43, respectively. The fair market value of restricted stock awards and units vested in 2010, 2009 and 2008 was $203&nbsp;million, $81&nbsp;million and $76&nbsp;million,
respectively. </font></p>
 <div style="padding:0pt;position:relative;width:57%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"140%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="140%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="68pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="44pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="56pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="68pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="44pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="56pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Options Outstanding </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="8" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Exercisable Options </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Shares </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Weighted<br>
Average<br>
Exercise<br>
Price </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Weighted<br>
Average<br>
Remaining<br>
Life&nbsp;(Years) </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Shares </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Weighted<br>
Average<br>
Exercise<br>
Price </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Weighted<br>
Average<br>
Remaining<br>
Life&nbsp;(Years) </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">December&nbsp;31, 2009</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 118,860,121</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">50.09</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 5.7</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 98,251,406</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">49.16</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 5.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Granted</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 2,187,246</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 56.38</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Exercised</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> (8,086,101</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 43.61</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Lapsed</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> (3,039,578</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 58.23</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">December&nbsp;31, 2010</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 109,921,688</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">50.46</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 4.9</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 100,739,252</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"> $</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">50.06</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 4.6</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
aggregate intrinsic value of options outstanding and exercisable at December&nbsp;31, 2010 was $194&nbsp;million and $193&nbsp;million, respectively. The total intrinsic value
of options exercised in 2010, 2009 and 2008 was $77&nbsp;million, $129&nbsp;million and $314&nbsp;million, respectively. The total unrecognized compensation cost related to all share-based
compensation plans at December&nbsp;31, 2010 amounted to approximately $270&nbsp;million which is expected to be recognized over the next three years. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total
non-cash compensation expense charged against income in 2010, 2009 and 2008 for share-based plans totaled approximately $385&nbsp;million, $365&nbsp;million and
$350&nbsp;million, respectively, and the tax benefit recognized was approximately $119&nbsp;million, $118&nbsp;million and $117&nbsp;million, respectively. Compensation cost capitalized as
part of inventory is not significant. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
fair value of an option granted in 2010, 2009 and 2008 was $9.24, $9.28 and $11.42, respectively. The fair value of an option grant was estimated using the Black-Scholes
option-pricing model with the following assumptions: </font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="37pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="37pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="37pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Risk-free interest rate</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 2.9</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">%</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 2.7</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">%</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 3.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">%</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Average life of options (years)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 6.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 6.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 6.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Volatility</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 22.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">%</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 22.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">%</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 24.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">%</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Dividend yield</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 3.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">%</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 3.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">%</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2"> 2.6</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">%</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
risk-free interest rate is based on the rates available at the time of the grant for zero-coupon U.S. government issues with a remaining term equal to the
option's expected life. The average life of an option is based on both historical and projected exercise and lapsing data. Expected volatility is based on implied volatilities from traded options on
Abbott's stock and historical volatility of Abbott's stock over the expected life of the option. Dividend yield is based on the option's exercise price and annual dividend rate at the time of grant. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">76</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=3,SEQ=77,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=430544,FOLIO='76',FILE='DISK114:[11ZAD1.11ZAD42901]GJ42901A.;16',USER='BHOLLIN',CD='16-FEB-2011;10:38' -->
<a name="page_gj42901_1_77"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>


<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;9 — Debt and Lines of Credit  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following is a summary of long-term debt at December&nbsp;31: (</font><font size="2"><i>dollars in millions</i></font><font size="2">) </font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="45pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="45pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="39pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">1.51% Yen notes, due 2010</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">157</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">3.75% Notes, due 2011</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 500</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 500</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">5.6% Notes, due 2011</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,500</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,500</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">5.15% Notes, due 2012</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,000</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,000</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,000</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">4.35% Notes, due 2014</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 500</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 500</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 500</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2.7% Notes, due 2015</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 750</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">5.875% Notes, due 2016</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2,000</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2,000</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2,000</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">5.6% Notes, due 2017</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,500</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,500</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,500</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">5.125% Notes, due 2019</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2,000</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2,000</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">4.125% Notes, due 2020</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,000</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">6.15% Notes, due 2037</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,000</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,000</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,000</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">6.0% Notes, due 2039</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,000</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,000</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">5.3% Notes, due 2040</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,250</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> —</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Other, including fair value adjustments relating to interest rate hedge contracts designated as fair value hedges</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 524</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 266</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 556</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total, net of current maturities</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 12,524</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 11,266</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 8,713</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Current maturities of long-term debt</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 2,045</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 211</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2"> 1,041</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total carrying amount</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">14,569</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">11,477</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> $</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">9,754</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Principal
payments required on long-term debt outstanding at December&nbsp;31, 2010, are $2.0&nbsp;billion in 2011, $1.0&nbsp;billion in 2012, $301&nbsp;million in
2013, $500&nbsp;million in 2014, $750&nbsp;million in 2015 and $9.8&nbsp;billion thereafter. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
December&nbsp;31, 2010, Abbott's long-term debt rating was AA by Standard&nbsp;&amp; Poor's Corporation and A1 by Moody's Investors Service. Abbott has readily available
financial resources, including unused lines of credit of $6.7&nbsp;billion that support commercial paper borrowing arrangements of which a $3.0&nbsp;billion facility expires in October 2012 and a
$3.7&nbsp;billion facility expires in 2013. Related compensating balances, which are subject to withdrawal by Abbott at its option, and commitment fees are not material. Abbott's weighted-average
interest rate on short-term borrowings was 0.4% at December&nbsp;31, 2010, 0.2% at December&nbsp;31, 2009 and 0.5% at December&nbsp;31, 2008. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;10 — Business Combinations, Technology Acquisitions and Related Transactions  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On January&nbsp;1, 2009, Abbott adopted the provisions of SFAS No.&nbsp;141 (revised 2007), "Business Combinations," as codified in FASB ASC No.&nbsp;805, "Business Combinations."
Under ASC No.&nbsp;805, acquired in-process research and development is accounted for as an indefinite-lived intangible asset until approval or discontinuation rather than as expense,
acquisition costs in connection with an acquisition are expensed rather than added to the cost of an acquisition and the fair value of contingent consideration at the date of an acquisition is added
to the cost of the acquisition. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">77</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=4,SEQ=78,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=739848,FOLIO='77',FILE='DISK114:[11ZAD1.11ZAD42901]GJ42901A.;16',USER='BHOLLIN',CD='16-FEB-2011;10:38' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_gk42901_1_78"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="gk42901_abbott_laboratories_and_subsid__abb03224"> </a>
<a name="toc_gk42901_1"> </a></font> <font size="2"><b><br>  Abbott Laboratories and Subsidiaries    <br>    <br>    Notes to Consolidated Financial Statements    <br>    </b></font></p>


<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;10 — Business Combinations, Technology Acquisitions and Related Transactions (Continued)  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On September&nbsp;8, 2010, Abbott acquired Piramal Healthcare Limited's Healthcare Solutions business, a leader in the Indian branded generics market, for $2.2&nbsp;billion, in cash,
plus additional payments of $400&nbsp;million annually in 2011, 2012, 2013 and 2014. Abbott recorded a $1.6&nbsp;billion liability for the present value of the additional payments at the
acquisition date. The acquisition was financed with current cash. The preliminary allocation of the fair value of the acquisition resulted in the recording of $2.7&nbsp;billion of deductible
acquired intangible assets and $1.0&nbsp;billion of deductible goodwill. Acquired intangible assets consist primarily of trade names, customer relationships and associated rights and will be
amortized over an average of 19&nbsp;years. The allocation of the fair value of the acquisition will be finalized when the valuation is completed. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
February 2010, Abbott acquired Solvay's pharmaceuticals business (Solvay Pharmaceuticals) for approximately $6.1&nbsp;billion, in cash, plus additional payments of up to EUR
100&nbsp;million per year if certain sales milestones are met in 2011, 2012 and 2013. Contingent consideration of approximately $290&nbsp;million was recorded based on a preliminary valuation. The
acquisition of Solvay Pharmaceuticals provides Abbott with a large and complementary portfolio of pharmaceutical products and expands Abbott's presence in key global emerging markets. Abbott acquired
control of this business on February&nbsp;15, 2010 and the financial results of the acquired operations are included in these financial statements beginning on that date. Net sales for the acquired
operations for 2010 were approximately $3.1&nbsp;billion. Pretax loss of the acquired operations, including acquisition, integration and restructuring expenses, for 2010 was approximately
$395&nbsp;million. The acquisition was funded with current cash and short-term
investments. The preliminary allocation of the fair value of the acquisition is shown in the table below </font><font size="2"><i>(in billions of dollars)</i></font><font size="2">. The allocation of the
fair value of the acquisition will be finalized when the valuation is completed. </font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="31pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Goodwill, non-deductible</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">2.2</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Acquired intangible assets, non-deductible</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">4.1</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Acquired in-process research and development, non-deductible</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">0.5</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Acquired net tangible assets</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">0.7</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Deferred income taxes recorded at acquisition</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1.1</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total preliminary allocation of fair value</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">6.4</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquired
intangible assets consist primarily of product rights for currently marketed products and are amortized over 2 to 14&nbsp;years (average of 11&nbsp;years). Acquired
in-process research and development is accounted for as indefinite lived intangible assets until regulatory approval or discontinuation. The net tangible assets acquired consist primarily
of trade accounts receivable of approximately $675&nbsp;million, inventory of approximately $390&nbsp;million, property and equipment of approximately $725&nbsp;million, net of assumed
liabilities, primarily trade accounts payable, accrued compensation and other liabilities. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following unaudited pro forma financial information reflects the consolidated results of operations of Abbott as if the acquisition of Solvay Pharmaceuticals had taken place on
January&nbsp;1, 2010 and January&nbsp;1, 2009. The pro forma information includes adjustments for amortization of intangible assets and fair value adjustments to acquisition-date
inventory as well as acquisition, integration and restructuring expenses. The pro forma financial information is not necessarily indicative of the results of </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">78</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=79,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=1011892,FOLIO='78',FILE='DISK114:[11ZAD1.11ZAD42901]GK42901A.;11',USER='EYOUNG',CD='14-FEB-2011;16:18' -->
<a name="page_gk42901_1_79"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;10 — Business Combinations, Technology Acquisitions and Related Transactions (Continued) </b></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">operations
as they would have been had the transaction been effected on the assumed date. (</font><font size="2"><i>in billions of dollars, except per share amounts</i></font><font size="2">) </font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="32pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="32pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net sales</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">35.8</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">34.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net earnings</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">4.6</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">5.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Diluted earnings per common share</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">2.96</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">3.36</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
March 2010, Abbott acquired STARLIMS Technologies for approximately $100&nbsp;million, in cash, net of cash held by STARLIMS, providing Abbott with leading products and expertise to
build its position in laboratory informatics. A substantial portion of the fair value of the acquisition has been allocated to goodwill and amortizable intangible assets. The allocation of the fair
value of the acquisition will be finalized when the valuation is completed. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
April 2010, Abbott acquired the outstanding shares of Facet Biotech Corporation for approximately $430&nbsp;million, in cash, net of cash held by Facet. The acquisition enhances
Abbott's early- and mid-stage pharmaceutical pipeline, including a biologic for multiple sclerosis and compounds that complement Abbott's oncology program. A substantial portion of the
fair value of the acquisition has been allocated to acquired in-process research and development that is accounted for as an indefinite-lived intangible asset until regulatory approval or
discontinuation. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
February 2009, Abbott acquired the outstanding shares of Advanced Medical Optics,&nbsp;Inc. (AMO) for approximately $1.4&nbsp;billion in cash, net of cash held by AMO. Prior to
the acquisition, Abbott held a small investment in AMO. Abbott acquired AMO to take advantage of increasing demand for vision care technologies due to population growth and demographic shifts and
AMO's premier position in its field. Abbott acquired control of this business on February&nbsp;25, 2009 and the financial results of the acquired operations are included in these financial
statements beginning on that date. The acquisition was financed with long-term debt. The allocation of the fair value of the acquisition is shown in the table below: </font> <font size="2"><i>(dollars in billions)</i></font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="31pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Goodwill, non-deductible</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1.7</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Acquired intangible assets, non-deductible</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">0.9</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Acquired in-process research and development, non-deductible</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">0.2</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Acquired net tangible assets</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">0.4</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Acquired debt</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(1.5</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Deferred income taxes recorded at acquisition</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(0.3</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Total allocation of fair value</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">1.4</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquired
intangible assets consist of established customer relationships, developed technology and trade names and are amortized over 2 to 30&nbsp;years (average of 15&nbsp;years).
Acquired in-process research and development is accounted for as an indefinite-lived intangible asset until regulatory approval or discontinuation. The net tangible assets acquired consist
primarily of trade accounts receivable, inventory, property and equipment and other assets, net of assumed liabilities, primarily trade accounts payable, accrued compensation and other liabilities. In
addition, subsequent to the acquisition, Abbott repaid substantially all of the acquired debt of AMO. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">79</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=2,SEQ=80,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=647134,FOLIO='79',FILE='DISK114:[11ZAD1.11ZAD42901]GK42901A.;11',USER='EYOUNG',CD='14-FEB-2011;16:18' -->
<a name="page_gk42901_1_80"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;10 — Business Combinations, Technology Acquisitions and Related Transactions (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
October 2009, Abbott acquired 100&nbsp;percent of Visiogen,&nbsp;Inc. for $400&nbsp;million, in cash, providing Abbott with a next-generation accommodating
intraocular lens (IOL) technology to address presbyopia for cataract patients. The allocation of the fair value of the acquisition resulted in
non-deductible acquired in-process research and development of approximately $200&nbsp;million which is accounted for as an indefinite-lived intangible asset until regulatory
approval or discontinuation, non-deductible definite-lived intangible assets of approximately $24&nbsp;million and goodwill of approximately $200&nbsp;million. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
October 2009, Abbott acquired Evalve,&nbsp;Inc. for $320&nbsp;million, in cash, plus an additional payment of $90&nbsp;million to be made upon completion of certain regulatory
milestones. Abbott acquired Evalve to obtain a presence in the growing area of non-surgical treatment for structural heart disease. Including a previous investment in Evalve, Abbott has
acquired 100&nbsp;percent of the outstanding shares of Evalve. In connection with the acquisition, the carrying amount of this investment was revalued to fair value resulting in recording
$28&nbsp;million of income, which is reported as Other (income) expense, net. The allocation of the fair value of the acquisition resulted in non-deductible definite-lived intangible
assets of approximately $140&nbsp;million, non-deductible acquired in-process research and development of approximately $220&nbsp;million which is accounted for as an
indefinite-lived intangible asset until regulatory approval or discontinuation, goodwill of approximately $100&nbsp;million and deferred income taxes of approximately $110&nbsp;million. Acquired
intangible assets consist of developed technology and will be amortized over 11&nbsp;years. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
January 2009, Abbott acquired Ibis Biosciences,&nbsp;Inc. (Ibis) for $175&nbsp;million, in cash, to expand Abbott's position in molecular diagnostics for infectious disease.
Including a $40&nbsp;million investment in Ibis in 2008, Abbott has acquired 100&nbsp;percent of the outstanding shares of Ibis. A substantial portion of the fair value of the acquisition has been
allocated to goodwill and amortizable intangible assets, and acquired in-process research and development which is accounted for as an indefinite-lived intangible asset until regulatory
approval or discontinuation. The investment in Ibis in 2008 resulted in a charge to acquired in-process research and development. In connection with the acquisition, the carrying amount of
this investment was revalued to fair value resulting in recording $33&nbsp;million of income, which is reported as Other (income) expense, net. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
for the acquisition of Solvay Pharmaceuticals, had the above acquisitions taken place on January&nbsp;1 of the previous year, consolidated net sales and income would not have
been significantly different from reported amounts. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2010, Abbott entered into an agreement to acquire licensing rights outside the U.S., excluding certain Asian markets, to a product in development for the treatment of chronic kidney
disease resulting in a charge to acquired in-process research and development of $238&nbsp;million. In addition, Abbott acquired an equity interest of approximately $62&nbsp;million.
An additional equity interest and additional milestone payments could be required upon the achievement of certain development and regulatory milestones. In 2010, Abbott also entered into an agreement
to develop and commercialize a product for the treatment of endometriosis resulting in a charge to acquired in-process research and development of $75&nbsp;million. Additional payments
of approximately $500&nbsp;million could be required for the achievement of certain development, regulatory and commercial milestones. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2009, Abbott acquired the global rights to a novel biologic for the treatment of chronic pain for $170&nbsp;million, in cash, resulting in a charge to acquired
in-process research and development. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">80</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=3,SEQ=81,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=736114,FOLIO='80',FILE='DISK114:[11ZAD1.11ZAD42901]GK42901A.;11',USER='EYOUNG',CD='14-FEB-2011;16:18' -->
<a name="page_gk42901_1_81"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;11 — Conclusion of TAP Pharmaceutical Products&nbsp;Inc. Joint Venture and Sale of Abbott's Spine Business  </b></font></p>


<p style="font-family:times;text-align:justify"><font size="2">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On April&nbsp;30, 2008, Abbott and Takeda concluded their TAP Pharmaceutical Products&nbsp;Inc. (TAP) joint venture, evenly splitting the value and assets of the joint venture.
Abbott exchanged its 50&nbsp;percent equity interest in TAP for the assets, liabilities and employees related to TAP's </font><font size="2"><i>Lupron</i></font><font size="2"> business. Subsequent to
the conclusion of the joint venture, TAP was merged into two Takeda entities. The exchange of Abbott's investment in TAP for TAP's </font><font size="2"><i>Lupron</i></font><font size="2"> business
resulted in a gain at closing of approximately $94&nbsp;million. The Internal Revenue Service has issued a private letter ruling that the transaction qualifies as tax-free for U.S.
income tax purposes. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beginning
on May&nbsp;1, 2008, Abbott began recording U.S. </font><font size="2"><i>Lupron</i></font><font size="2"> net sales and costs in its operating results and no longer records
income from the TAP joint venture. TAP's sales of </font><font size="2"><i>Lupron</i></font><font size="2"> were $182&nbsp;million for the four months ended April&nbsp;30, 2008. Abbott also receives
payments based on specified development, approval and commercial events being achieved with respect to products retained by Takeda and payments from Takeda based on sales of products retained by
Takeda, which are recorded by Abbott as Other (income) expense, net when the specified event is achieved or as the applicable sales are made. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
exchange transaction was accounted for as a sale of Abbott's equity interest in TAP and as an acquisition of TAP's </font><font size="2"><i>Lupron</i></font><font size="2"> business.
The sale of Abbott's equity interest in TAP resulted in the recording of net assets related to the </font><font size="2"><i>Lupron</i></font><font size="2"> business, primarily cash, receivables,
inventory and other assets, net of accounts payable and other accrued liabilities, offset by a credit to Abbott's investment in TAP in the amount of approximately $280&nbsp;million. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the acquired </font><font size="2"><i>Lupron</i></font><font size="2"> business, Abbott recorded intangible assets, primarily </font><font size="2"><i>Lupron</i></font><font size="2">
product rights, of approximately $700&nbsp;million, goodwill of approximately $350&nbsp;million and deferred tax liabilities related primarily to the intangible assets of approximately
$260&nbsp;million. The intangible assets are being amortized over 15&nbsp;years. Abbott agreed to remit cash to Takeda if certain research and development events were not achieved on the
development assets retained by Takeda. These amounts were recorded as a liability at closing in the amount of approximately $1.1&nbsp;billion. Related deferred tax assets of approximately
$410&nbsp;million were also recorded. Of the $1.1&nbsp;billion, Abbott made tax-deductible payments of $36&nbsp;million, $83&nbsp;million and $200&nbsp;million in 2010, 2009 and
2008. In 2009 events occurred resulting in the remaining payments not being required and the remaining liability in the amount of $797&nbsp;million was derecognized and recorded as income in Other
(income) expense, net. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2008, Abbott sold its spine business for approximately $360&nbsp;million in cash, resulting in an after-tax gain of approximately $147&nbsp;million which is presented
as Gain on sale of discontinued operations, net of taxes, in the accompanying statement of income. The operations and financial position of the spine business are not presented as discontinued
operations because the effects would not be significant. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;12 — Goodwill and Intangible Assets  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott recorded goodwill of approximately $3.4&nbsp;billion in 2010 related to the acquisitions of Solvay's pharmaceuticals business, Piramal Healthcare Limited's Healthcare Solutions
business, Facet Biotech and STARLIMS Technologies. Goodwill related to the Solvay, Piramal and Facet acquisitions was allocated to the Pharmaceutical Products segment. In addition, in 2010, Abbott
paid $250&nbsp;million to Boston Scientific as a result of the approval to market the </font><font size="2"><i>Xience V</i></font><font size="2"> drug-eluting stent in Japan, resulting in
an increase in goodwill in the Vascular Products segment. Abbott recorded goodwill of approximately $2.2&nbsp;billion in 2009 related to the acquisitions of Advanced Medical Optics,&nbsp;Inc.,
Ibis Biosciences,&nbsp;Inc., Visiogen,&nbsp;Inc. and Evalve,&nbsp;Inc. Goodwill of approximately $120&nbsp;million related to the Ibis acquisition was allocated to the </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">81</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=4,SEQ=82,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=858480,FOLIO='81',FILE='DISK114:[11ZAD1.11ZAD42901]GK42901A.;11',USER='EYOUNG',CD='14-FEB-2011;16:18' -->
<a name="page_gk42901_1_82"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;12 — Goodwill and Intangible Assets (Continued) </b></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">Diagnostic
Products segment and goodwill of approximately $160&nbsp;million related to the Evalve acquisition was allocated to the Vascular Products segment. In connection with the dissolution of
the TAP Pharmaceutical Products&nbsp;Inc. (TAP) joint venture in 2008, Abbott recorded approximately $350&nbsp;million of goodwill related to the Pharmaceutical Products segment. In 2008, Abbott
paid $250&nbsp;million to Boston Scientific as a result of the FDA's approval to market the </font><font size="2"><i>Xience V</i></font><font size="2"> drug-eluting stent in the U.S.,
resulting in an increase in goodwill in the Vascular Products segment. Foreign currency translation and other adjustments (decreased) increased goodwill in 2010, 2009 and 2008 by
$(879)&nbsp;million, $997&nbsp;million and $(677)&nbsp;million, respectively. The amount of goodwill related to reportable segments at December&nbsp;31, 2010 was $9.4&nbsp;billion for the
Pharmaceutical Products segment, $208&nbsp;million for the Nutritional Products segment, $383&nbsp;million for the Diagnostic Products segment, and $2.6&nbsp;billion for the Vascular Products
segment. Goodwill was reduced by approximately $64&nbsp;million in connection with the sale of Abbott's spine business in 2008. There were no other significant reductions of goodwill relating to
impairments or disposal of all or a portion of a business. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
gross amount of amortizable intangible assets, primarily product rights and technology was $17.3&nbsp;billion, $10.8&nbsp;billion and $9.4&nbsp;billion as of
December&nbsp;31, 2010, 2009 and 2008, respectively, and accumulated amortization was $6.5&nbsp;billion, $5.1&nbsp;billion and $4.2&nbsp;billion as of December&nbsp;31, 2010, 2009 and 2008,
respectively. Indefinite-lived intangible assets, which relate to in-process research and development acquired in a business combination, were approximately $1.4&nbsp;billion and
$610&nbsp;million at
December&nbsp;31, 2010 and 2009, respectively. The estimated annual amortization expense for intangible assets recorded at December&nbsp;31, 2010 is approximately $1.6&nbsp;billion in 2011,
$1.3&nbsp;billion in 2012, $1.1&nbsp;billion in 2013, $895&nbsp;million in 2014 and $790&nbsp;million in 2015. Amortizable intangible assets are amortized over 2 to 30&nbsp;years (average
12&nbsp;years). </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;13 — Restructuring Plans  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In 2010, Abbott management approved a restructuring plan primarily related to the acquisition of Solvay's pharmaceuticals business. This plan streamlines operations, improves
efficiencies and reduces costs in certain Solvay sites and functions as well as in certain Abbott and Solvay commercial organizations in various countries. Action plans have been identified and most
are expected to be implemented within the next two years. This plan will result in pretax charges of approximately $810&nbsp;million to $970&nbsp;million over the life of the plan. These charges
include employee-related costs of approximately $650&nbsp;million, accelerated depreciation and asset write-downs of approximately $105&nbsp;million, and other related exit costs of up to
approximately $215&nbsp;million, mainly related to discontinuation of certain research and development programs and product transfers. Under this plan, Abbott recorded charges to Cost of products
sold, Research and development and Selling, general and administrative of approximately $99&nbsp;million, $152&nbsp;million and $272&nbsp;million, respectively. Additional charges of
$12&nbsp;million were subsequently recorded primarily for accelerated depreciation. The following summarizes the activity for this restructuring: </font><font size="2"><i>(dollars in
millions)</i></font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="34pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2010 restructuring charge</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">523</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Payments, impairments and other adjustments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(113</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Accrued balance at December&nbsp;31, 2010</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">410</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2010 and prior years, Abbott management approved plans to realign its worldwide pharmaceutical and vascular manufacturing operations and selected domestic and international commercial
and research </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">82</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=5,SEQ=83,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=159958,FOLIO='82',FILE='DISK114:[11ZAD1.11ZAD42901]GK42901A.;11',USER='EYOUNG',CD='14-FEB-2011;16:18' -->
<a name="page_gk42901_1_83"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued) </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;13 — Restructuring Plans (Continued) </b></font></p>

<br>

<p style="font-family:times;text-align:justify"><font size="2">and
development operations in order to reduce costs. In 2010, 2009 and 2008, Abbott recorded charges of approximately $56&nbsp;million, $114&nbsp;million and $36&nbsp;million, respectively,
reflecting the impairment of manufacturing facilities and other assets, employee severance and other related charges. Approximately $56&nbsp;million in 2010 is classified as Cost of products sold
and $114&nbsp;million and $36&nbsp;million in 2009 and 2008, respectively, are classified as Selling, general and administrative. An additional $13&nbsp;million, $47&nbsp;million and
$81&nbsp;million were subsequently recorded in 2010, 2009 and 2008, respectively, relating to these restructurings, primarily for accelerated depreciation. The following summarizes the activity for
these restructurings: </font><font size="2"><i>(dollars in millions)</i></font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="34pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Accrued balance at January&nbsp;1, 2008</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">194</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2008 restructuring charges</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">36</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Payments, impairments and other adjustments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(125</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Accrued balance at December&nbsp;31, 2008</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">105</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2009 restructuring charges</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">114</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Payments, impairments and other adjustments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(74</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Accrued balance at December&nbsp;31, 2009</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">145</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2010 restructuring charges</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">56</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Payments and other adjustments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(124</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Accrued balance at December&nbsp;31, 2010</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">77</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2008, Abbott management approved a plan to streamline global manufacturing operations, reduce overall costs, and improve efficiencies in Abbott's core diagnostic business. In 2008,
Abbott recorded a charge to Cost of products sold of approximately $129&nbsp;million under the plan. Additional charges of approximately $60&nbsp;million, $54&nbsp;million and $16&nbsp;million
were recorded in 2010, 2009 and 2008, respectively, relating to this restructuring, primarily for accelerated depreciation and product transfer costs. Additional charges will be incurred through 2011
as a result of product re-registration timelines required under manufacturing regulations in a number of countries and product transition timelines. The following summarizes the activity
for this restructuring: </font><font size="2"><i>(dollars in millions)</i></font></p>
 <div style="padding:0pt;position:relative;width:60%;margin-left:20%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="30pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2008 restructuring charge</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">129</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Payments and other adjustments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(19</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Accrued balance at December&nbsp;31, 2008</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">110</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Payments and other adjustments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(12</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Accrued balance at December&nbsp;31, 2009</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">98</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Payments and other adjustments</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">(10</font></td>
<td style="font-family:times;"><font size="2">)</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Accrued balance at December&nbsp;31, 2010</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">88</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr style="font-size:1.5pt;" valign="TOP">
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
<td colspan="2" style="font-family:times;border-bottom:double #000000 2.25pt;" valign="BOTTOM" align="RIGHT">&nbsp;</td>
<td style="font-family:times;" valign="BOTTOM">&nbsp;</td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;14 — Subsequent Event  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In January 2011, Abbott management approved a restructuring plan to streamline manufacturing and commercial operations, improve efficiencies and reduce costs in the pharmaceutical
business. This plan
will result in pre-tax charges of approximately $295&nbsp;million over the next several years based on the timing of events, including product transfers. Approximately
$165&nbsp;million of the charges are forecast to occur in 2011, with about $140&nbsp;million projected in the first quarter of 2011. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">83</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=6,SEQ=84,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=956747,FOLIO='83',FILE='DISK114:[11ZAD1.11ZAD42901]GK42901A.;11',USER='EYOUNG',CD='14-FEB-2011;16:18' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_gl42901_1_84"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b><br>
Abbott Laboratories and Subsidiaries  </b></font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><b> Notes to Consolidated Financial Statements (Continued)  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Note&nbsp;15 — Quarterly Results (Unaudited)  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b><i>(dollars in millions except per share data)  </i></b></font></p>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="49pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="49pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="49pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" align="LEFT"><font size="2">&nbsp;</font><br></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2010 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2009 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>2008 </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2"><b>First Quarter</b></font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net Sales</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">7,698.4</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">6,718.4</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">6,765.6</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Gross Profit</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">4,363.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">3,782.4</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">3,804.5</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net Earnings</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,003.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,438.6</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">937.9</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Basic Earnings Per Common Share (a)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.65</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.93</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.61</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Diluted Earnings Per Common Share (a)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.64</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.92</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.60</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Market Price Per Share — High</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">56.79</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">57.39</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">61.09</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Market Price Per Share — Low</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">52.21</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">44.10</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">50.09</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2"><b>Second Quarter</b></font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net Sales</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">8,826.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">7,494.9</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">7,314.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Gross Profit</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">5,282.1</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">4,365.9</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">4,194.4</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net Earnings</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,291.7</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,288.1</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,322.0</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Basic Earnings Per Common Share (a)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.83</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.83</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.86</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Diluted Earnings Per Common Share (a)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.83</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.83</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.85</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Market Price Per Share — High</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">53.25</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">48.37</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">57.04</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Market Price Per Share — Low</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">45.26</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">41.27</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">50.09</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2"><b>Third Quarter</b></font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net Sales</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">8,674.5</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">7,761.3</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">7,497.7</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Gross Profit</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">4,933.4</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">4,401.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">4,144.8</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net Earnings</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">890.7</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,480.4</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,084.6</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Basic Earnings Per Common Share (a)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.58</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.95</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.70</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Diluted Earnings Per Common Share (a)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.57</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.95</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.69</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Market Price Per Share — High</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">52.86</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">49.69</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">60.78</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Market Price Per Share — Low</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">44.59</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">43.45</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">52.63</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2"><b>Fourth Quarter</b></font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net Sales</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">9,967.8</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">8,790.1</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">7,950.3</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Gross Profit</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">5,922.8</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">5,005.9</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">4,771.9</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Net Earnings</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,440.8</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,538.7</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">1,536.2</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Basic Earnings Per Common Share (a)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.93</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.99</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.99</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Diluted Earnings Per Common Share (a)</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.92</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.98</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">.98</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Market Price Per Share — High</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">53.75</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">54.97</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">59.93</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Market Price Per Share — Low</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">46.03</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">48.41</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">45.75</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
<div style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(a)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">The
sum of the quarters' basic earnings per share for 2010 and 2009 and diluted earnings per share for 2009 do not add to the full year earnings per share
amounts due to rounding. </font></dd></dl>
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">84</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=85,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=1002933,FOLIO='84',FILE='DISK114:[11ZAD1.11ZAD42901]GL42901A.;14',USER='VSTEFAN',CD='14-FEB-2011;04:12' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_gm42901_1_85"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="gm42901_management_report_on_internal___man02570"> </a>
<a name="toc_gm42901_1"> </a>
<br></font><font size="2"><b>  Management Report on Internal Control<br>  Over Financial Reporting    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The management of Abbott Laboratories is responsible for establishing and maintaining adequate internal control over financial
reporting. Abbott's internal control system was designed to provide reasonable assurance to the company's management and board of directors regarding the preparation and fair presentation of published
financial statements. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with
respect to financial statement preparation and presentation. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott's
management assessed the effectiveness of the company's internal control over financial reporting as of December&nbsp;31, 2010. In making this assessment, it used the criteria
set forth in </font><font size="2"><i>Internal Control&nbsp;— Integrated Framework</i></font><font size="2"> issued by the Committee of Sponsoring Organizations of the Treadway Commission.
As allowed by SEC guidance, management excluded from its assessment the 2010 acquisitions of Solvay's pharmaceuticals business and Piramal Healthcare Limited's Healthcare Solutions business which
accounted for approximately 20&nbsp;percent of consolidated total assets and 9&nbsp;percent of consolidated net sales as of and for the year ended December&nbsp;31, 2010. Based on our
assessment, we believe that, as of December&nbsp;31, 2010, the company's internal control over financial reporting was effective based on those criteria. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott's
independent registered public accounting firm has issued an audit report on their assessment of the effectiveness of the company's internal control over financial reporting.
This report appears on page&nbsp;87. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Miles
D. White<br>
CHAIRMAN OF THE BOARD AND CHIEF EXECUTIVE OFFICER </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Thomas
C. Freyman<br>
EXECUTIVE VICE PRESIDENT, FINANCE AND CHIEF FINANCIAL OFFICER </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Greg
W. Linder<br>
VICE PRESIDENT AND CONTROLLER </font></p>


<p style="font-family:times;text-align:justify"><font size="2">February&nbsp;18,
2011 </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">85</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=86,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=886821,FOLIO='85',FILE='DISK114:[11ZAD1.11ZAD42901]GM42901A.;10',USER='EYOUNG',CD='14-FEB-2011;16:19' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_gn42901_1_86"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="gn42901_reports_of_independent__gn402342"> </a>
<a name="toc_gn42901_1"> </a>
<br></font><font size="2"><b>  Reports of Independent Registered Public Accounting Firm    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">To
the Board of Directors and Shareholders of Abbott Laboratories: </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have audited the accompanying consolidated balance sheets of Abbott Laboratories and subsidiaries (the "Company") as of December&nbsp;31, 2010, 2009, and 2008, and the related
consolidated statements of earnings, shareholders' investment, and cash flows for the years then ended. These financial statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on our audits. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to
obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement
presentation. We believe that our audits provide a reasonable basis for our opinion. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December&nbsp;31, 2010, 2009, and 2008, and
the results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
discussed in Note&nbsp;10 to the consolidated financial statements, the Company adopted the provisions of a new accounting standard relating to business combinations in 2009. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the Company's internal control over financial reporting as of
December&nbsp;31, 2010, based on the criteria established in </font><font size="2"><i>Internal Control — Integrated Framework</i></font><font size="2"> issued by the Committee of Sponsoring
Organizations of the Treadway Commission and our report dated February&nbsp;18, 2011 expressed an unqualified opinion on the Company's internal control over financial reporting. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">/s/
DELOITTE&nbsp;&amp; TOUCHE&nbsp;LLP </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Chicago,
Illinois<br>
February&nbsp;18, 2011 </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">86</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=87,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=383279,FOLIO='86',FILE='DISK114:[11ZAD1.11ZAD42901]GN42901A.;9',USER='VSTEFAN',CD='14-FEB-2011;04:12' -->
<a name="page_gn42901_1_87"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<p style="font-family:times;text-align:justify"><font size="2">To
the Board of Directors and Shareholders of Abbott Laboratories: </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have audited the internal control over financial reporting of Abbott Laboratories and subsidiaries (the "Company") as of December&nbsp;31, 2010, based on criteria established in </font> <font size="2"><i>Internal Control&nbsp;— Integrated
Framework</i></font><font size="2"> issued by the Committee of Sponsoring Organizations of the Treadway Commission. As described
in Management Report on Internal Control Over Financial Reporting, management excluded from its assessment the 2010 acquisitions of Solvay's pharmaceuticals business and Piramal Healthcare Limited's
Healthcare Solutions business which accounted for approximately 20&nbsp;percent of consolidated total assets and 9&nbsp;percent of consolidated net sales as of and for the year ended
December&nbsp;31, 2010. Accordingly, our audit did not include the internal control over financial reporting at Solvay's pharmaceuticals business or Piramal Healthcare Limited's Healthcare Solutions
business. The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial
reporting, included in the accompanying Management Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company's internal control over financial
reporting based on our audit. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to
obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control
over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and
performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
company's internal control over financial reporting is a process designed by, or under the supervision of, the company's principal executive and principal financial officers, or
persons performing similar functions, and effected by the company's board of directors, management, and other personnel to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those
policies and procedures that (1)&nbsp;pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company;
(2)&nbsp;provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that
receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3)&nbsp;provide reasonable assurance regarding
prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Because
of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material
misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to
future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December&nbsp;31, 2010, based on the criteria established in </font> <font size="2"><i>Internal Control&nbsp;— Integrated
Framework</i></font><font size="2"> issued by the Committee of Sponsoring Organizations of the Treadway Commission. </font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated financial statements of the Company as of and
for the year ended December&nbsp;31, 2010 and our report dated February&nbsp;18, 2011 expresses an unqualified opinion on those financial statements and includes an explanatory paragraph regarding
the Company's adoption of a new accounting standard in 2009. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">/s/
DELOITTE&nbsp;&amp; TOUCHE&nbsp;LLP </font></p>


<p style="font-family:times;text-align:justify"><font size="2">Chicago,
Illinois<br>
February&nbsp;18, 2011 </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">87</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=2,SEQ=88,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=622767,FOLIO='87',FILE='DISK114:[11ZAD1.11ZAD42901]GN42901A.;9',USER='VSTEFAN',CD='14-FEB-2011;04:12' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_go42901_1_88"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><a name="go42901_item_9._changes_in_and_disagre__ite03576"> </a>
<a name="toc_go42901_1"> </a></font> <font size="2"><b>  ITEM&nbsp;9.&nbsp;&nbsp;&nbsp;&nbsp;CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None.  </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><a name="go42901_item_9a._controls_and_procedures"> </a>
<a name="toc_go42901_2"> </a></font> <font size="2"><b>  ITEM&nbsp;9A.&nbsp;&nbsp;&nbsp;&nbsp;CONTROLS AND PROCEDURES    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Disclosure Controls and Procedures  </b></font></p>


<p style="font-family:times;text-align:justify"><font size="2"><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Evaluation of disclosure controls and procedures.</i></font><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;The Chief Executive Officer, Miles D. White, and the Chief Financial Officer, Thomas
C. Freyman,
evaluated the effectiveness of Abbott Laboratories' disclosure controls and procedures as of the end of the period covered by this report, and concluded that Abbott Laboratories' disclosure controls
and procedures were effective to ensure that information Abbott is required to disclose in the reports that it files or submits with the Securities and Exchange Commission under the Securities
Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in the Commission's rules and forms, and to ensure that information required to be disclosed by
Abbott in the reports that it files or submits under the Exchange Act is accumulated and communicated to Abbott's management, including its principal executive officer and principal financial officer,
as appropriate to allow timely decisions regarding required disclosure. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><b> Internal Control Over Financial Reporting  </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><i> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Management's annual report on internal control over financial reporting.</i></font><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;Management's report on Abbott's internal control over
financial reporting is
included on page&nbsp;85 hereof. The report of Abbott's independent registered public accounting firm related to their assessment of the effectiveness of internal control over financial reporting is
included on page&nbsp;87 hereof. </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><i> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in internal control over financial reporting.</i></font><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;During the quarter ended December&nbsp;31, 2010, there were no changes in
Abbott's internal
control over financial reporting (as defined in Rule&nbsp;13a-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, Abbott's
internal control over financial reporting.  </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><a name="go42901_item_9b._other_information"> </a>
<a name="toc_go42901_3"> </a></font> <font size="2"><b>  ITEM&nbsp;9B.&nbsp;&nbsp;&nbsp;&nbsp;OTHER INFORMATION    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">88</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=89,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=741625,FOLIO='88',FILE='DISK114:[11ZAD1.11ZAD42901]GO42901A.;8',USER='EYOUNG',CD='14-FEB-2011;16:19' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_gq42901_1_89"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->



<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="gq42901_part_iii"> </a>
<a name="toc_gq42901_1"> </a>
<br></font><font size="2"><b>  PART III    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><a name="gq42901_item_10._directors,_executive___ite02336"> </a>
<a name="toc_gq42901_2"> </a></font> <font size="2"><b>  ITEM 10.&nbsp;&nbsp;&nbsp;&nbsp;DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated herein by reference are "Information Concerning Nominees for Directors," "Committees of the Board of Directors,"
"Section&nbsp;16(a) Beneficial Ownership Reporting
Compliance," and "Procedure for Recommendation and Nomination of Directors and Transaction of Business at Annual Meeting" to be included in the 2011 Abbott Laboratories Proxy Statement. The 2011 Proxy
Statement will be filed on or about March&nbsp;15, 2011. Also incorporated herein by reference is the text found under the caption, "Executive Officers of the Registrant" on pages&nbsp;21 through
24 hereof. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott
has adopted a code of ethics that applies to its principal executive officer, principal financial officer, and principal accounting officer and controller. That code is part of
Abbott's code of business conduct which is available free of charge through Abbott's investor relations website (www.abbottinvestor.com). Abbott intends to include on its website (www.abbott.com) any
amendment to, or waiver from, a provision of its code of ethics that applies to Abbott's principal executive officer, principal financial officer, and principal accounting officer and controller that
relates to any element of the code of ethics definition enumerated in Item&nbsp;406(b) of Regulation&nbsp;S-K.  </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><a name="gq42901_item_11._executive_compensation"> </a>
<a name="toc_gq42901_3"> </a></font> <font size="2"><b>  ITEM 11.&nbsp;&nbsp;&nbsp;&nbsp;EXECUTIVE COMPENSATION    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The material to be included in the 2011 Proxy Statement under the headings "Director Compensation," "Executive Compensation," and
"Compensation Committee Report" is incorporated herein by reference. The 2011 Proxy Statement will be filed on or about March&nbsp;15, 2011.  </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><a name="gq42901_item_12._security_ownership_of__ite04004"> </a>
<a name="toc_gq42901_4"> </a></font> <font size="2"><b>  ITEM 12.&nbsp;&nbsp;&nbsp;&nbsp;SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS    <br>    </b></font></p>

<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(a)</font></dt><dd style="font-family:times;text-align:justify"><font size="2"><i>Equity Compensation Plan Information.  </i></font></dd></dl>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="81pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="81pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="6pt" align="RIGHT"></td>
<td style="font-family:times;" width="81pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" nowrap="" align="LEFT"><div style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:50pt;"><font size="1"><b>Plan Category

<!-- COMMAND=ADD_SCROPPEDRULE,50pt -->

 </b></font></div></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>(a)<br>
Number of<br>
securities to be<br>
issued upon<br>
exercise of<br>
outstanding<br>
options,<br>
warrants and<br>
rights </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>(b)<br>
Weighted-<br>
average exercise<br>
price of<br>
outstanding<br>
options,<br>
warrants and<br>
rights </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>(c)<br>
Number of<br>
securities<br>
remaining<br>
available for<br>
future issuance<br>
under equity<br>
compensation<br>
plans (excluding<br>
securities<br>
reflected in<br>
column (a)) </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Equity compensation plans approved by security holders<sup>1</sup></font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">109,921,688</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">50.46</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">208,928,115</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Equity compensation plans not approved by security holders</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">0</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">—</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">0</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><font size="2"> </font><font size="2">Total<sup>1</sup></font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">109,921,688</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">50.46</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><font size="2">208,928,115</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<hr width="26%" size="1.0PT" noshade="" color="#000000" align="LEFT">


<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">1.</font></dt><dd style="font-family:times;text-align:justify"><font size="2">(i)
</font><font size="2"><i>Abbott Laboratories 1996 Incentive Stock Program</i></font><font size="2">. Benefits under the 1996 Program include stock options
intended to qualify for special tax treatment under Section&nbsp;422 of the Internal Revenue Code ("incentive stock options"), stock options that do not qualify for that special tax treatment
("non-qualified stock options"), restricted stock, restricted stock units, stock appreciation rights, performance awards, and foreign qualified benefits. The shares that remain available
for issuance under the 1996 Program may be issued in connection with any one of these benefits and may be either authorized but unissued shares or treasury shares (except that restricted stock awards
may be satisfied only from treasury shares). </font></dd></dl>
<ul>

<p style="font-family:times;text-align:justify"><font size="2">If
there is a lapse, expiration, termination, forfeiture or cancellation of any benefit granted under the 1996 Program without the issuance of shares or payment of cash thereunder, the shares subject
to or reserved for that benefit, or so reacquired, may again be used for new stock options, rights, or awards </font></p>

</ul>
<p style="font-family:times;" align="CENTER"><font size="2">89</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=90,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=274230,FOLIO='89',FILE='DISK114:[11ZAD1.11ZAD42901]GQ42901A.;11',USER='BHOLLIN',CD='16-FEB-2011;10:40' -->
<a name="page_gq42901_1_90"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<ul>

<p style="font-family:times;text-align:justify"><font size="2">of
any type authorized under the 1996 Program. If shares are issued under any benefit under the 1996 Program and thereafter are reacquired by Abbott pursuant to rights reserved upon their issuance, or
pursuant to the payment of the purchase price of shares under stock options by delivery of other common shares of Abbott, the shares subject to or reserved for that benefit, or so reacquired, may not
again be used for new stock options, rights, or awards of any type authorized under the 1996 Program. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">In
April 2009, the 1996 Program was replaced by the Abbott Laboratories 2009 Incentive Stock Program. No further awards will be granted under the 1996 Program. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">(ii)
</font><font size="2"><i>Abbott Laboratories 2009 Incentive Stock Program.</i></font><font size="2"> Benefits under the 2009 Program include stock options that do not qualify for special tax
treatment under Section&nbsp;422 of the Internal Revenue Code ("non-qualified stock options"), restricted stock, restricted stock units, performance awards, other share-based awards
(including stock appreciation rights, dividend equivalents and recognition awards), awards to non-employee directors, and foreign benefits. The shares that remain available for issuance
under the 2009 Program may be issued in connection with any one of these benefits and may be either authorized but unissued shares or treasury shares (except that restricted stock awards may be
satisfied only from treasury shares). </font></p>

<p style="font-family:times;text-align:justify"><font size="2">If
there is a lapse, expiration, termination, forfeiture or cancellation of any benefit granted under the 2009 Program without the issuance of shares or payment of cash thereunder, the shares subject
to or reserved for that benefit, or so reacquired, may again be used for new stock options, rights, or awards of any type authorized under the 2009 Program. If shares are issued under any benefit
under the 2009 Program and thereafter are reacquired by Abbott pursuant to rights reserved upon their issuance, or pursuant to the payment of the purchase price of shares under stock options by
delivery of other common shares of Abbott, the shares subject to or reserved for that benefit, or so reacquired, may not again be used for new stock options, rights, or awards of any type authorized
under the 2009 Program. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">(iii)
</font><font size="2"><i>Abbott Laboratories 2009 Employee Stock Purchase Plan for Non-U.S. Employees.</i></font><font size="2"> Eligible employees of participating non-U.S.
affiliates of Abbott may participate in this plan. An eligible employee may authorize payroll deductions at the rate of 1% to 10% of eligible compensation (in multiples of one percent) subject to a
limit of US $12,500 during any purchase cycle. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Purchase
cycles are generally six months long and usually begin on August&nbsp;1 and February&nbsp;1. On the last day of each purchase cycle, Abbott uses participant contributions to acquire
Abbott common shares. The shares acquired come from treasury shares. The purchase price is 85% of the lower of the fair market value of the shares on that date or on the first day of that purchase
cycle. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">(iv)
</font><font size="2"><i>Advanced Medical Optics,&nbsp;Inc. Plans.</i></font><font size="2"> In 2009, in connection with its acquisition of Advanced Medical Optics,&nbsp;Inc., Abbott assumed
options outstanding under the Amended and Restated Advanced Medical Optics,&nbsp;Inc. 2002 Incentive Compensation Plan, as amended; AMO's 2004 Stock Incentive Plan, as amended and restated; the
Advanced Medical Optics,&nbsp;Inc. 2005 Incentive Compensation Plan; the VISX, Incorporated 1995 Director Option and Stock Deferral Plan, as amended and restated; the VISX, Incorporated 1995 Stock
Plan, as amended; the VISX, Incorporated 2000 Stock Plan; and the VISX, Incorporated 2001 Nonstatutory Stock Option Plan. As of December&nbsp;31, 2010, 2,195,856 options remained outstanding under
the plans. These options have a weighted average purchase price of $67.68. No further awards will be granted under the plans. </font></p>

</ul>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
additional information concerning the Abbott Laboratories 1996 Incentive Stock Program, the Abbott Laboratories 2009 Incentive Stock Program, and the Abbott Laboratories 2009
Employee Stock Purchase Plan for Non-U.S. Employees, see the discussion in Note&nbsp;8 entitled "Incentive Stock Program" of the Notes to Consolidated Financial Statements included under
Item&nbsp;8, "Financial Statements and Supplementary Data." </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">90</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=2,SEQ=91,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=524276,FOLIO='90',FILE='DISK114:[11ZAD1.11ZAD42901]GQ42901A.;11',USER='BHOLLIN',CD='16-FEB-2011;10:40' -->
<a name="page_gq42901_1_91"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>

<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(b)</font></dt><dd style="font-family:times;text-align:justify"><font size="2"><i>Information Concerning Security Ownership</i></font><font size="2">. Incorporated herein by reference is the material under the
heading "Security Ownership of Executive Officers and Directors" in the 2011 Proxy Statement. The 2011 Proxy Statement will be filed on or about March&nbsp;15, 2011.  </font></dd></dl>

<p style="font-family:times;text-align:justify"><font size="2"><a name="gq42901_item_13._certain_relationships__ite03067"> </a>
<a name="toc_gq42901_5"> </a></font> <font size="2"><b>  ITEM 13.&nbsp;&nbsp;&nbsp;&nbsp;CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The material to be included in the 2011 Proxy Statement under the headings "The Board of Directors," "Committees of the Board of
Directors," "Corporate Governance Materials," and "Approval Process for Related Person Transactions" is incorporated herein by reference. The 2011 Proxy Statement will be filed on or about
March&nbsp;15, 2011.  </font></p>

<p style="font-family:times;text-align:justify"><font size="2"><a name="gq42901_item_14._principal_accounting_fees_and_services"> </a>
<a name="toc_gq42901_6"> </a></font> <font size="2"><b>  ITEM 14.&nbsp;&nbsp;&nbsp;&nbsp;PRINCIPAL ACCOUNTING FEES AND SERVICES    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The material to be included in the 2011 Proxy Statement under the headings "Audit Fees and Non-Audit Fees" and "Policy on
Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of the Independent Auditor" is incorporated herein by reference. The 2011 Proxy Statement will be filed
on or about March&nbsp;15, 2011. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">91</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=3,SEQ=92,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=864187,FOLIO='91',FILE='DISK114:[11ZAD1.11ZAD42901]GQ42901A.;11',USER='BHOLLIN',CD='16-FEB-2011;10:40' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_gs42901_1_92"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="gs42901_part_iv"> </a>
<a name="toc_gs42901_1"> </a>
<br></font><font size="2"><b>  PART IV    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2"><a name="gs42901_item_15._exhibits,_financial_statement_schedules"> </a>
<a name="toc_gs42901_2"> </a></font> <font size="2"><b>  ITEM 15.&nbsp;&nbsp;&nbsp;&nbsp;EXHIBITS, FINANCIAL STATEMENT SCHEDULES    <br>    </b></font></p>

<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(a)</font></dt><dd style="font-family:times;text-align:justify"><font size="2"><i>Documents filed as part of this Form&nbsp;10-K.</i></font><font size="2">
<br><br></font>
<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(1)</font></dt><dd style="font-family:times;text-align:justify"><font size="2"><i>Financial Statements:</i></font><font size="2"> See Item&nbsp;8, "Financial Statements and Supplementary Data," on page&nbsp;49
hereof, for a list of financial statements.
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(2)</font></dt><dd style="font-family:times;text-align:justify"><font size="2"><i>Financial Statement Schedules:</i></font><font size="2"> The required financial statement schedules are found on the pages indicated
below. These schedules should be read in conjunction with the Consolidated Financial Statements of Abbott Laboratories: </font></dd></dl>
</dd></dl>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="40pt"></td>
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="100pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;"><font size="2">&nbsp;</font></th>
<th style="font-family:times;" nowrap="" align="LEFT"><div style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:182pt;"><font size="1"><b>Abbott Laboratories Financial Statement Schedules

<!-- COMMAND=ADD_SCROPPEDRULE,182pt -->

 </b></font></div></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Page No. </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Valuation and Qualifying Accounts (Schedule&nbsp;II)</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="CENTER"><font size="2">95</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Schedules&nbsp;I, III, IV, and V are not submitted because they are not applicable or not required</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="#CCEEFF">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Report of Independent Registered Public Accounting Firm</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="CENTER"><font size="2">96</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="BOTTOM" bgcolor="White">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">Individual Financial Statements of businesses acquired by the registrant have been omitted pursuant to Rule&nbsp;3.05 of Regulation&nbsp;S-X</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <ul>
<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(3)</font></dt><dd style="font-family:times;text-align:justify"><font size="2"><i>Exhibits Required by Item&nbsp;601 of Regulation&nbsp;S-K:</i></font><font size="2"> The information called for by
this paragraph is incorporated herein by reference to the Exhibit Index on pages 97 through 105 of this Form&nbsp;10-K.
<br><br></font></dd></dl>
</ul>
<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(b)</font></dt><dd style="font-family:times;text-align:justify"><font size="2"><i>Exhibits filed (see Exhibit Index on pages&nbsp;97 through 105).</i></font><font size="2">
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(c)</font></dt><dd style="font-family:times;text-align:justify"><font size="2"><i>Financial Statement Schedule filed (page&nbsp;95).  </i></font></dd></dl>
<p style="font-family:times;" align="CENTER"><font size="2">92</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=93,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=479575,FOLIO='92',FILE='DISK114:[11ZAD1.11ZAD42901]GS42901A.;12',USER='ANEETZ',CD='15-FEB-2011;17:13' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_jc42901_1_93"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="jc42901_signatures"> </a>
<a name="toc_jc42901_1"> </a>
<br></font><font size="2"><b>  SIGNATURES    <br>    </b></font></p>

<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934, Abbott Laboratories has duly caused
this report to be signed on its behalf by the undersigned, thereunto duly authorized. </font></p>
 <div style="padding:0pt;position:relative;width:100%;text-align:l;margin-left:0%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="48%"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="18pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="43%"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="TOP">
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td colspan="3" style="font-family:times;"><font size="2">ABBOTT LABORATORIES</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;" valign="BOTTOM"><font size="2"><br>
&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"><br>&nbsp;</font></td>
<td style="font-family:times;"><br><font size="2"> By</font></td>
<td style="font-family:times;"><font size="2"><br>&nbsp;</font></td>
<td style="font-family:times;"><br><font size="2"> /s/&nbsp;MILES D. WHITE<br>


<hr width="100%" size="1.0pt" noshade="" color="#000000">

</font> <font size="2"> Miles D. White<br>
Chairman of the Board and<br>
Chief Executive Officer</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;" valign="BOTTOM"><font size="2"><br>
&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2"><br>&nbsp;</font></td>
<td colspan="3" style="font-family:times;"><br><font size="2">Date: February&nbsp;18, 2011</font></td>
</tr>
</tbody></table>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of Abbott Laboratories on February 18, 2011 in
the capacities indicated below. </font></p>
 <div style="padding:0pt;position:relative;width:100%;text-align:l;margin-left:0%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="48%"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="48%"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="TOP">
<td style="font-family:times;"><font size="2">/s/&nbsp;MILES D. WHITE<br>


<hr width="100%" size="1.0pt" noshade="" color="#000000">

</font> <font size="2"> Miles D. White<br>
Chairman of the Board, Chief Executive Officer and Director of Abbott Laboratories (principal&nbsp;executive officer)</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> /s/&nbsp;THOMAS C. FREYMAN<br>


<hr width="100%" size="1.0pt" noshade="" color="#000000">

</font> <font size="2"> Thomas C. Freyman<br>
Executive Vice President, Finance and Chief Financial Officer (principal financial officer)</font></td>
</tr>
<tr valign="BOTTOM">
<td style="font-family:times;" valign="TOP"><br><font size="2">/s/&nbsp;GREG W. LINDER<br>


<hr width="100%" size="1.0pt" noshade="" color="#000000">

</font> <font size="2"> Greg W. Linder<br>
Vice President and Controller<br>
(principal accounting officer)</font></td>
<td style="font-family:times;" valign="TOP"><font size="2"><br>&nbsp;</font></td>
<td style="font-family:times;" valign="TOP"><font size="2"><br>
&nbsp;</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><br><font size="2">/s/&nbsp;ROBERT J. ALPERN, M.D.<br>


<hr width="100%" size="1.0pt" noshade="" color="#000000">

</font> <font size="2"> Robert J. Alpern, M.D.<br>
Director of Abbott Laboratories</font></td>
<td style="font-family:times;"><font size="2"><br>&nbsp;</font></td>
<td style="font-family:times;"><br><font size="2"> /s/&nbsp;ROXANNE S. AUSTIN<br>


<hr width="100%" size="1.0pt" noshade="" color="#000000">

</font> <font size="2"> Roxanne S. Austin<br>
Director of Abbott Laboratories</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><br><font size="2">/s/&nbsp;W. JAMES FARRELL<br>


<hr width="100%" size="1.0pt" noshade="" color="#000000">

</font> <font size="2"> W. James Farrell<br>
Director of Abbott Laboratories</font></td>
<td style="font-family:times;"><font size="2"><br>&nbsp;</font></td>
<td style="font-family:times;"><br><font size="2"> /s/&nbsp;H. LAURANCE FULLER<br>


<hr width="100%" size="1.0pt" noshade="" color="#000000">

</font> <font size="2"> H. Laurance Fuller<br>
Director of Abbott Laboratories</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><br><font size="2">/s/&nbsp;EDWARD M. LIDDY<br>


<hr width="100%" size="1.0pt" noshade="" color="#000000">

</font> <font size="2"> Edward M. Liddy<br>
Director of Abbott Laboratories</font></td>
<td style="font-family:times;"><font size="2"><br>&nbsp;</font></td>
<td style="font-family:times;"><br><font size="2"> /s/&nbsp;PHEBE N. NOVAKOVIC<br>


<hr width="100%" size="1.0pt" noshade="" color="#000000">

</font> <font size="2"> Phebe N. Novakovic<br>
Director of Abbott Laboratories</font></td>
</tr>
</tbody></table>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">93</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=94,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=274901,FOLIO='93',FILE='DISK114:[11ZAD1.11ZAD42901]JC42901A.;11',USER='MWEINST',CD='15-FEB-2011;10:27' -->
<a name="page_jc42901_1_94"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>
 <div style="padding:0pt;position:relative;width:100%;text-align:l;margin-left:0%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="48%"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="48%"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="TOP">
<td style="font-family:times;"><font size="2">/s/&nbsp;WILLIAM A. OSBORN<br>


<hr width="100%" size="1.0pt" noshade="" color="#000000">

</font> <font size="2"> William A. Osborn<br>
Director of Abbott Laboratories</font></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><font size="2"> /s/&nbsp;DAVID A. L. OWEN<br>


<hr width="100%" size="1.0pt" noshade="" color="#000000">

</font> <font size="2"> David A. L. Owen<br>
Director of Abbott Laboratories</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><br><font size="2">/s/&nbsp;ROY S. ROBERTS<br>


<hr width="100%" size="1.0pt" noshade="" color="#000000">

</font> <font size="2"> Roy S. Roberts<br>
Director of Abbott Laboratories</font></td>
<td style="font-family:times;"><font size="2"><br>&nbsp;</font></td>
<td style="font-family:times;"><br><font size="2"> /s/&nbsp;SAMUEL C. SCOTT III<br>


<hr width="100%" size="1.0pt" noshade="" color="#000000">

</font> <font size="2"> Samuel C. Scott III<br>
Director of Abbott Laboratories</font></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><br><font size="2">/s/&nbsp;WILLIAM D. SMITHBURG<br>


<hr width="100%" size="1.0pt" noshade="" color="#000000">

</font> <font size="2"> William D. Smithburg<br>
Director of Abbott Laboratories</font></td>
<td style="font-family:times;"><font size="2"><br>&nbsp;</font></td>
<td style="font-family:times;"><br><font size="2"> /s/&nbsp;GLENN F. TILTON<br>


<hr width="100%" size="1.0pt" noshade="" color="#000000">

</font> <font size="2"> Glenn F. Tilton<br>
Director of Abbott Laboratories</font></td>
</tr>
</tbody></table>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">94</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=2,SEQ=95,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=457210,FOLIO='94',FILE='DISK114:[11ZAD1.11ZAD42901]JC42901A.;11',USER='MWEINST',CD='15-FEB-2011;10:27' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_je42901_1_95"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->



<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="je42901_abbott_laboratories_and_subsid__abb05375"> </a>
<a name="toc_je42901_1"> </a>
<br></font><font size="2"><b>  ABBOTT LABORATORIES AND SUBSIDIARIES<br>  SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS<br>  FOR THE YEARS ENDED DECEMBER 31, 2010, 2009, AND 2008<br>  (in thousands of dollars)    <br>    </b></font></p>
 <div style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width=""></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="60pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="53pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="59pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="56pt"></td>
<td style="font-family:times;" width="12pt"></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th style="font-family:times;" nowrap="" align="LEFT"><div style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:119pt;"><font size="1"><b>Allowances for Doubtful Accounts

<!-- COMMAND=ADD_SCROPPEDRULE,119pt -->

 </b></font></div></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Balance<br>
at Beginning<br>
of Year </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Provisions/<br>
Charges<br>
to Income </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Amounts<br>
Charged Off<br>
Net of<br>
Recoveries </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>Balance at<br>
End of Year </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2010</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">311,546</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">93,086</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">(1)</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(16,068</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">$</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">388,564</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="White">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2009</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">263,632</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">75,703</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(27,789</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">311,546</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
<tr valign="TOP" bgcolor="#CCEEFF">
<td style="font-family:times;" valign="BOTTOM"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><font size="2"> </font><font size="2">2008</font></p></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">258,288</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">20,057</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">(14,713</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">)</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" valign="BOTTOM" align="RIGHT"><font size="2">263,632</font></td>
<td style="font-family:times;" valign="BOTTOM"><font size="2">&nbsp;</font></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
<div style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<hr width="26%" size="1.0PT" noshade="" color="#000000" align="LEFT">


<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">(1)</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Includes
increases in the allowance due to business acquisitions of $64,862. </font></dd></dl>
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">95</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=96,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=494966,FOLIO='95',FILE='DISK114:[11ZAD1.11ZAD42901]JE42901A.;9',USER='GLOPEZA',CD='14-FEB-2011;16:23' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_jg42901_1_96"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="jg42901_report_of_independent___jg402288"> </a>
<a name="toc_jg42901_1"> </a>
<br></font><font size="2"><b>  REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM    <br>    </b></font></p>


<p style="font-family:times;text-align:justify"><font size="2">To
the Board of Directors and Shareholders of Abbott Laboratories: </font></p>

<p style="font-family:times;text-align:justify"><font size="2">We
have audited the consolidated financial statements of Abbott Laboratories and subsidiaries (the "Company") as of and for the years ended December&nbsp;31, 2010, 2009, and 2008, and the Company's
internal control over financial reporting as of December&nbsp;31, 2010, and have issued our reports thereon dated February&nbsp;18, 2011, which report relating to the consolidated financial
statements expresses an unqualified opinion and includes an explanatory paragraph regarding the Company's adoption of a new
accounting standard in 2009; such reports are included elsewhere in this Form&nbsp;10-K. Our audits also included the consolidated financial statement schedule of the Company listed in
Item&nbsp;15. This consolidated financial statement schedule is the responsibility of the Company's management. Our responsibility is to express an opinion based on our audits. In our opinion, such
consolidated financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set
forth therein. </font></p>

<p style="font-family:times;text-align:justify"><font size="2">/s/
DELOITTE&nbsp;&amp; TOUCHE&nbsp;LLP </font></p>

<p style="font-family:times;text-align:justify"><font size="2">Chicago,
Illinois<br>
February&nbsp;18, 2011 </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">96</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=97,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=633808,FOLIO='96',FILE='DISK114:[11ZAD1.11ZAD42901]JG42901A.;11',USER='MWEINST',CD='18-FEB-2011;11:54' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<p style="font-family:times;text-align:justify"><font size="2"><a name="page_ka42901_1_97"> </a>


<!-- COMMAND=ADD_BASECOLOR,"Black" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
</font></p>

<!-- TOC_END -->

<p style="font-family:times;text-align:justify"><font size="2">
<a href="#du42901a_main_toc">Table of Contents</a> </font></p>

<p style="font-family:times;" align="CENTER"><font size="2"><a name="ka42901_exhibit_index_abbott_laborator__exh02125"> </a>
<a name="toc_ka42901_1"> </a>
<br></font><font size="2"><b>  EXHIBIT INDEX<br>  ABBOTT LABORATORIES<br>  ANNUAL REPORT<br>  FORM 10-K<br>  2010    <br>    </b></font></p>


<p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits&nbsp;32.1 and 32.2 are furnished herewith and should not be deemed to be "filed under the Securities Exchange Act of 1934." </font></p>
 <div style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="42pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width=""></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>10-K<br>
Exhibit<br>
Table<br>
Item No. </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">2.1</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Stock and Asset Purchase Agreement among Solvay&nbsp;SA and the other Sellers (as defined in the Agreement) and Abbott Laboratories and the
other Buyers (as defined in the Agreement), dated as of September&nbsp;26, 2009, filed as Exhibit&nbsp;2.1 to the Abbott Laboratories Quarterly Report on Form&nbsp;10-Q for the quarter ended September&nbsp;30, 2009.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">2.2</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Amendment No.&nbsp;1, dated February&nbsp;15, 2010, to Stock and Asset Purchase Agreement among Solvay&nbsp;SA and the other
Sellers (as defined in the Agreement) and Abbott Laboratories and the other Buyers (as defined in the Agreement), dated as of September&nbsp;26, 2009, filed as Exhibit&nbsp;2.2 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated
February&nbsp;16, 2010.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">2.3</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Business Transfer Agreement, dated May&nbsp;21, 2010, by and among Abbott Healthcare Private Limited, Abbott Laboratories,
Piramal and certain shareholders of Piramal, filed as Exhibit&nbsp;2.1 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated May&nbsp;21, 2010.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">2.4</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Amendment No.&nbsp;1 to Business Transfer Agreement, dated September&nbsp;8, 2010, by and among Abbott Healthcare Private
Limited, Abbott Laboratories, Piramal Healthcare Limited ("Piramal") and certain shareholders of Piramal, filed as Exhibit&nbsp;2.2 to the Abbott Laboratories Current Report on Form&nbsp;8-K filed September&nbsp;8, 2010.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">3.1</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Articles of Incorporation, Abbott Laboratories, filed as Exhibit&nbsp;3.1 to the Abbott Laboratories Quarterly Report on
Form&nbsp;10-Q for the quarter ended March&nbsp;31, 1998.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">3.2</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *By-Laws of Abbott Laboratories, as amended and restated effective as of January&nbsp;7, 2011, filed as Exhibit&nbsp;3.1 to
the Abbott Laboratories Current Report on Form&nbsp;8-K dated January&nbsp;13, 2011.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.1</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Indenture dated as of February&nbsp;9, 2001, between Abbott Laboratories and The Bank of New York Mellon Trust Company, N.A.
(as successor to J.P. Morgan Trust Company, National Association, successor to Bank One Trust Company, N.A.) (including form of Security), filed as Exhibit&nbsp;4.1 to the Abbott Laboratories Registration Statement on Form&nbsp;S-3 dated
February&nbsp;12, 2001.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.2</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Supplemental Indenture dated as of February&nbsp;27, 2006, between Abbott Laboratories and The Bank of New York Mellon Trust
Company, N.A. (as successor to J.P. Morgan Trust Company, National Association), filed as Exhibit&nbsp;4.2 to the Abbott Laboratories Registration Statement on Form&nbsp;S-3 dated February&nbsp;28, 2006.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.3</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of 3.5% Note, filed as Exhibit&nbsp;4.29 to the 2003 Abbott Laboratories Annual Report on Form&nbsp;10-K.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.4</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Actions of Authorized Officers with Respect to Abbott's 3.5% Notes, filed as Exhibit&nbsp;4.30 to the 2003 Abbott
Laboratories Annual Report on Form&nbsp;10-K.</font></p></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">97</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=1,SEQ=98,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=783057,FOLIO='97',FILE='DISK114:[11ZAD1.11ZAD42901]KA42901A.;8',USER='GLOPEZA',CD='14-FEB-2011;16:20' -->
<a name="page_ka42901_1_98"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>
 <div style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="42pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width=""></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>10-K<br>
Exhibit<br>
Table<br>
Item No. </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.5</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Officers' Certificate and Company Order with respect to Abbott's 3.5% Notes, filed as Exhibit&nbsp;4.31 to the 2003 Abbott Laboratories
Annual Report on Form&nbsp;10-K.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.6</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of 3.75% Note, filed as Exhibit&nbsp;4.28 to the 2004 Abbott Laboratories Annual Report on Form&nbsp;10-K.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.7</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of 4.35% Note, filed as Exhibit&nbsp;4.29 to the 2004 Abbott Laboratories Annual Report on Form&nbsp;10-K.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.8</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Actions of Authorized Officers with respect to Abbott's 3.75% Notes and 4.35% Notes, filed as Exhibit&nbsp;4.30 to the 2004
Abbott Laboratories Annual Report on Form&nbsp;10-K.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.9</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Officers' Certificate and Company Order with respect to Abbott's 3.75% Notes and 4.35% Notes, filed as Exhibit&nbsp;4.31 to
the 2004 Abbott Laboratories Annual Report on Form&nbsp;10-K.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.10</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of 5.600% Note, filed as Exhibit&nbsp;99.3 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated May&nbsp;9,
2006.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.11</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of 5.875% Note, filed as Exhibit&nbsp;99.3 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated May&nbsp;9,
2006.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.12</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Actions of the Authorized Officers with respect to Abbott's 5.375% Notes, 5.600% Notes and 5.875% Notes, filed as
Exhibit&nbsp;99.3 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated May&nbsp;9, 2006.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.13</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Officers' Certificate and Company Order with respect to Abbott's 5.375% Notes, 5.600% Notes and 5.875% Notes, filed as
Exhibit&nbsp;4.25 to the 2006 Abbott Laboratories Report on Form&nbsp;10-K.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.14</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of $1,000,000,000 5.150% Note due 2012, filed as Exhibit&nbsp;99.4 to the Abbott Laboratories Current Report on
Form&nbsp;8-K dated November&nbsp;6, 2007.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.15</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of $1,500,000,000 5.600% Note due 2017, filed as Exhibit&nbsp;99.5 to the Abbott Laboratories Current Report on
Form&nbsp;8-K dated November&nbsp;6, 2007.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.16</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of $1,000,000,000 6.150% Note due 2037, filed as Exhibit&nbsp;99.6 to the Abbott Laboratories Current Report on
Form&nbsp;8-K dated November&nbsp;6, 2007.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.17</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Actions of the Authorized Officers with respect to Abbott's 5.150% Notes due 2012, 5.600% Notes due 2017 and 6.150% Notes
due 2037, filed as Exhibit&nbsp;99.3 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated November&nbsp;6, 2007.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.18</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of $2,000,000,000 5.125% Note due 2019, filed as Exhibit&nbsp;99.4 to the Abbott Laboratories Current Report on
Form&nbsp;8-K dated February&nbsp;26, 2009.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.19</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of $1,000,000,000 6.000% Note due 2039, filed as Exhibit&nbsp;99.5 to the Abbott Laboratories Current Report on
Form&nbsp;8-K dated February&nbsp;26, 2009.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.20</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Actions of the Authorized Officers with respect to Abbott's 5.125% Note due 2019 and 6.000% Note due 2039, filed as
Exhibit&nbsp;99.3 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated February&nbsp;26, 2009.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.21</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of 2015 Note, filed as Exhibit&nbsp;99.4 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated May&nbsp;27,
2010.</font></p></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">98</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=2,SEQ=99,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=281049,FOLIO='98',FILE='DISK114:[11ZAD1.11ZAD42901]KA42901A.;8',USER='GLOPEZA',CD='14-FEB-2011;16:20' -->
<a name="page_ka42901_1_99"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>
 <div style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="42pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width=""></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>10-K<br>
Exhibit<br>
Table<br>
Item No. </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.22</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of 2020 Note, filed as Exhibit&nbsp;99.5 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated May&nbsp;27,
2010.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.23</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of 2040 Note, filed as Exhibit&nbsp;99.6 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated May&nbsp;27,
2010.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">4.24</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Actions of the Authorized Officers with respect to Abbott's 2.70% Notes, 4.125% Notes and 5.30% Notes, filed as
Exhibit&nbsp;99.3 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated May&nbsp;27, 2010.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> Other debt instruments are omitted in accordance with Item&nbsp;601(b)(4)(iii)(A) of Regulation&nbsp;S-K. Copies of such
agreements will be furnished to the Securities and Exchange Commission upon request.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.1</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Supplemental Plan Abbott Laboratories Extended Disability Plan, filed as an exhibit (pages&nbsp;50-51) to the 1992 Abbott
Laboratories Annual Report on Form&nbsp;10-K.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.2</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Abbott Laboratories Deferred Compensation Plan, as amended effective January&nbsp;1, 2008, filed as Exhibit&nbsp;4.1 to the
2008 Abbott Laboratories Annual Report on Form&nbsp;10-K.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.3</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Abbott Laboratories 401(k) Supplemental Plan, as amended and restated, filed as Exhibit&nbsp;10.3 to the 2009 Abbott
Laboratories Annual Report on Form&nbsp;10-K.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.4</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Abbott Laboratories Supplemental Pension Plan, as amended and restated, filed as Exhibit&nbsp;10.4 to the 2009 Abbott
Laboratories Annual Report on Form&nbsp;10-K.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.5</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *The 1986 Abbott Laboratories Management Incentive Plan, as amended and restated, filed as Exhibit&nbsp;10.5 to the 2009
Abbott Laboratories Annual Report on Form&nbsp;10-K.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.6</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *1998 Abbott Laboratories Performance Incentive Plan, as amended effective January&nbsp;1, 2008, filed as Exhibit&nbsp;10.7
to the 2008 Abbott Laboratories Annual Report on Form&nbsp;10-K.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.7</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Rules for the 1998 Abbott Laboratories Performance Incentive Plan, as amended and restated, filed as Exhibit&nbsp;10.7 to
the 2009 Abbott Laboratories Annual Report on Form&nbsp;10-K.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.8</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *The Abbott Laboratories 1996 Incentive Stock Program, as amended and restated through the 6th&nbsp;Amendment
February&nbsp;20, 2009, filed as Exhibit&nbsp;10.11 to the Abbott Laboratories Quarterly Report on Form&nbsp;10-Q for the quarter ended March&nbsp;31, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.9</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Abbott Laboratories 2009 Incentive Stock Program, filed as Exhibit&nbsp;B to the Abbott Laboratories Definitive Proxy
Statement on Schedule&nbsp;14A dated March&nbsp;13, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.10</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Abbott Laboratories Non-Employee Directors' Fee Plan, as amended and restated, filed as Exhibit&nbsp;10.10 to the 2009
Abbott Laboratories Annual Report on Form&nbsp;10-K.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.11</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Non-Employee Director Stock Option Agreement under the Abbott Laboratories 1996 Incentive Stock Program granted on
or after February&nbsp;18, 2005, filed as Exhibit&nbsp;10.7 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated February&nbsp;18, 2005.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.12</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Employee Stock Option Agreement for a Non-Qualified Stock Option granted with an Incentive Stock Option under the
Abbott Laboratories 1996 Incentive Stock Program, filed as Exhibit&nbsp;10.1 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated August&nbsp;20, 2004.**</font></p></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">99</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=3,SEQ=100,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=49260,FOLIO='99',FILE='DISK114:[11ZAD1.11ZAD42901]KA42901A.;8',USER='GLOPEZA',CD='14-FEB-2011;16:20' -->
<a name="page_ka42901_1_100"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>
 <div style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="42pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width=""></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>10-K<br>
Exhibit<br>
Table<br>
Item No. </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.13</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Employee Stock Option Agreement for a Non-Qualified Stock Option under the Abbott Laboratories 1996 Incentive Stock Program, filed
as Exhibit&nbsp;10.2 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated August&nbsp;20, 2004.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.14</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Employee Stock Option Agreement for an Incentive Stock Option granted with a Non-Qualified Stock Option under the
Abbott Laboratories 1996 Incentive Stock Program, filed as Exhibit&nbsp;10.3 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated August&nbsp;20, 2004.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.15</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Employee Stock Option Agreement for an Incentive Stock Option under the Abbott Laboratories 1996 Incentive Stock
Program, filed as Exhibit&nbsp;10.4 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated August&nbsp;20, 2004.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.16</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Employee Stock Option Agreement for a Replacement Stock Option under the Abbott Laboratories 1996 Incentive Stock
Program, filed as Exhibit&nbsp;10.5 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated August&nbsp;20, 2004.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.17</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Employee Restricted Stock Agreement under the Abbott Laboratories 1996 Incentive Stock Program, filed as
Exhibit&nbsp;10.6 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated August&nbsp;20, 2004.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.18</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Employee Restricted Stock Unit Agreement under the Abbott Laboratories 1996 Incentive Stock Program, filed as
Exhibit&nbsp;10.7 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated August&nbsp;20, 2004.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.19</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Non-Employee Director Stock Option Agreement under the Abbott Laboratories 1996 Incentive Stock Program, filed as
Exhibit&nbsp;10.8 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated August&nbsp;20, 2004.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.20</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Non-Employee Director Restricted Stock Unit Agreement under Abbott Laboratories 1996 Incentive Stock Program, filed
as Exhibit&nbsp;10.2 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated December&nbsp;10, 2004.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.21</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Employee Stock Option Agreement for a Non-Qualified Stock Option granted with an Incentive Stock Option under the
Abbott Laboratories 1996 Incentive Stock Program on or after February&nbsp;18, 2005, filed as Exhibit&nbsp;10.1 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated February&nbsp;18, 2005.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.22</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Employee Stock Option Agreement for a new Non-Qualified Stock Option under the Abbott Laboratories 1996 Incentive
Stock Program granted on or after February&nbsp;18, 2005, filed as Exhibit&nbsp;10.2 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated February&nbsp;18, 2005.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.23</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Employee Stock Option Agreement for an Incentive Stock Option granted with a Non-Qualified Stock Option under the
Abbott Laboratories 1996 Incentive Stock Program on or after February&nbsp;18, 2005, filed as Exhibit&nbsp;10.3 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated February&nbsp;18, 2005.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.24</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Employee Stock Option Agreement for an Incentive Stock Option under the Abbott Laboratories 1996 Incentive Stock
Program granted on or after February&nbsp;18, 2005, filed as Exhibit&nbsp;10.4 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated February&nbsp;18, 2005.**</font></p></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">100</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=4,SEQ=101,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=1004760,FOLIO='100',FILE='DISK114:[11ZAD1.11ZAD42901]KA42901A.;8',USER='GLOPEZA',CD='14-FEB-2011;16:20' -->
<a name="page_ka42901_1_101"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>
 <div style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="42pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width=""></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>10-K<br>
Exhibit<br>
Table<br>
Item No. </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.25</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Employee Restricted Stock Agreement under the Abbott Laboratories 1996 Incentive Stock Program, filed as Exhibit&nbsp;10.5 to the
Abbott Laboratories Current Report on Form&nbsp;8-K dated February&nbsp;18, 2005.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.26</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Employee Restricted Stock Unit Agreement under the Abbott Laboratories 1996 Incentive Stock Program, filed as
Exhibit&nbsp;10.6 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated February&nbsp;18, 2005.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.27</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Performance Restricted Stock Agreement for an award of performance restricted stock under Section&nbsp;10 of the
Abbott Laboratories 1996 Incentive Stock Program granted on or after February&nbsp;17, 2006, filed as Exhibit&nbsp;10.1 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated February&nbsp;16, 2006.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.28</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Performance Restricted Stock Agreement for an award of performance restricted stock under Section&nbsp;11 of the
Abbott Laboratories 1996 Incentive Stock Program granted on or after February&nbsp;17, 2006, filed as Exhibit&nbsp;10.2 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated February&nbsp;16, 2006.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.29</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Performance Restricted Stock Unit Agreement for an award of performance restricted stock units under the Abbott
Laboratories 1996 Incentive Stock Program granted on or after February&nbsp;17, 2006, filed as Exhibit&nbsp;10.3 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated February&nbsp;16, 2006.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.30</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Non-Qualified Stock Option Agreement for an award of non-qualified stock options under the Abbott Laboratories 1996
Incentive Stock Program granted on or after February&nbsp;17, 2006, filed as Exhibit&nbsp;10.4 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated February&nbsp;16, 2006.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.31</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Restricted Stock Unit Agreement for an award of restricted stock units under the Abbott Laboratories 1996 Incentive
Stock Program granted on or after February&nbsp;17, 2006, filed as Exhibit&nbsp;10.5 to the Abbott Laboratories Current Report on Form&nbsp;8-K dated February&nbsp;16, 2006.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.32</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Performance Restricted Stock Agreement for an award of performance restricted stock under Section&nbsp;10 of the
Abbott Laboratories 1996 Incentive Stock Program granted on or after February&nbsp;16, 2007, filed as Exhibit&nbsp;10.49 to the 2006 Abbott Laboratories Report on Form&nbsp;10-K.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.33</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Performance Restricted Stock Agreement for an award of performance restricted stock under Section&nbsp;11 of the
Abbott Laboratories 1996 Incentive Stock Program granted on or after February&nbsp;16, 2007, filed as Exhibit&nbsp;10.50 to the 2006 Abbott Laboratories Report on Form&nbsp;10-K.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.34</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Performance Restricted Stock Unit Agreement for an award of performance restricted stock units under the Abbott
Laboratories 1996 Incentive Stock Program granted on or after February&nbsp;16, 2007, filed as Exhibit&nbsp;10.51 to the 2006 Abbott Laboratories Report on Form&nbsp;10-K.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.35</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Restricted Stock Unit Agreement for an award of restricted stock units under the Abbott Laboratories 1996 Incentive
Stock Program granted on or after February&nbsp;16, 2007, filed as Exhibit&nbsp;10.52 to the 2006 Abbott Laboratories Report on Form&nbsp;10-K.**</font></p></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">101</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=5,SEQ=102,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=147281,FOLIO='101',FILE='DISK114:[11ZAD1.11ZAD42901]KA42901A.;8',USER='GLOPEZA',CD='14-FEB-2011;16:20' -->
<a name="page_ka42901_1_102"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>
 <div style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="42pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width=""></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>10-K<br>
Exhibit<br>
Table<br>
Item No. </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.36</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Performance Restricted Stock Agreement for an award of performance restricted stock under Section&nbsp;10 of the Abbott Laboratories
1996 Incentive Stock Program granted on or after February&nbsp;20, 2009, filed as Exhibit&nbsp;10.1 to the Abbott Laboratories Current Report on 8-K dated February&nbsp;20, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.37</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Performance Restricted Stock Agreement for an award of performance restricted stock under the Abbott Laboratories
1996 Incentive Stock Program granted on or after February&nbsp;20, 2009, filed as Exhibit&nbsp;10.2 to the Abbott Laboratories Current Report on 8-K dated February&nbsp;20, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.38</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Non-Qualified Stock Option Agreement for an award of non-qualified stock options under the Abbott Laboratories 1996
Incentive Stock Program granted on or after February&nbsp;20, 2009, filed as Exhibit&nbsp;10.3 to the Abbott Laboratories Current Report on 8-K dated February&nbsp;20, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.39</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Non-Qualified Replacement Stock Option Agreement for an award of non-qualified replacement stock options under the
Abbott Laboratories 1996 Incentive Stock Program granted on or after February&nbsp;20, 2009, filed as Exhibit&nbsp;10.4 to the Abbott Laboratories Current Report on 8-K dated February&nbsp;20, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.40</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Restricted Stock Agreement for an award of restricted stock under the Abbott Laboratories 1996 Incentive Stock
Program granted on or after February&nbsp;20, 2009 (ratable vesting), filed as Exhibit&nbsp;10.5 to the Abbott Laboratories Current Report on 8-K dated February&nbsp;20, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.41</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Restricted Stock Agreement for an award of restricted stock under the Abbott Laboratories 1996 Incentive Stock
Program granted on or after February&nbsp;20, 2009 (cliff vesting), filed as Exhibit&nbsp;10.6 to the Abbott Laboratories Current Report on 8-K dated February&nbsp;20, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.42</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Restricted Stock Unit Agreement for an award of restricted stock units under the Abbott Laboratories 1996 Incentive
Stock Program granted on or after February&nbsp;20, 2009, filed as Exhibit&nbsp;10.7 to the Abbott Laboratories Current Report on 8-K dated February&nbsp;20, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.43</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Non-Employee Director Non-Qualified Replacement Stock Option Agreement for an award of non-qualified replacement
stock options under the Abbott Laboratories 1996 Incentive Stock Program granted on or after February&nbsp;20, 2009, filed as Exhibit&nbsp;10.8 to the Abbott Laboratories Current Report on 8-K dated February&nbsp;20, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.44</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Non-Employee Director Non-Qualified Stock Option Agreement, filed as Exhibit&nbsp;10.2 to the Abbott Laboratories
Current Report on Form&nbsp;8-K dated April&nbsp;24, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.45</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Non-Employee Director Restricted Stock Unit Agreement, filed as Exhibit&nbsp;10.3 to the Abbott Laboratories Current
Report on Form&nbsp;8-K dated April&nbsp;24, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.46</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Non-Employee Director Non-Qualified Replacement Stock Option Agreement, filed as Exhibit&nbsp;10.4 to the Abbott
Laboratories Current Report on Form&nbsp;8-K dated April&nbsp;24, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.47</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Non-Qualified Stock Option Agreement (ratably vested), filed as Exhibit&nbsp;10.5 to the Abbott Laboratories Current
Report on Form&nbsp;8-K dated April&nbsp;24, 2009.**</font></p></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">102</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=6,SEQ=103,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=243021,FOLIO='102',FILE='DISK114:[11ZAD1.11ZAD42901]KA42901A.;8',USER='GLOPEZA',CD='14-FEB-2011;16:20' -->
<a name="page_ka42901_1_103"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>
 <div style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="42pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width=""></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>10-K<br>
Exhibit<br>
Table<br>
Item No. </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.48</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Non-Qualified Replacement Stock Option Agreement, filed as Exhibit&nbsp;10.6 to the Abbott Laboratories Current Report on
Form&nbsp;8-K dated April&nbsp;24, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.49</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Performance Restricted Stock Agreement, filed as Exhibit&nbsp;10.7 to the Abbott Laboratories Current Report on
Form&nbsp;8-K dated April&nbsp;24, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.50</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Restricted Stock Agreement (ratably vested), filed as Exhibit&nbsp;10.8 to the Abbott Laboratories Current Report on
Form&nbsp;8-K dated April&nbsp;24, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.51</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Restricted Stock Agreement (cliff vested), filed as Exhibit&nbsp;10.9 to the Abbott Laboratories Current Report on
Form&nbsp;8-K dated April&nbsp;24, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.52</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Performance Restricted Stock Agreement (annual performance based), filed as Exhibit&nbsp;10.10 to the Abbott
Laboratories Current Report on Form&nbsp;8-K dated April&nbsp;24, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.53</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Performance Restricted Stock Agreement (interim performance based), filed as Exhibit&nbsp;10.11 to the Abbott
Laboratories Current Report on Form&nbsp;8-K dated April&nbsp;24, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.54</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Restricted Stock Unit Agreement (cliff vested), filed as Exhibit&nbsp;10.12 to the Abbott Laboratories Current
Report on Form&nbsp;8-K dated April&nbsp;24, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.55</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Restricted Stock Unit Agreement (ratably vested), filed as Exhibit&nbsp;10.13 to the Abbott Laboratories Current
Report on Form&nbsp;8-K dated April&nbsp;24, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.56</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Agreement Regarding Change in Control by and between Abbott Laboratories and its named executive officers (other
than Messrs.&nbsp;White and Freyman), filed as Exhibit&nbsp;10.34 to the 2008 Abbott Laboratories Annual Report on Form&nbsp;10-K.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.57</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> Base Salary of Named Executive Officers.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.58</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Abbott Laboratories Europe Work Contract, dated February&nbsp;28, 2010, between Abbott Laboratories&nbsp;SA and
Mr.&nbsp;Olivier Bohuon, filed as Exhibit&nbsp;10.1 to the Abbott Laboratories Quarterly Report on Form&nbsp;10-Q for the quarter ended March&nbsp;31, 2010.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.59</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Employment and Retention Agreement, dated as of January&nbsp;11, 2009, by and among James&nbsp;V. Mazzo, Abbott and the
Purchaser, filed as Exhibit&nbsp;10.3 to the Advanced Medical Optics,&nbsp;Inc. Current Report on Form&nbsp;8-K dated January&nbsp;13, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.60</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Transaction Agreement between Boston Scientific Corporation and Abbott Laboratories, dated as of January&nbsp;8, 2006, filed
as Exhibit&nbsp;10.28 to the 2005 Abbott Laboratories Annual Report on Form&nbsp;10-K.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.61</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Amendment No.&nbsp;1 to Transaction Agreement, dated as of January&nbsp;16, 2006, between Boston Scientific Corporation and
Abbott Laboratories, filed as Exhibit&nbsp;10.29 to the 2005 Abbott Laboratories Annual Report on Form&nbsp;10-K.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.62</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Amendment No.&nbsp;2 to Transaction Agreement, dated as of January&nbsp;16, 2006, between Boston Scientific Corporation and
Abbott Laboratories, filed as Exhibit&nbsp;10.30 to the 2005 Abbott Laboratories Annual Report on Form&nbsp;10-K.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.63</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Amendment No.&nbsp;3 to Transaction Agreement, dated as of February&nbsp;22, 2006, between Boston Scientific Corporation and
Abbott Laboratories, filed as Exhibit&nbsp;10.1 to the Abbott Laboratories Quarterly Report on Form&nbsp;10-Q for the quarter ended March&nbsp;31, 2006.</font></p></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">103</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=7,SEQ=104,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=560780,FOLIO='103',FILE='DISK114:[11ZAD1.11ZAD42901]KA42901A.;8',USER='GLOPEZA',CD='14-FEB-2011;16:20' -->
<a name="page_ka42901_1_104"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>
 <div style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="42pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width=""></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>10-K<br>
Exhibit<br>
Table<br>
Item No. </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.64</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Amendment No.&nbsp;4 to Transaction Agreement, dated as of April&nbsp;5, 2006, between Boston Scientific Corporation and Abbott Laboratories,
 filed as Exhibit&nbsp;10.2 to the Abbott Laboratories Quarterly Report on Form&nbsp;10-Q for the quarter ended March&nbsp;31, 2006.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.65</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Purchase Agreement, dated as of April&nbsp;21, 2006, between Guidant Corporation and Abbott Laboratories, filed as
Exhibit&nbsp;10.1 to the Abbott Laboratories Quarterly Report on Form&nbsp;10-Q for the quarter ended June&nbsp;30, 2006.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.66</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Amendment to Purchase Agreement, dated as of April&nbsp;21, 2006, between Guidant Corporation and Abbott Laboratories, filed
as Exhibit&nbsp;10.2 to the Abbott Laboratories Quarterly Report on Form&nbsp;10-Q for the quarter ended June&nbsp;30, 2006.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.67</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Subscription and Stockholder Agreement, dated as of April&nbsp;21, 2006, between Boston Scientific Corporation and Abbott
Laboratories, filed as Exhibit&nbsp;10.4 to the Abbott Laboratories Quarterly Report on Form&nbsp;10-Q for the quarter ended June&nbsp;30, 2006.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.68</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Amendment to Subscription and Stockholder Agreement, dated as of April&nbsp;21, 2006, between Boston Scientific Corporation
and Abbott Laboratories, filed as Exhibit&nbsp;10.5 to the Abbott Laboratories Quarterly Report on Form&nbsp;10-Q for the quarter ended June&nbsp;30, 2006.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.69</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Form of Time Sharing Agreement between Abbott Laboratories,&nbsp;Inc. and M.D.&nbsp;White and T.C.&nbsp;Freyman, filed as
Exhibit&nbsp;10.6 to the Abbott Laboratories Quarterly Report on Form&nbsp;10-Q for the quarter ended June&nbsp;30, 2006.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.70</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Amended and Restated Advanced Medical Optics,&nbsp;Inc. 2002 Incentive Compensation Plan, as amended, filed as
Exhibit&nbsp;4.3 to the Abbott Laboratories Registration Statement on Form&nbsp;S-8 dated March&nbsp;20, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.71</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *First Amendment to Amended and Restated Advanced Medical Optics,&nbsp;Inc. 2002 Incentive Compensation Plan, filed as
Exhibit&nbsp;4.4 to the Abbott Laboratories Registration Statement on Form&nbsp;S-8 dated March&nbsp;20, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.72</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *2004 Stock Incentive Plan, as amended and restated, filed as Exhibit&nbsp;4.5 to the Abbott Laboratories Registration
Statement on Form&nbsp;S-8 dated March&nbsp;20, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.73</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *Advanced Medical Optics,&nbsp;Inc. 2005 Incentive Compensation Plan, filed as Exhibit&nbsp;4.6 to the Abbott Laboratories
Registration Statement on Form&nbsp;S-8 dated March&nbsp;20, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.74</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *VISX, Incorporated 2001 Nonstatutory Stock Option Plan, filed as Exhibit&nbsp;4.7 to the Abbott Laboratories Registration
Statement on Form&nbsp;S-8 dated March&nbsp;20, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.75</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *VISX, Incorporated 2000 Stock Plan, filed as Exhibit&nbsp;4.8 to the Abbott Laboratories Registration Statement on
Form&nbsp;S-8 dated March&nbsp;20, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.76</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *VISX, Incorporated 1995 Director Option and Stock Deferral Plan, as amended and restated, filed as Exhibit&nbsp;4.9 to the
Abbott Laboratories Registration Statement on Form&nbsp;S-8 dated March&nbsp;20, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">10.77</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> *VISX, Incorporated 1995 Stock Plan, as amended, filed as Exhibit&nbsp;4.10 to the Abbott Laboratories Registration Statement
on Form&nbsp;S-8 dated March&nbsp;20, 2009.**</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">12</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> Computation of Ratio of Earnings to Fixed Charges.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">21</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> Subsidiaries of Abbott Laboratories.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">23.1</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> Consent of Independent Registered Public Accounting Firm.</font></p></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
 <p style="font-family:times;" align="CENTER"><font size="2">104</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=8,SEQ=105,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=114942,FOLIO='104',FILE='DISK114:[11ZAD1.11ZAD42901]KA42901A.;8',USER='GLOPEZA',CD='14-FEB-2011;16:20' -->
<a name="page_ka42901_1_105"> </a>

<p style="font-family:times;text-align:justify"><font size="2"><a href="#du42901a_main_toc">Table of Contents</a></font></p>
 <div style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


 </font></p>

<!-- User-specified TAGGED TABLE -->
<div align="CENTER"><table width="100%" cellspacing="0" cellpadding="0" border="0">
<tbody><tr><!-- TABLE COLUMN WIDTHS SET -->
<td style="font-family:times;" width="7pt" align="RIGHT"></td>
<td style="font-family:times;" width="42pt"></td>
<td style="font-family:times;" width="12pt"></td>
<td style="font-family:times;" width=""></td>
<!-- TABLE COLUMN WIDTHS END --></tr>

<tr valign="BOTTOM">
<th colspan="2" style="font-family:times;border-bottom:solid #000000 1.0pt;" align="CENTER"><font size="1"><b>10-K<br>
Exhibit<br>
Table<br>
Item No. </b></font></th>
<th style="font-family:times;"><font size="1">&nbsp;</font></th>
<th style="font-family:times;" align="LEFT"><font size="1">&nbsp;</font><br></th>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">31.1</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> Certification of Chief Executive Officer Required by Rule&nbsp;13a-14(a) (17 CFR 240.13a-14(a)).</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">31.2</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> Certification of Chief Financial Officer Required by Rule&nbsp;13a-14(a) (17 CFR 240.13a-14(a)).</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">32.1</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section&nbsp;1350, as adopted pursuant to Section&nbsp;906 of
the Sarbanes-Oxley Act of 2002.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">32.2</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section&nbsp;1350, as adopted pursuant to Section&nbsp;906 of
the Sarbanes-Oxley Act of 2002.</font></p></td>
</tr>
<tr valign="TOP">
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;" align="RIGHT"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:-0pt;"><font size="2"> </font><font size="2">101</font></p></td>
<td style="font-family:times;"><font size="2">&nbsp;</font></td>
<td style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;" align="left"><font size="2"> </font><font size="2"> The following financial statements and notes from the Abbott Laboratories Annual Report on Form&nbsp;10-K for the year ended
December&nbsp;31, 2010 filed on February&nbsp;18, 2011, formatted in XBRL: (i)&nbsp;Consolidated Statement of Earnings; (ii)&nbsp;Consolidated Statement of Cash Flows; (iii)&nbsp;Consolidated Balance Sheet; (iv)&nbsp;Consolidated Statement of
Shareholders' Investment; and (iv)&nbsp;the notes to the consolidated financial statements.</font></p></td>
</tr>
</tbody></table></div>
<!-- end of user-specified TAGGED TABLE -->
 </div>
<div style="padding:0pt;position:relative;text-align:left;margin-left:0%;">
<p style="font-family:times;text-align:justify"><font size="1"></font><font size="2">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The 2011 Abbott Laboratories Proxy Statement will be filed with the Securities and Exchange Commission under separate cover on or about March&nbsp;15, 2011. </font></p>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<hr width="26%" size="1.0PT" noshade="" color="#000000" align="LEFT">


<dl compact="">
<dt style="font-family:times;margin-bottom:-11pt;"><font size="2">*</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Incorporated
herein by reference. Commission file number&nbsp;1-2189.
<br><br></font></dd><dt style="font-family:times;margin-bottom:-11pt;"><font size="2">**</font></dt><dd style="font-family:times;text-align:justify"><font size="2">Denotes
management contract or compensatory plan or arrangement required to be filed as an exhibit hereto. </font></dd></dl>
 </div>
 <p style="font-family:times;text-align:justify"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott
will furnish copies of any of the above exhibits to a shareholder upon written request to the Secretary, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois
60064-6400. </font></p>

<p style="font-family:times;" align="CENTER"><font size="2">105</font></p>

<hr noshade="">
<p style="font-family:times;page-break-before:always"></p>
<!-- ZEQ.=9,SEQ=106,EFW="2201962",CP="ABBOTT LABORATORIES",DN="1",CHK=182993,FOLIO='105',FILE='DISK114:[11ZAD1.11ZAD42901]KA42901A.;8',USER='GLOPEZA',CD='14-FEB-2011;16:20' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<br>
<!-- TOCEXISTFLAG -->


</text>
</description></filename></sequence></type></document>
</body></html>